SABRA HEALTH CARE REIT, INC., 10-K filed on 2/12/2026
Annual Report
v3.25.4
Cover - USD ($)
$ in Billions
12 Months Ended
Dec. 31, 2025
Feb. 04, 2026
Jun. 30, 2025
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2025    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-34950    
Entity Registrant Name SABRA HEALTH CARE REIT, INC.    
Entity Incorporation, State or Country Code MD    
Entity Tax Identification Number 27-2560479    
Entity Address, Address Line One 1781 Flight Way    
Entity Address, City or Town Tustin    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 92782    
City Area Code 888    
Local Phone Number 393-8248    
Title of 12(b) Security Common Stock, $0.01 par value    
Trading Symbol SBRA    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction false    
Entity Shell Company false    
Entity Public Float     $ 4.4
Entity Common Stock, Shares Outstanding   252,145,717  
Documents Incorporated by Reference
Portions of the Proxy Statement for the registrant’s 2026 Annual Meeting of Stockholders, to be filed with the Securities and Exchange Commission not later than 120 days after December 31, 2025, are incorporated by reference in Part III herein.
   
Entity Central Index Key 0001492298    
Document Fiscal Year Focus 2025    
Document Fiscal Period Focus FY    
Amendment Flag false    
v3.25.4
Audit Information
12 Months Ended
Dec. 31, 2025
Audit Information [Abstract]  
Auditor Name PricewaterhouseCoopers LLP
Auditor Location Irvine, California
Auditor Firm ID 238
v3.25.4
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Assets    
Real estate investments, net of accumulated depreciation of $1,224,663 and $1,102,030 as of December 31, 2025 and 2024, respectively $ 4,686,377 $ 4,513,734
Loans receivable and other investments, net 434,100 442,584
Investment in unconsolidated joint ventures 118,166 121,803
Cash and cash equivalents 71,537 60,468
Restricted cash 6,603 5,871
Lease intangible assets, net 65,321 27,464
Accounts receivable, prepaid expenses and other assets, net 111,292 131,755
Total assets 5,493,396 5,303,679
Liabilities    
Secured debt, net 43,275 45,316
Revolving credit facility 217,584 106,554
Term loans, net 1,032,311 529,753
Senior unsecured notes, net 1,235,726 1,736,025
Accounts payable and accrued liabilities 119,329 117,896
Lease intangible liabilities, net 21,383 26,847
Total liabilities 2,669,608 2,562,391
Commitments and contingencies (Note 16)
Equity    
Preferred stock, $0.01 par value; 10,000,000 shares authorized, zero shares issued and outstanding as of December 31, 2025 and 2024 0 0
Common stock, $0.01 par value; 500,000,000 shares authorized, 251,697,456 and 237,586,882 shares issued and outstanding as of December 31, 2025 and 2024, respectively 2,517 2,376
Additional paid-in capital 4,836,270 4,592,605
Cumulative distributions in excess of net income (2,013,375) (1,874,633)
Accumulated other comprehensive (loss) income (3,571) 20,940
Total Sabra Health Care REIT, Inc. stockholders’ equity 2,821,841 2,741,288
Noncontrolling interests 1,947 0
Total equity 2,823,788 2,741,288
Total liabilities and equity $ 5,493,396 $ 5,303,679
v3.25.4
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Assets    
Accumulated depreciation $ 1,224,663 $ 1,102,030
Preferred Stock    
Par value (in dollars per share) $ 0.01 $ 0.01
Shares authorized (in shares) 10,000,000 10,000,000
Shares issued (in shares) 0 0
Shares outstanding (in shares) 0 0
Common Stock    
Par value (in dollars per share) $ 0.01 $ 0.01
Shares authorized (in shares) 500,000,000 500,000,000
Shares issued (in shares) 251,697,456 237,586,882
Shares outstanding (in shares) 251,697,456 237,586,882
v3.25.4
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Revenues:      
Rental and related revenues $ 374,131 $ 381,495 $ 376,266
Resident fees and services 356,883 284,581 236,153
Interest and other income 43,618 37,159 35,095
Total revenues 774,632 703,235 647,514
Expenses:      
Depreciation and amortization 186,996 169,623 183,087
Interest 112,489 115,272 112,964
General and administrative 53,710 50,067 47,472
(Recovery of) provision for loan losses (1,047) (571) 191
Impairment of real estate 7,322 18,472 14,332
Total expenses 630,576 579,951 553,291
Other income (expense):      
Loss on extinguishment of debt (1,154) 0 (1,541)
Other income 14,036 2,735 2,598
Net (loss) gain on sales of real estate (3,519) 2,095 (76,625)
Total other income (expense) 9,363 4,830 (75,568)
Income before income (loss) from unconsolidated joint ventures and income tax expense 153,419 128,114 18,655
Income (loss) from unconsolidated joint ventures 3,928 (397) (2,897)
Income tax expense (1,837) (1,005) (2,002)
Net income 155,510 126,712 13,756
Net loss attributable to noncontrolling interests 99 0 0
Net income attributable to Sabra Health Care REIT, Inc. $ 155,609 $ 126,712 $ 13,756
Net income attributable to Sabra Health Care REIT, Inc., per:      
Basic common share (in dollars per share) $ 0.64 $ 0.54 $ 0.06
Diluted common share (in dollars per share) $ 0.64 $ 0.54 $ 0.06
Weighted-average number of common shares outstanding, basic (in shares) 241,312,309 233,498,736 231,203,391
Weighted-average number of common shares outstanding, diluted (in shares) 244,497,242 236,045,862 232,792,778
Revenue, type, extensible enumeration Health Care, Resident Service [Member] Health Care, Resident Service [Member] Health Care, Resident Service [Member]
Triple-net portfolio      
Expenses:      
Operating expenses $ 14,487 $ 17,072 $ 17,932
Senior housing - managed portfolio      
Expenses:      
Operating expenses $ 256,619 $ 210,016 $ 177,313
v3.25.4
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Statement of Comprehensive Income [Abstract]      
Net income $ 155,510 $ 126,712 $ 13,756
Unrealized gain (loss), net of tax:      
Foreign currency translation gain (loss) 3,407 (5,741) (205)
Unrealized (loss) gain on cash flow hedges (27,918) 2,936 4,887
Total other comprehensive (loss) income (24,511) (2,805) 4,682
Comprehensive income 130,999 123,907 18,438
Comprehensive loss attributable to noncontrolling interests 99 0 0
Comprehensive income attributable to Sabra Health Care REIT, Inc. $ 131,098 $ 123,907 $ 18,438
v3.25.4
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Total Stockholders’ Equity
Common Stock
Additional Paid-in Capital
Cumulative Distributions in Excess of Net Income
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2022     231,009,295        
Beginning balance at Dec. 31, 2022 $ 3,056,395 $ 3,056,395 $ 2,310 $ 4,486,967 $ (1,451,945) $ 19,063 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 13,756 13,756     13,756    
Other comprehensive income (loss) 4,682 4,682       4,682  
Amortization of stock-based compensation 10,559 10,559   10,559      
Common stock issuance, net (in shares)     256,725        
Common stock issuance, net (2,768) (2,768) $ 3 (2,771)      
Common dividends (280,090) (280,090)     (280,090)    
Ending balance (in shares) at Dec. 31, 2023     231,266,020        
Ending balance at Dec. 31, 2023 2,802,534 2,802,534 $ 2,313 4,494,755 (1,718,279) 23,745 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 126,712 126,712     126,712    
Other comprehensive income (loss) (2,805) (2,805)       (2,805)  
Amortization of stock-based compensation 11,902 11,902   11,902      
Common stock issuance, net (in shares)     6,320,862        
Common stock issuance, net 86,011 86,011 $ 63 85,948      
Common dividends (283,066) (283,066)     (283,066)    
Ending balance (in shares) at Dec. 31, 2024     237,586,882        
Ending balance at Dec. 31, 2024 2,741,288 2,741,288 $ 2,376 4,592,605 (1,874,633) 20,940 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 155,510 155,609     155,609   (99)
Other comprehensive income (loss) (24,511) (24,511)       (24,511)  
Contribution from noncontrolling interests 2,046           2,046
Amortization of stock-based compensation 16,215 16,215   16,215      
Common stock issuance, net (in shares)     14,110,574        
Common stock issuance, net 227,591 227,591 $ 141 227,450      
Common dividends (294,351) (294,351)     (294,351)    
Ending balance (in shares) at Dec. 31, 2025     251,697,456        
Ending balance at Dec. 31, 2025 $ 2,823,788 $ 2,821,841 $ 2,517 $ 4,836,270 $ (2,013,375) $ (3,571) $ 1,947
v3.25.4
CONSOLIDATED STATEMENTS OF EQUITY (Parenthetical) - $ / shares
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Statement of Stockholders' Equity [Abstract]      
Common dividends (in dollars per share) $ 1.20 $ 1.20 $ 1.20
v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:      
Net income $ 155,510 $ 126,712 $ 13,756
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 186,996 169,623 183,087
Non-cash rental and related revenues (1,020) (3,856) (8,699)
Non-cash interest income 7 29 (372)
Non-cash interest expense 7,970 10,479 12,265
Stock-based compensation expense 11,360 8,987 7,917
Loss on extinguishment of debt 1,154 0 1,541
(Recovery of) provision for loan losses (1,047) (571) 191
Net loss (gain) on sales of real estate 3,519 (2,095) 76,625
Impairment of real estate 7,322 18,472 14,332
(Income) loss from unconsolidated joint ventures (3,928) 397 2,897
Distributions of earnings from unconsolidated joint ventures 7,813 5,447 3,469
Other non-cash items (17,190) (534) (3,704)
Changes in operating assets and liabilities:      
Accounts receivable, prepaid expenses and other assets, net (11,449) (15,462) (11,078)
Accounts payable and accrued liabilities 1,596 (7,087) 8,344
Net cash provided by operating activities 348,613 310,541 300,571
Cash flows from investing activities:      
Acquisition of real estate and lease intangibles (452,933) (136,430) (78,530)
Origination and fundings of loans receivable (6,910) (21,645) (11,418)
Origination and fundings of preferred equity investments (9) (2,832) (11,023)
Additions to real estate (41,521) (54,712) (84,855)
Repayments of loans receivable 20,671 3,551 9,274
Repayments of preferred equity investments 2,533 5,944 5,460
Investment in unconsolidated joint ventures (1,241) (1,258) (5,235)
Net proceeds from the sales of real estate 88,637 95,999 247,622
Net proceeds from sales-type lease 0 0 25,490
Proceeds from net investment hedges 4,462 0 0
Insurance proceeds 1,589 2,382 5,801
Distributions in excess of earnings from unconsolidated joint ventures 6,762 0 544
Net cash (used in) provided by investing activities (377,960) (109,001) 103,130
Cash flows from financing activities:      
Net borrowings from revolving credit facility 109,805 14,595 (104,338)
Principal payments on senior unsecured notes (500,000) 0 0
Proceeds from term loans 500,000 0 12,188
Principal payments on secured debt (2,089) (2,033) (1,979)
Payments of deferred financing costs (4,405) (94) (18,142)
Payments related to extinguishment of debt (2,884) 0 0
Contributions from noncontrolling interests 2,046 0 0
Payment of contingent consideration 0 0 (17,900)
Issuance of common stock, net 227,781 86,121 (2,682)
Dividends paid on common stock (289,497) (280,150) (277,447)
Net cash provided by (used in) financing activities 40,757 (181,561) (410,300)
Net increase (decrease) in cash, cash equivalents and restricted cash 11,410 19,979 (6,599)
Effect of foreign currency translation on cash, cash equivalents and restricted cash 391 (359) (614)
Cash, cash equivalents and restricted cash, beginning of period 66,339 46,719 53,932
Cash, cash equivalents and restricted cash, end of period 78,140 66,339 46,719
Supplemental disclosure of cash flow information:      
Interest paid 110,957 105,200 102,409
Income taxes paid 1,496 1,389 1,670
Supplemental disclosure of non-cash investing activities:      
Decrease in loans receivable and other investments due to acquisition of real estate $ 0 $ 0 $ 4,644
v3.25.4
BUSINESS
12 Months Ended
Dec. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
BUSINESS BUSINESS
Overview
Sabra Health Care REIT, Inc. (“Sabra” or the “Company”) was incorporated on May 10, 2010 as a wholly owned subsidiary of Sun Healthcare Group, Inc. (“Sun”) and commenced operations on November 15, 2010 following Sabra’s separation from Sun. Sabra elected to be treated as a real estate investment trust (“REIT”) with the filing of its United States (“U.S.”) federal income tax return for the taxable year beginning January 1, 2011. Sabra believes that it has been organized and operated, and it intends to continue to operate, in a manner to qualify as a REIT. Sabra’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector. Sabra primarily generates revenues by leasing properties to tenants throughout the U.S. and Canada. Sabra owns substantially all of its assets and properties and conducts its operations through Sabra Health Care Limited Partnership, a Delaware limited partnership (the “Operating Partnership”), of which Sabra is the sole general partner and a wholly owned subsidiary of Sabra is currently the only limited partner, or by subsidiaries of the Operating Partnership. The Company’s investment portfolio is primarily comprised of skilled nursing/transitional care facilities, senior housing communities (“Senior Housing - Leased”), behavioral health facilities and specialty hospitals and other facilities, in each case leased to tenants who are responsible for the operations of these facilities; senior housing communities operated by third-party property managers pursuant to property management agreements (“Senior Housing - Managed”); investments in joint ventures; investments in loans receivable; and preferred equity investments.
v3.25.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Principles of Consolidation and Basis of Presentation
The accompanying consolidated financial statements include the accounts of Sabra and its wholly owned subsidiaries as of December 31, 2025 and 2024 and for the years ended December 31, 2025, 2024 and 2023. All significant intercompany transactions and balances have been eliminated in consolidation. The consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”).
GAAP requires the Company to identify entities for which control is achieved through voting rights or other means and to determine which business enterprise is the primary beneficiary of variable interest entities (“VIEs”). A VIE is broadly defined as an entity with one or more of the following characteristics: (a) the total equity investment at risk is insufficient to finance the entity’s activities without additional subordinated financial support; (b) as a group, the holders of the equity investment at risk lack (i) the ability to make decisions about the entity’s activities through voting or similar rights, (ii) the obligation to absorb the expected losses of the entity, or (iii) the right to receive the expected residual returns of the entity; or (c) the equity investors have voting rights that are not proportional to their economic interests, and substantially all of the entity’s activities either involve, or are conducted on behalf of, an investor that has disproportionately few voting rights. If the Company were determined to be the primary beneficiary of the VIE, the Company would consolidate investments in the VIE. The Company may change its original assessment of a VIE due to events such as modifications of contractual arrangements that affect the characteristics or adequacy of the entity’s equity investments at risk and the disposal of all or a portion of an interest held by the primary beneficiary.
The Company identifies the primary beneficiary of a VIE as the enterprise that has both: (i) the power to direct the activities of the VIE that most significantly impact the entity’s economic performance; and (ii) the obligation to absorb losses or the right to receive benefits of the VIE that could be significant to the entity. The Company performs this analysis on an ongoing basis. As of December 31, 2025, the Company determined that it was the primary beneficiary of two VIEs, a joint venture variable interest entity owning three senior housing communities and another joint venture variable interest entity under which the three senior housing communities are operated by a third-party property manager pursuant to property management agreements. The Company has consolidated these entities in the accompanying consolidated financial statements, and aggregate total assets and total liabilities of the two VIEs were $99.2 million and $2.0 million as of December 31, 2025, respectively. Assets of the consolidated VIEs can only be used to settle obligations of such VIEs, and liabilities of the consolidated VIEs represent claims against the specific assets of such VIEs. Except for capital contributions associated with the initial entity formations, the entities have been and are expected to be funded from the ongoing operations of the underlying properties.
As it relates to investments in loans, in addition to the Company’s assessment of VIEs and whether the Company is the primary beneficiary of those VIEs, the Company evaluates the loan terms and other pertinent facts to determine whether the
loan investment should be accounted for as a loan or as a real estate joint venture. If an investment has the characteristics of a real estate joint venture, including if the Company participates in the majority of the borrower’s expected residual profit, the Company would account for the investment as an investment in a real estate joint venture and not as a loan investment. Expected residual profit is defined as the amount of profit, whether called interest or another name, such as an equity kicker, above a reasonable amount of interest and fees expected to be earned by a lender. At December 31, 2025 and 2024, none of the Company’s investments in loans were accounted for as real estate joint ventures.
As it relates to investments in joint ventures, the Company assesses any partners’ rights and their impact on the presumption of control of the partnership by any single partner. The Company also applies this guidance to managing member interests in limited liability companies. The Company reassesses its determination of which entity controls the joint venture if: there is a change to the terms or in the exercisability of the rights of any partners or members, the general partner or managing member increases or decreases its ownership interests, or there is an increase or decrease in the number of outstanding ownership interests. As of December 31, 2025, the Company’s determination of which entity controls its investments in joint ventures has not changed as a result of any reassessment.
Use of Estimates
The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.
Real Estate Investments and Rental Revenue Recognition
Real Estate Acquisition Valuation
All assets acquired and liabilities assumed in an acquisition of real estate accounted for as a business combination are measured at their acquisition date fair values. For acquisitions of real estate accounted for as an asset acquisition, the fair value of consideration transferred by the Company (including transaction costs) is allocated to all assets acquired and liabilities assumed on a relative fair value basis. The acquisition value of land, building and improvements are included in real estate investments on the accompanying consolidated balance sheets. The acquisition value of above market lease, tenant origination and absorption costs and tenant relationship intangible assets is included in lease intangible assets, net on the accompanying consolidated balance sheets. The acquisition value of below market lease intangible liabilities is included in lease intangible liabilities, net on the accompanying consolidated balance sheets. Acquisition costs associated with real estate acquisitions deemed asset acquisitions are capitalized, and costs associated with real estate acquisitions deemed business combinations are expensed as incurred. Restructuring costs that do not meet the definition of a liability at the acquisition date are expensed in periods subsequent to the acquisition date.
Estimates of the fair values of the tangible assets, identifiable intangibles and assumed liabilities require the Company to make significant assumptions to estimate market lease rates, property operating expenses, carrying costs during lease-up periods, discount rates, market absorption periods, and the number of years the property will be held for investment. The Company makes its best estimate based on the Company’s evaluation of the specific characteristics of each tenant’s lease. The use of inappropriate assumptions would result in an incorrect valuation of the Company’s acquired tangible assets, identifiable intangibles and assumed liabilities, which would impact the amount of the Company’s net income.
Depreciation and Amortization
Real estate costs related to the acquisition and improvement of properties are capitalized and amortized on a straight-line basis over the lesser of the expected useful life of the asset and the remaining lease term of any property subject to a ground lease. Tenant improvements are capitalized and amortized on a straight-line basis over the lesser of the expected useful life of the asset and the remaining lease term. Depreciation is discontinued when a property is identified as held for sale. Repair and maintenance costs are charged to expense as incurred and significant replacements and betterments are capitalized. Repair and maintenance costs include all costs that do not extend the useful life of the real estate asset. The Company considers the period of future benefit of an asset to determine its appropriate useful life. Depreciation of real estate assets and amortization of tenant origination and absorption costs and tenant relationship lease intangibles are included in depreciation and amortization on the accompanying consolidated statements of income. Amortization of above and below market lease intangibles is included in rental income on the accompanying consolidated statements of income. The Company anticipates the estimated useful lives of its assets by class to be generally as follows: land improvements, 15 to 20 years; buildings and building improvements, five to 40 years; and furniture and equipment, three to 10 years. Intangibles are generally amortized over the remaining noncancellable lease terms, with tenant relationship intangible amortization periods including extension periods.
Impairment of Real Estate Investments
The Company regularly monitors events and changes in circumstances, including investment operating performance and general market conditions, that could indicate that the carrying amounts of its real estate investments may not be recoverable. When indicators of potential impairment suggest that the carrying value of real estate investments may not be recoverable, the Company assesses the recoverability by estimating whether the Company will recover the carrying value of its real estate investments through the undiscounted future cash flows and the eventual disposition of the investment. In some instances, there may be various potential outcomes for an investment and its potential undiscounted future cash flows. In these instances, the undiscounted future cash flows models used to assess recoverability are based on several assumptions and are probability-weighted based on the Company’s best estimates as of the date of evaluation. These assumptions include, among others, market rent, revenue and expense growth rates, absorption period, stabilized occupancy, holding period, market capitalization rates, and estimated market values based on analysis of letters of intent, purchase and sale agreements, and comparable sales and other local and national industry market data. When discounted cash flow is used to determine fair value, a discount rate assumption is also used. The assumptions are generally based on management’s experience in its local real estate markets, and the effects of current market conditions, which are subject to economic and market uncertainties. If, based on this analysis, the Company does not believe that it will be able to recover the carrying value of its real estate investments, the Company would record an impairment loss to the extent that the carrying value exceeds the estimated fair value of its real estate investments. The Company determines estimated fair value based primarily upon (i) estimated sale prices from signed contracts or letters of intent from third-party offers, (ii) discounted cash flow models of the investment over its remaining hold period, (iii) third-party appraisals and (iv) comparable sales and other local and national industry market data.
Revenue Recognition
The Company recognizes rental revenue from tenants, including rental abatements, lease incentives and contractual fixed increases attributable to operating leases, on a straight-line basis over the term of the related leases when it is probable that substantially all rents over the life of a lease are collectible. Certain of the Company’s leases provide for contingent rents equal to a percentage of the facility’s revenue in excess of specified base amounts or other thresholds. Such revenue is recognized when actual results reported by the tenant, or estimates of tenant results, exceed the applicable base amount or other threshold.
The Company assesses the collectability of rents on a lease-by-lease basis, and in doing so, considers such things as historical bad debts, tenant creditworthiness, current economic trends, facility operating performance, lease structure, credit enhancements (including guarantees), current developments relevant to a tenant’s business specifically and to its business category generally, and changes in tenants’ payment patterns. The Company’s assessment includes an estimation of a tenant’s ability to fulfill all of its rental obligations over the remaining lease term. In addition, with respect to tenants in bankruptcy, management makes estimates of the expected recovery of pre-petition and post-petition claims in assessing the estimated collectability of the related receivable. If at any time the Company cannot determine that it is probable that substantially all rents over the life of a lease are collectible, rental revenue will be recognized only to the extent of payments received, and all receivables associated with the lease will be written off irrespective of amounts expected to be collectible. Any recoveries of these amounts will be recorded in future periods upon receipt of payment. Write-offs of receivables and any recoveries of previously written-off receivables are recorded as adjustments to rental revenue.
Revenue from resident fees and services is recorded monthly as services are provided and includes resident room and care charges, ancillary services charges and other resident charges. These charges are combined and accounted for as a single lease component.
Casualty Gains and Losses
Income resulting from insurance recoveries of property damage or business interruption losses is recognized when proceeds are received or contingencies related to the insurance recoveries are resolved.
Assets Held for Sale, Dispositions and Discontinued Operations
The Company generally considers real estate to be “held for sale” when the following criteria are met: (i) management commits to a plan to sell the property, (ii) the property is available for sale immediately, (iii) the property is actively being marketed for sale at a price that is reasonable in relation to its current fair value, (iv) the sale of the property within one year is considered probable and (v) significant changes to the plan to sell are not expected. Real estate that is held for sale and its related assets are classified as assets held for sale and are included in accounts receivable, prepaid expenses and other assets, net on the accompanying consolidated balance sheets. Secured indebtedness and other liabilities related to real estate held for sale are classified as liabilities related to assets held for sale and are included in accounts payable and accrued liabilities on the accompanying consolidated balance sheets. Real estate classified as held for sale is no longer depreciated and is reported at the
lower of its carrying value or its estimated fair value less estimated costs to sell. As of December 31, 2025 and 2024, the Company did not have any assets held for sale.
For sales of real estate where the Company has collected the consideration to which it is entitled in exchange for transferring the real estate, the related assets and liabilities are removed from the balance sheet and the resultant gain or loss is recorded in the period in which the transaction closes. Any post-sale involvement is accounted for as separate performance obligations, and when the separate performance obligations are satisfied, the portion of the sales price allocated to each such obligation is recognized.
Additionally, the Company records the operating results related to real estate that has been disposed of or classified as held for sale as discontinued operations for all periods presented if it represents a strategic shift that has or will have a major effect on the Company’s operations and financial results.
Investment in Unconsolidated Joint Ventures
The Company reports investments in unconsolidated entities over whose operating and financial policies it has the ability to exercise significant influence under the equity method of accounting. Under this method of accounting, the Company’s share of the investee’s earnings or losses is included in the Company’s consolidated statements of income. The initial carrying value of the investment is based on the amount paid to purchase the joint venture interest. Differences between the Company’s cost basis and the basis reflected at the joint venture level are generally amortized over the lives of the related assets and liabilities, and such amortization is included in the Company’s share of earnings of the joint venture. In addition, distributions received from unconsolidated entities are classified based on the nature of the activity or activities that generated the distribution.
The Company regularly monitors events and changes in circumstances, including investment operating performance, changes in anticipated holding period and general market conditions, that could indicate that the carrying amounts of its equity method investments may be impaired. An equity method investment's value is impaired when the fair value of the investment is less than its carrying value and the Company determines the decline in value is other-than-temporary. The fair value is estimated based on discounted cash flows models that include all estimated cash inflows and outflows and any estimated debt premiums or discounts. The discounted cash flows are based on several assumptions, including management fee, absorption period, terminal capitalization rates, revenue and expense per bed, revenue and expense growth percentage, replacement reserve per unit, stabilized occupancy, stabilized operating margin, price per bed and discount rates. The assumptions are generally based on management’s experience in its local real estate markets, and the effects of current market conditions, which are subject to economic and market uncertainties. If the Company believes that there is an other-than-temporary decline in the value of an equity method investment, the Company would record an impairment loss to the extent that the carrying value exceeds the estimated fair value of such equity method investment.
Noncontrolling Interests
The Company presents the portion of any equity that it does not own in consolidated entities as noncontrolling interests and classifies those interests as a component of total equity, separate from total Sabra Health Care REIT, Inc. stockholders’ equity on the accompanying consolidated balance sheets. For consolidated joint ventures with pro rata distribution allocations, net income or loss and comprehensive income is allocated between the joint venture partners based on their respective stated ownership percentages. The Company includes net income or loss attributable to noncontrolling interests in net income on the accompanying consolidated statements of income and includes comprehensive income or loss attributable to noncontrolling interests in comprehensive income on the accompanying consolidated statements of comprehensive income.
Loans Receivable and Credit Losses
Loans Receivable
The Company’s loans receivable are reflected at amortized cost on the accompanying consolidated balance sheets. The amortized cost of a loan receivable is the outstanding unpaid principal balance, net of unamortized discounts, costs and fees directly associated with the origination of the loan.
Loans acquired in connection with a business combination are recorded at their acquisition date fair value. The Company determines the fair value of loans receivable based on estimates of expected discounted cash flows, collateral, credit risk and other factors. The Company does not establish a valuation allowance at the acquisition date, as the amount of estimated future cash flows reflects its judgment regarding their uncertainty. The Company recognizes the difference between the acquisition date fair value and the total expected cash flows as interest income using the effective interest method over the life of the applicable loan. The Company immediately recognizes in income any unamortized balances if the loan is repaid before its contractual maturity.
Interest income on the Company’s loans receivable is recognized on an accrual basis over the life of the investment using the interest method. Direct loan origination costs are amortized over the term of the loan as an adjustment to interest income. When concerns exist as to the ultimate collection of principal or interest due under a loan, the loan is placed on nonaccrual status, and the Company will not recognize interest income until the cash is received, or the loan returns to accrual status. If the Company determines that the collection of interest according to the contractual terms of the loan or through the receipts of assets in satisfaction of contractual amounts due is probable, the Company will resume the accrual of interest. In instances where borrowers are in default under the terms of their loans, the Company may continue recognizing interest income provided that all amounts owed under the contractual terms of the loan, including accrued and unpaid interest, do not exceed the estimated fair value of the collateral, less costs to sell.
On a quarterly basis, the Company evaluates the collectability of its interest income receivable and establishes a reserve for amounts not expected to be collected. The Company’s evaluation includes reviewing credit quality indicators such as payment status, changes affecting the operations of the facilities securing the loans, and national and regional economic factors. The reserve is a valuation allowance that reflects management’s estimate of losses inherent in the interest income receivable balance as of the balance sheet date. The reserve is adjusted through provision for loan losses and other reserves on the Company’s consolidated statements of income and is decreased by charge-offs to specific receivables.
Credit Losses
On a quarterly basis, the Company evaluates the collectability of its loan portfolio, including the portion of unfunded loan commitments expected to be funded, and establishes an allowance for credit losses. The allowance for credit losses is calculated using the related amortization schedules, payment histories and loan-to-value ratios. The following rates are applied to determine the aggregate expected losses, which is recorded as the allowance for credit losses: (i) a default rate, (ii) a liquidation cost rate and (iii) a distressed property reduction rate. If no loan-to-value ratio is available, a loss severity rate is applied in place of the liquidation cost rate and the distressed property reduction rate. The default rate is based on average charge-off and delinquency rates from the Federal Reserve, and the other rates are based on industry research and historical performance of a similar portfolio of financial assets. The allowance for credit losses is a valuation allowance that reflects management’s estimate of losses inherent in the loan portfolio as of the balance sheet date. The reserve is adjusted through provision for loan losses and other reserves on the Company’s consolidated statements of income and is decreased by charge-offs to specific loans.
Preferred Equity Investments and Preferred Return
Preferred equity investments are accounted for at unreturned capital contributions, plus accrued and unpaid preferred returns. The Company recognizes preferred return income on a monthly basis based on the outstanding investment including any previously accrued and unpaid return. As a preferred member of the preferred equity joint ventures in which the Company participates, the Company is not entitled to share in the joint venture’s earnings or losses. Rather, the Company is entitled to receive a preferred return, which is deferred if the cash flow of the joint venture is insufficient to currently pay the accrued preferred return.
The Company regularly monitors events and changes in circumstances that could indicate that the carrying amounts of its preferred equity investments may not be recoverable or realized. On a quarterly basis, the Company evaluates its preferred equity investments for impairment based on a comparison of the fair value of the investment to its carrying value. The fair value is estimated based on discounted cash flows that include all estimated cash inflows and outflows over a specified holding period. If, based on this analysis, the Company does not believe that it will be able to recover the carrying value of its preferred equity investment, the Company would record an impairment loss to the extent that the carrying value exceeds the estimated fair value of its preferred equity investment.
Cash and Cash Equivalents
The Company considers all short-term (with an original maturity of three months or less), highly-liquid investments utilized as part of the Company’s cash-management activities to be cash equivalents. Cash equivalents may include cash and short-term investments. Short-term investments are stated at cost, which approximates fair value.
The Company’s cash and cash equivalents balance exceeded federally insurable limits as of December 31, 2025. To date, the Company has experienced no loss or lack of access to cash in its operating accounts. The Company has a corporate banking relationship with Bank of America, N.A. in which it deposits the majority of its cash.
Restricted Cash
Restricted cash primarily consists of amounts held by an exchange accommodation titleholder or by secured debt lenders to provide for future real estate tax expenditures, tenant improvements and capital expenditures. Pursuant to the terms of the Company’s leases with certain tenants, the Company has assigned its interests in certain of these restricted cash accounts with secured debt lenders to the tenants, and this amount is included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets. As of December 31, 2025 and 2024, restricted cash totaled $6.6 million and $5.9 million, respectively, and restricted cash obligations totaled $1.2 million and $5.5 million, respectively.
Stock-Based Compensation
Stock-based compensation expense for stock-based awards granted to Sabra’s employees (teammates) and its non-employee directors is recognized in the consolidated statements of income based on the estimated grant date fair value, as adjusted. Compensation expense for awards with graded vesting schedules is generally recognized ratably over the period from the grant date to the date when the award is no longer contingent on the recipient providing additional services. Compensation expense for awards with performance-based vesting conditions is recognized based on the Company’s estimate of the ultimate value of such award after considering the Company’s expectations of future performance. Forfeitures of stock-based awards are recognized as they occur.
Deferred Financing Costs
Deferred financing costs representing fees paid to third parties are amortized over the terms of the respective financing agreements using the interest method. Deferred financing costs related to secured debt, term loans and senior unsecured notes are recorded as a reduction of the related debt liability, and deferred financing costs related to the revolving credit facility are recorded in accounts receivable, prepaid expenses and other assets, net. Unamortized deferred financing costs are generally expensed when the associated debt is refinanced or repaid before maturity. Costs incurred in seeking financings that do not close are expensed in the period in which it is determined that the financing will not close.
Income Taxes
The Company elected to be treated as a REIT with the filing of its U.S. federal income tax return for the taxable year beginning January 1, 2011. The Company believes that it has been organized and operated, and it intends to continue to operate, in a manner to qualify as a REIT. To qualify as a REIT, the Company must meet certain organizational and operational requirements, including a requirement to distribute at least 90% of the Company’s annual REIT taxable income to stockholders (which is computed without regard to the dividends-paid deduction or net capital gains and which does not necessarily equal net income as calculated in accordance with GAAP). As a REIT, the Company generally will not be subject to federal income tax on income that it distributes as dividends to its stockholders. If the Company fails to qualify as a REIT in any taxable year, it will be subject to U.S. federal income tax on its taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost, unless the Internal Revenue Service grants the Company relief under certain statutory provisions. Such an event could materially and adversely affect the Company’s net income and net cash available for distribution to stockholders. However, the Company believes that it is organized and operates in such a manner as to qualify for treatment as a REIT.
As a result of certain investments, the Company now records income tax expense or benefit with respect to certain of its entities that are taxed as taxable REIT subsidiaries under provisions similar to those applicable to regular corporations and not under the REIT provisions.
The Company accounts for deferred income taxes using the asset and liability method and recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the Company’s financial statements or tax returns. Under this method, the Company determines deferred tax assets and liabilities based on the differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Any increase or decrease in the deferred tax liability that results from a change in circumstances, and that causes a change in the Company’s judgment about expected future tax consequences of events, is included in the tax provision when such changes occur. Deferred income taxes also reflect the impact of operating loss and tax credit carryforwards. A valuation allowance is provided if the Company believes it is more likely than not that all or some portion of the deferred tax asset will not be realized. Any increase or decrease in the valuation allowance that results from a change in circumstances, and that causes a change in the Company’s judgment about the realizability of the related deferred tax asset, is included in the tax provision when such changes occur. 
The Company evaluates its tax positions using a two-step approach: step one (recognition) occurs when the Company concludes that a tax position, based solely on its technical merits, is more likely than not to be sustained upon examination, and step two (measurement) is only addressed if step one has been satisfied (i.e., the position is more likely than not to be sustained). Under step two, the tax benefit is measured as the largest amount of benefit (determined on a cumulative probability basis) that is more likely than not to be realized upon ultimate settlement. The Company will recognize tax penalties relating to unrecognized tax benefits as additional tax expense.
Foreign Currency
Certain of the Company’s subsidiaries’ functional currencies are the local currencies of their respective foreign jurisdictions. The Company translates the results of operations of its foreign subsidiaries into U.S. dollars using average rates of exchange in effect during the period presented, and it translates balance sheet accounts using exchange rates in effect at the end of the period presented. The Company records resulting currency translation adjustments in accumulated other comprehensive loss, a component of stockholders’ equity, on its consolidated balance sheets, and it records foreign currency transaction gains and losses as a component of other income (expense) on its consolidated statements of income.
Derivative Instruments
The Company uses certain types of derivative instruments for the purpose of managing interest rate and currency risk. To qualify for hedge accounting, derivative instruments used for risk management purposes must effectively reduce the risk exposure that they are designed to hedge. In addition, at inception, the Company must make an assessment that the transaction that the Company intends to hedge is probable of occurring, and this assessment must be updated each reporting period.
The Company recognizes all derivative instruments as assets or liabilities on the consolidated balance sheets at their fair value. For derivatives designated and qualified as a hedge, the change in fair value of the effective portion of the derivatives is recognized in accumulated other comprehensive (loss) income. Changes in the fair value of derivative instruments that are not designated in hedging relationships or that do not meet the criteria for hedge accounting would be recognized in earnings. In addition, the Company classifies cash flows from qualifying cash flow hedging relationships in the same category as the cash flows from the hedged items.
The Company formally documents all relationships between hedging instruments and hedged items, as well as its risk-management objectives and strategy for undertaking various hedge transactions. This process includes designating all derivatives that are part of a hedging relationship to specific transactions, as well as recognizing obligations or assets on the consolidated balance sheets. The Company also assesses and documents, both at inception of the hedging relationship and on a quarterly basis thereafter, whether the derivatives are highly effective in offsetting the designated risks associated with the respective hedged items. If it is determined that a derivative ceases to be highly effective as a hedge, or that it is probable the underlying transaction will not occur, the Company would discontinue hedge accounting prospectively and record the appropriate adjustment to earnings based on the then-current fair value of the derivative.
Fair Value Measurements
Under GAAP, the Company is required to measure certain financial instruments at fair value on a recurring basis. In addition, the Company is required to measure other financial instruments and balances at fair value on a non-recurring basis (e.g., carrying value of impaired loans receivable and long-lived assets). Fair value is defined as the price that would be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The GAAP fair value framework uses a three-tiered approach. Fair value measurements are classified and disclosed in one of the following three categories:
Level 1: unadjusted quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities;
Level 2: quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and
Level 3: prices or valuation techniques where little or no market data is available that requires inputs that are both significant to the fair value measurement and unobservable.
When available, the Company utilizes quoted market prices from an independent third-party source to determine fair value and classifies such items as Level 1 or Level 2. In instances where the market for a financial instrument is not active, regardless of the availability of a nonbinding quoted market price, observable inputs might not be relevant and could require the Company to make a significant adjustment to derive a fair value measurement. Additionally, in an inactive market, a market price quoted from an independent third party may rely more on models with inputs based on information available only to that
independent third party. When the Company determines the market for a financial instrument owned by the Company to be illiquid or when market transactions for similar instruments do not appear orderly, the Company may use several valuation sources (including internal valuations, discounted cash flow analysis and quoted market prices) to establish a fair value. If more than one valuation source is used, the Company will assign weights to the various valuation sources. Additionally, when determining the fair value of liabilities in circumstances in which a quoted price in an active market for an identical liability is not available, the Company measures fair value using (i) a valuation technique that uses the quoted price of the identical liability when traded as an asset or quoted prices for similar liabilities or similar liabilities when traded as assets or (ii) another valuation technique that is consistent with the principles of fair value measurement, such as the income approach or the market approach.
Changes in assumptions or estimation methodologies can have a material effect on these estimated fair values. In this regard, the derived fair value estimates cannot be substantiated by comparison to independent markets and, in many cases, may not be realized in an immediate settlement of the instrument.
The Company considers the following factors to be indicators of an inactive market: (i) there are few recent transactions, (ii) price quotations are not based on current information, (iii) price quotations vary substantially either over time or among market makers (for example, some brokered markets), (iv) indexes that previously were highly correlated with the fair values of the asset or liability are demonstrably uncorrelated with recent indications of fair value for that asset or liability, (v) there is a significant increase in implied liquidity risk premiums, yields, or performance indicators (such as delinquency rates or loss severities) for observed transactions or quoted prices when compared with the Company’s estimate of expected cash flows, considering all available market data about credit and other nonperformance risk for the asset or liability, (vi) there is a wide bid-ask spread or significant increase in the bid-ask spread, (vii) there is a significant decline or absence of a market for new issuances (that is, a primary market) for the asset or liability or similar assets or liabilities, and (viii) little information is released publicly (for example, a principal-to-principal market).
The Company considers the following factors to be indicators of non-orderly transactions: (i) there was not adequate exposure to the market for a period before the measurement date to allow for marketing activities that are usual and customary for transactions involving such assets or liabilities under current market conditions, (ii) there was a usual and customary marketing period, but the seller marketed the asset or liability to a single market participant, (iii) the seller is in or near bankruptcy or receivership (that is, distressed), or the seller was required to sell to meet regulatory or legal requirements (that is, forced), and (iv) the transaction price is an outlier when compared with other recent transactions for the same or similar assets or liabilities.
Per Share Data
Basic earnings per common share is computed by dividing net income applicable to common stockholders by the weighted average number of shares of common stock and common equivalents outstanding during the period. Diluted earnings per common share is calculated by including the effect of dilutive securities, such as the impact of forward equity sales agreements using the treasury stock method and common shares issuable from certain performance restricted stock units and unvested restricted stock units. See Note 15, “Earnings Per Common Share.”
Segment
The Company conducts and manages its business of investing in the healthcare sector as one reportable segment for internal reporting and internal decision-making purposes. The presentation of financial results as one reportable segment is consistent with the manner in which the Company’s Chief Operating Decision Maker (“CODM”), Sabra’s Chief Executive Officer, evaluates performance and makes resource allocation and operating decisions for the Company. The CODM reviews assets as shown on the accompanying consolidated balance sheets and evaluates performance and makes resource allocation and operating decisions based on net income. Expenses that are significant are the same as shown on the accompanying consolidated statements of income.
Beds, Units and Other Measures
The number of beds, units and other measures used to describe the Company’s real estate investments included in the Notes to Consolidated Financial Statements are presented on an unaudited pro rata basis.
Recently Issued Accounting Standards Updates
Adopted
In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 is intended to
improve income tax disclosures, primarily through enhanced rate reconciliation disclosures, including specified categories, and enhanced income taxes paid disclosures, including disaggregation by federal, state and foreign jurisdictions. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. The additional disclosures related to ASU 2023-09 do not apply to the Company as the related amounts are immaterial.
Issued but Not Yet Adopted
In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40), and in January 2025, the FASB issued ASU 2025-01 to clarify the effective date (together, herein referred to as “ASU 2024-03”). ASU 2024-03 is intended to improve expense disclosures, primarily through disaggregated disclosures of specified information about certain costs and expenses included in relevant expense captions on the statement of income. ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026 and interim reporting periods within annual reporting periods beginning after December 15, 2027. The Company is currently evaluating the impact this guidance will have on its consolidated financial statements when adopted.
v3.25.4
RECENT REAL ESTATE ACQUISITIONS (CONSOLIDATED)
12 Months Ended
Dec. 31, 2025
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
RECENT REAL ESTATE ACQUISITIONS (CONSOLIDATED) RECENT REAL ESTATE ACQUISITIONS (CONSOLIDATED)
During the year ended December 31, 2025, the Company acquired 11 Senior Housing - Managed communities, three of which were acquired through a consolidated joint venture in which the Company has a 95% equity interest, and exercised its option to acquire 24 units on the campus of one of its Senior Housing - Leased communities. During the year ended December 31, 2024, the Company acquired three Senior Housing - Managed communities and one Senior Housing - Leased community. The consideration was allocated as follows (in thousands):
Year Ended December 31,
20252024
Land$53,350 $9,222 
Building and improvements340,806 121,664 
Tenant origination and absorption costs intangible assets40,274 5,338 
Tenant relationship intangible assets30 206 
Total consideration$434,460 $136,430 
The tenant origination and absorption costs intangible assets had a weighted-average amortization period as of the respective dates of acquisition of two years for the acquisitions completed during the year ended December 31, 2025. The tenant origination and absorption costs intangible assets and tenant relationship intangible assets had weighted-average amortization periods as of the respective dates of acquisition of three years and 25 years, respectively, for acquisitions completed during the year ended December 31, 2024.
For the year ended December 31, 2025, the Company recognized $31.9 million and $2.4 million of total revenues and net income, respectively, from the facilities acquired during the year ended December 31, 2025. For the year ended December 31, 2024, the Company recognized $12.5 million and $2.5 million of total revenues and net income, respectively, from the facilities acquired during the year ended December 31, 2024.
Additionally, during the year ended December 31, 2025, the Company purchased the operations of four Senior Housing - Managed communities previously leased under triple-net operating leases for an aggregate $19.7 million. Concurrent with the purchase, the triple-net operating leases were terminated and the Company entered into property management agreements with the former tenant. The consideration was allocated as follows: (i) $17.4 million to tenant origination and absorption costs intangible assets, (ii) $1.1 million to furniture and equipment and (iii) $1.2 million to lease termination expense which is included in other (expense) income on the accompanying consolidated statements of income.
v3.25.4
INVESTMENT IN REAL ESTATE PROPERTIES
12 Months Ended
Dec. 31, 2025
Real Estate [Abstract]  
INVESTMENT IN REAL ESTATE PROPERTIES INVESTMENT IN REAL ESTATE PROPERTIES
The Company’s real estate properties held for investment consisted of the following (dollars in thousands):
As of December 31, 2025  
Property TypeNumber of
Properties
Number of
Beds/Units
Total
Real Estate
at Cost
Accumulated
Depreciation
Total
Real Estate
Investments, Net
Skilled Nursing/Transitional Care210 23,537 $2,802,561 $(635,685)$2,166,876 
Senior Housing - Leased32 2,668 376,590 (90,236)286,354 
Senior Housing - Managed87 8,677 2,030,267 (349,213)1,681,054 
Behavioral Health16 1,138 473,813 (90,644)383,169 
Specialty Hospitals and Other15 392 225,498 (58,291)167,207 
360 36,412 5,908,729 (1,224,069)4,684,660 
Corporate Level2,311 (594)1,717 
$5,911,040 $(1,224,663)$4,686,377 
As of December 31, 2024
Property TypeNumber of
Properties
Number of
Beds/Units
Total
Real Estate
at Cost
Accumulated
Depreciation
Total
Real Estate
Investments, Net
Skilled Nursing/Transitional Care224 25,492 $2,926,349 $(588,107)$2,338,242 
Senior Housing - Leased39 3,319 508,586 (102,111)406,475 
Senior Housing - Managed69 6,680 1,474,267 (278,328)1,195,939 
Behavioral Health17 1,164 478,318 (79,819)398,499 
Specialty Hospitals and Other15 392 225,498 (52,872)172,626 
364 37,047 5,613,018 (1,101,237)4,511,781 
Corporate Level2,746 (793)1,953 
$5,615,764 $(1,102,030)$4,513,734 
As of December 31,
20252024
Building and improvements$5,115,662 $4,853,151 
Furniture and equipment203,721 207,265 
Land improvements12,071 11,813 
Land579,586 543,535 
Total real estate at cost5,911,040 5,615,764 
Accumulated depreciation(1,224,663)(1,102,030)
Total real estate investments, net$4,686,377 $4,513,734 
During the year ended December 31, 2023, the Company received $6.2 million of insurance proceeds related to a vacant facility owned by the Company that suffered damages as a result of vandalism and theft and recorded a $3.7 million gain related to the property damage which is included in other income on the accompanying consolidated statements of income.
Capital and Other Expenditures
As of December 31, 2025, the Company’s aggregate commitment for future capital and other expenditures associated with facilities leased under triple-net operating leases was approximately $17 million. These commitments are principally for improvements to its facilities.
Senior Housing - Managed Communities
The Company’s Senior Housing - Managed communities offer residents certain ancillary services that are not contemplated in the lease with each resident (i.e., housekeeping, laundry, guest meals, etc.). These services are provided and paid for in addition to the standard services included in each resident lease (i.e., room and board, standard meals, etc.). The
Company bills residents for ancillary services one month in arrears and recognizes revenue as the services are provided, as the Company has no continuing performance obligation related to those services. Resident fees and services includes ancillary service revenue of $4.9 million, $3.9 million and $2.0 million for the years ended December 31, 2025, 2024 and 2023, respectively.
The Company received business interruption insurance proceeds related to a fire that occurred at one of the Company’s Senior Housing - Managed communities of $0.4 million, $2.1 million and $1.1 million during the years ended December 31, 2025, 2024 and 2023, respectively. The Company recorded business interruption insurance income, which is included in other income on the accompanying consolidated statements of income, of $0.4 million, $1.7 million and $0.5 million during the years ended December 31, 2025, 2024 and 2023, respectively. The remaining proceeds were recorded as expense reimbursements in Senior Housing - Managed portfolio operating expenses on the accompanying consolidated statements of income. Additionally, during the years ended December 31, 2025 and 2024, the Company received property insurance proceeds of $1.3 million and $2.4 million, respectively, and recorded a $1.3 million and $0.5 million gain, respectively, related to the property damage which is included in other income on the accompanying consolidated statements of income.
Investment in Unconsolidated Joint Ventures
The following is a summary of the Company’s investment in unconsolidated joint ventures (dollars in thousands):
Property Type
Number of
Properties as of
December 31, 2025
Ownership as of
December 31, 2025 (1)
Book Value as of December 31,
20252024
Sienna Joint VentureSenior Housing - Managed12 50 %$110,283 $107,732 
Marlin Spring Joint VentureSenior Housing - Managed85 %7,883 14,071 
$118,166 $121,803 
(1)    These investments are not consolidated because the Company does not control, through voting rights or other means, the joint ventures.
v3.25.4
IMPAIRMENT OF REAL ESTATE AND DISPOSITIONS
12 Months Ended
Dec. 31, 2025
Discontinued Operations and Disposal Groups [Abstract]  
IMPAIRMENT OF REAL ESTATE AND DISPOSITIONS IMPAIRMENT OF REAL ESTATE AND DISPOSITIONS
Impairment of Real Estate
During the years ended December 31, 2025, 2024 and 2023, the Company recognized real estate impairments of $7.3 million, $18.5 million and $14.3 million, respectively, related to three, six and three facilities, respectively. These facilities are closed, have been sold or are expected to sell.
To estimate the fair value of the impaired facilities, the Company utilized a market approach which considered binding sale agreements, non-binding offers from unrelated third parties, listing agreements or model-derived valuations with significant unobservable inputs, including comparable sales and other local and national industry market data (Level 3 measurements), as applicable. The Company utilized sales price per square foot values ranging from $4 to $73 in its fair value calculations for two non-operational facilities impaired during the year ended December 31, 2024 that were subsequently sold.
The Company continues to evaluate additional assets for sale as part of its initiative to recycle capital and further improve its portfolio quality. This could lead to a shorter hold period for such assets and could result in the determination that the full amount of the Company’s investment in such assets is not recoverable, resulting in an impairment charge or loss on sale which could be material.
Dispositions
The following table summarizes the Company’s dispositions for the periods presented (dollars in millions):
Year Ended December 31,
202520242023
Number of facilities151828
Consideration, net of closing costs$88.5 $96.0 $255.6 
Net carrying value92.0 93.9 332.2 
Net (loss) gain on sale$(3.5)$2.1 $(76.6)
Related to these facilities, the Company recognized net loss of $3.9 million, $11.6 million and $81.0 million during the years ended December 31, 2025, 2024 and 2023, respectively, which includes (i) impairment of $18.0 million and $14.3 million for the years ended December 31, 2024 and 2023, respectively, and (ii) net (loss) gain on sale.
The sale of the disposition facilities does not represent a strategic shift that has or will have a major effect on the Company’s operations and financial results, and therefore the results of operations attributable to these facilities have remained in continuing operations.
v3.25.4
OPERATING LEASES
12 Months Ended
Dec. 31, 2025
Leases [Abstract]  
OPERATING LEASES OPERATING LEASES
Lessor Accounting
As of December 31, 2025, the substantial majority of the Company’s real estate properties (excluding 87 Senior Housing - Managed communities) were leased under triple-net operating leases with expirations ranging from less than one year to 18 years. As of December 31, 2025, the leases had a weighted-average remaining term of seven years. The leases generally include provisions to extend the lease terms and other negotiated terms and conditions. The Company, through its subsidiaries, retains substantially all of the risks and benefits of ownership of the real estate assets leased to the tenants. The Company may receive additional security under these operating leases in the form of letters of credit and security deposits from the lessee or guarantees from the parent of the lessee. Security deposits received in cash related to tenant leases are included in accounts payable and accrued liabilities on the accompanying consolidated balance sheets and totaled $10.5 million and $9.0 million as of December 31, 2025 and 2024, respectively, and letters of credit deposited with the Company totaled approximately $63 million and $64 million as of December 31, 2025 and 2024, respectively. In addition, the Company’s tenants have deposited with the Company $10.8 million as of each of December 31, 2025 and 2024, respectively, for future real estate taxes, insurance expenditures and tenant improvements related to the Company’s properties and their operations, and these amounts are included in accounts payable and accrued liabilities on the accompanying consolidated balance sheets.
Lessor costs that are paid by the lessor and reimbursed by the lessee are included in the measurement of variable lease revenue and the associated expense. As a result, the Company recognized variable lease revenue and the associated expense of $14.2 million, $14.5 million and $15.3 million during the years ended December 31, 2025, 2024 and 2023, respectively.
The Company monitors the creditworthiness of its tenants by evaluating the ability of the tenants to meet their lease obligations to the Company based on the tenants’ financial performance, including, as applicable and appropriate, the evaluation of any parent guarantees (or the guarantees of other related parties) of such lease obligations. The primary basis for the Company’s evaluation of the credit quality of its tenants (and more specifically the tenant’s ability to pay their rent obligations to the Company) is the tenant’s lease coverage ratio as supplemented by the parent’s fixed charge coverage ratio for those entities with a parent guarantee. These coverage ratios include earnings before interest, taxes, depreciation, amortization and rent (“EBITDAR”) to rent and earnings before interest, taxes, depreciation, amortization, rent and management fees (“EBITDARM”) to rent at the lease level and consolidated EBITDAR to total fixed charges at the parent guarantor level when such a guarantee exists. The Company obtains various financial and operational information from the majority of its tenants each month and reviews this information in conjunction with the above-described coverage metrics to identify financial and operational trends, evaluate the impact of the industry’s operational and financial environment (including the impact of government reimbursement), and evaluate the management of the tenant’s operations. These metrics help the Company identify potential areas of concern relative to its tenants’ credit quality and ultimately the tenant’s ability to generate sufficient liquidity to meet its obligations, including its obligation to continue to pay the rent due to the Company.
For the year ended December 31, 2025, no tenant relationship represented 10% or more of the Company’s total revenues.
As of December 31, 2025, the future minimum rental payments from the Company’s properties held for investment under non-cancelable operating leases were as follows and may materially differ from actual future rental payments received (in thousands):
2026$355,230 
2027343,478 
2028323,161 
2029273,867 
2030246,425 
Thereafter909,657 
$2,451,818 
Lessee Accounting
For operating leases greater than 12 months for which the Company is the lessee, such as corporate office leases and ground leases, the Company recognizes a right-of-use (“ROU”) asset and related lease liability on its consolidated balance sheets at inception of the lease. ROU assets represent the Company’s right to use underlying assets for the lease term, and lease liabilities are determined based on the estimated present value of the Company’s minimum lease payments under the agreements. The discount rate used to determine the lease liabilities is based on the estimated incremental borrowing rate on a lease-by-lease basis. Certain of the Company’s lease agreements have options to extend or terminate the contract terms upon meeting certain criteria. The lease term utilized in the calculation of the lease liability includes these options if exercise is considered reasonably certain. As of December 31, 2025 and 2024, the Company had $6.5 million and $7.0 million of ROU assets included in accounts receivable, prepaid expenses and other assets, net, and $7.4 million and $8.3 million of lease liabilities included in accounts payable and accrued liabilities, respectively, on its consolidated balance sheets.
During the years ended December 31, 2025, 2024 and 2023, the Company incurred lease expense of $1.0 million, $1.3 million and $1.4 million, respectively. As of December 31, 2025, the weighted average remaining lease term and discount rate were 12 years and 8%, respectively, and the future minimum lease payments under the operating leases included in the Company’s lease liability were as follows (in thousands):
2026$1,032 
20271,047 
20281,021 
20291,050 
20301,069 
Thereafter6,819 
Undiscounted minimum lease payments included in the lease liability12,038 
Less: imputed interest(4,659)
Present value of lease liability$7,379 
OPERATING LEASES OPERATING LEASES
Lessor Accounting
As of December 31, 2025, the substantial majority of the Company’s real estate properties (excluding 87 Senior Housing - Managed communities) were leased under triple-net operating leases with expirations ranging from less than one year to 18 years. As of December 31, 2025, the leases had a weighted-average remaining term of seven years. The leases generally include provisions to extend the lease terms and other negotiated terms and conditions. The Company, through its subsidiaries, retains substantially all of the risks and benefits of ownership of the real estate assets leased to the tenants. The Company may receive additional security under these operating leases in the form of letters of credit and security deposits from the lessee or guarantees from the parent of the lessee. Security deposits received in cash related to tenant leases are included in accounts payable and accrued liabilities on the accompanying consolidated balance sheets and totaled $10.5 million and $9.0 million as of December 31, 2025 and 2024, respectively, and letters of credit deposited with the Company totaled approximately $63 million and $64 million as of December 31, 2025 and 2024, respectively. In addition, the Company’s tenants have deposited with the Company $10.8 million as of each of December 31, 2025 and 2024, respectively, for future real estate taxes, insurance expenditures and tenant improvements related to the Company’s properties and their operations, and these amounts are included in accounts payable and accrued liabilities on the accompanying consolidated balance sheets.
Lessor costs that are paid by the lessor and reimbursed by the lessee are included in the measurement of variable lease revenue and the associated expense. As a result, the Company recognized variable lease revenue and the associated expense of $14.2 million, $14.5 million and $15.3 million during the years ended December 31, 2025, 2024 and 2023, respectively.
The Company monitors the creditworthiness of its tenants by evaluating the ability of the tenants to meet their lease obligations to the Company based on the tenants’ financial performance, including, as applicable and appropriate, the evaluation of any parent guarantees (or the guarantees of other related parties) of such lease obligations. The primary basis for the Company’s evaluation of the credit quality of its tenants (and more specifically the tenant’s ability to pay their rent obligations to the Company) is the tenant’s lease coverage ratio as supplemented by the parent’s fixed charge coverage ratio for those entities with a parent guarantee. These coverage ratios include earnings before interest, taxes, depreciation, amortization and rent (“EBITDAR”) to rent and earnings before interest, taxes, depreciation, amortization, rent and management fees (“EBITDARM”) to rent at the lease level and consolidated EBITDAR to total fixed charges at the parent guarantor level when such a guarantee exists. The Company obtains various financial and operational information from the majority of its tenants each month and reviews this information in conjunction with the above-described coverage metrics to identify financial and operational trends, evaluate the impact of the industry’s operational and financial environment (including the impact of government reimbursement), and evaluate the management of the tenant’s operations. These metrics help the Company identify potential areas of concern relative to its tenants’ credit quality and ultimately the tenant’s ability to generate sufficient liquidity to meet its obligations, including its obligation to continue to pay the rent due to the Company.
For the year ended December 31, 2025, no tenant relationship represented 10% or more of the Company’s total revenues.
As of December 31, 2025, the future minimum rental payments from the Company’s properties held for investment under non-cancelable operating leases were as follows and may materially differ from actual future rental payments received (in thousands):
2026$355,230 
2027343,478 
2028323,161 
2029273,867 
2030246,425 
Thereafter909,657 
$2,451,818 
Lessee Accounting
For operating leases greater than 12 months for which the Company is the lessee, such as corporate office leases and ground leases, the Company recognizes a right-of-use (“ROU”) asset and related lease liability on its consolidated balance sheets at inception of the lease. ROU assets represent the Company’s right to use underlying assets for the lease term, and lease liabilities are determined based on the estimated present value of the Company’s minimum lease payments under the agreements. The discount rate used to determine the lease liabilities is based on the estimated incremental borrowing rate on a lease-by-lease basis. Certain of the Company’s lease agreements have options to extend or terminate the contract terms upon meeting certain criteria. The lease term utilized in the calculation of the lease liability includes these options if exercise is considered reasonably certain. As of December 31, 2025 and 2024, the Company had $6.5 million and $7.0 million of ROU assets included in accounts receivable, prepaid expenses and other assets, net, and $7.4 million and $8.3 million of lease liabilities included in accounts payable and accrued liabilities, respectively, on its consolidated balance sheets.
During the years ended December 31, 2025, 2024 and 2023, the Company incurred lease expense of $1.0 million, $1.3 million and $1.4 million, respectively. As of December 31, 2025, the weighted average remaining lease term and discount rate were 12 years and 8%, respectively, and the future minimum lease payments under the operating leases included in the Company’s lease liability were as follows (in thousands):
2026$1,032 
20271,047 
20281,021 
20291,050 
20301,069 
Thereafter6,819 
Undiscounted minimum lease payments included in the lease liability12,038 
Less: imputed interest(4,659)
Present value of lease liability$7,379 
v3.25.4
INTANGIBLE ASSETS AND LIABILITIES
12 Months Ended
Dec. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
INTANGIBLE ASSETS AND LIABILITIES INTANGIBLE ASSETS AND LIABILITIES
The following table summarizes the Company’s intangible assets and liabilities as of December 31, 2025 and 2024 (in thousands):
As of December 31,
20252024
Lease Intangible Assets:
Above market leases$5,606 $5,606 
Tenant origination and absorption costs90,430 40,544 
Tenant relationship14,595 15,914 
Gross lease intangible assets110,631 62,064 
Accumulated amortization(45,310)(34,600)
Lease intangible assets, net$65,321 $27,464 
Lease Intangible Liabilities:
Below market leases$61,537 $64,538 
Accumulated amortization(40,154)(37,691)
Lease intangible liabilities, net$21,383 $26,847 
The following is a summary of real estate intangible amortization income (expense) for the years ended December 31, 2025, 2024 and 2023 (in thousands): 
Year Ended December 31,
202520242023
Increase to rental income related to above/below market leases, net$4,880 $4,867 $5,821 
Depreciation and amortization related to tenant origination and absorption costs and tenant relationship(19,085)(7,501)(11,616)
The remaining unamortized balance for these outstanding intangible assets and liabilities as of December 31, 2025 will be amortized for the years ending December 31 as follows (dollars in thousands):
Lease Intangible
Assets
 Lease Intangible
Liabilities
2026$34,296 $4,564 
202717,521 4,438 
20284,274 4,296 
20291,997 4,190 
20301,767 3,895 
Thereafter5,466 — 
$65,321 $21,383 
  
Weighted-average remaining amortization period3.5 years4.8 years
v3.25.4
LOANS RECEIVABLE AND OTHER INVESTMENTS
12 Months Ended
Dec. 31, 2025
Receivables [Abstract]  
LOANS RECEIVABLE AND OTHER INVESTMENTS LOANS RECEIVABLE AND OTHER INVESTMENTS
As of December 31, 2025 and 2024, the Company’s loans receivable and other investments consisted of the following (dollars in thousands):
As of December 31, 2025
Investment
Quantity
as of
December 31, 2025
Property Type
Principal Balance as of December 31, 2025 (1)
Book Value
as of
December 31, 2025
Book Value
as of
December 31, 2024
Weighted Average Contractual Interest Rate / Rate of ReturnWeighted Average Annualized Effective Interest Rate / Rate of ReturnMaturity Date
Loans Receivable:
MortgageBehavioral Health /
Skilled Nursing
$335,600 $335,600 $335,600 7.7 %7.7 %11/01/26 - 06/01/29
Other10 Multiple41,649 38,194 51,962 7.4 %6.9 %02/28/26 - 08/31/33
13 377,249 373,794 387,562 7.7 %7.6 %
Allowance for loan losses— (5,047)(6,094)
$377,249 $368,747 $381,468 
Other Investments:
Preferred EquitySkilled Nursing / Senior Housing65,171 65,353 61,116 11.0 %11.0 %N/A
Total17 $442,420 $434,100 $442,584 8.2 %8.1 %
(1)    Principal balance includes amounts funded and accrued but unpaid interest / preferred return and excludes capitalizable fees.
As of December 31, 2025, the Company has committed to provide up to $0.5 million of future funding related to two loan receivable investments.
Additional information regarding the Company’s loans receivable is as follows (dollars in thousands):
Year Ended December 31,
202520242023
Allowance for loan losses:
Balance at the beginning of the year$6,094 $6,665 $6,611 
(Recovery of) provision for loan losses(1,047)(571)191 
Write-off of uncollectible balances— — (137)
Balance at the end of the year$5,047 $6,094 $6,665 
As of each of December 31, 2025 and 2024, the Company had one loan receivable investment with a principal balance of $1.2 million and a book value of zero, and three loans receivable investments with zero book value were on nonaccrual status.
As of December 31, 2025 and 2024, the Company did not consider any preferred equity investments to be impaired, and no preferred equity investments were on nonaccrual status.
v3.25.4
DEBT
12 Months Ended
Dec. 31, 2025
Debt Disclosure [Abstract]  
DEBT DEBT
Secured Indebtedness
The Company’s secured debt consists of the following (dollars in thousands):
Principal Balance as of December 31, (1)
As of December 31, 2025
Weighted Average Interest Rate
Weighted Average Effective Interest Rate (2)
Interest Rate Type
2025
2024
Maturity Date
Fixed Rate$44,021 $46,110 2.86 %3.36 %May 2031 - 
August 2051
(1)    Principal balance does not include deferred financing costs, net of $0.7 million and $0.8 million as of December 31, 2025 and 2024, respectively.
(2)    Weighted average effective interest rate includes private mortgage insurance.
Senior Unsecured Notes
The Company’s senior unsecured notes consist of the following (dollars in thousands):
Principal Balance as of December 31, (1)
TitleMaturity Date
2025
2024
5.125% senior unsecured notes due 2026 (“2026 Notes”)
August 15, 2026$— $500,000 
5.38% senior unsecured notes due 2027 (“2027 Notes”)
May 17, 2027100,000 100,000 
3.90% senior unsecured notes due 2029 (“2029 Notes”)
October 15, 2029350,000 350,000 
3.20% senior unsecured notes due 2031 (“2031 Notes”)
December 1, 2031800,000 800,000 
$1,250,000 $1,750,000 
(1)    Principal balance does not include discount, net of $6.9 million and deferred financing costs, net of $7.4 million as of December 31, 2025 and does not include discount, net of $5.0 million and deferred financing costs, net of $9.0 million as of December 31, 2024. In addition, the weighted average effective interest rate as of December 31, 2025 was 3.66%.
The 2026 Notes and the 2027 Notes were assumed as a result of the Company’s merger with Care Capital Properties, Inc. in 2017 and accrue interest at a rate of 5.125% and 5.38%, respectively, per annum. Interest is payable semiannually on February 15 and August 15 of each year for the 2026 Notes and on May 17 and November 17 of each year for the 2027 Notes.
On June 30, 2025, the Company issued a notice of redemption for all $500.0 million aggregate principal amount outstanding of the 2026 Notes. On July 31, 2025, the Operating Partnership redeemed the 2026 Notes at a cash redemption price of 100.575% of the principal amount being redeemed, plus accrued and unpaid interest. As a result of the redemption, the Company recognized $1.2 million of redemption related costs and write-offs, consisting of $2.9 million in payments made to noteholders for early redemption net of $1.7 million of write-offs associated with unamortized premium.
The 2027 Notes may be prepaid by Operating Partnership, in whole at any time or in part from time to time, at 100% of the principal amount to be prepaid plus a make-whole premium.
The 2029 Notes were issued by the Operating Partnership and, until redemption of the Company’s previously outstanding 5.375% senior notes due 2023 in 2019, Sabra Capital Corporation, a wholly-owned subsidiary of the Company, and accrue interest at a rate of 3.90% per annum. Interest is payable semiannually on April 15 and October 15 of each year.
The 2029 Notes are redeemable at the option of the Operating Partnership, in whole or in part at any time and from time to time, prior to July 15, 2029, at a price equal to 100% of the principal amount, together with any accrued and unpaid interest to, but not including, the redemption date, plus a make-whole premium. The Operating Partnership may also redeem the 2029 Notes on or after July 15, 2029, at a price equal to 100% of the principal amount, together with any accrued and unpaid interest to, but not including, the redemption date.
The 2031 Notes were issued by the Operating Partnership and accrue interest at a rate of 3.20% per annum. Interest is payable semiannually on June 1 and December 1 of each year, commencing on June 1, 2022.
The 2031 Notes are redeemable at the option of the Operating Partnership, in whole or in part at any time and from time to time, prior to September 1, 2031, at a price equal to 100% of the principal amount, together with any accrued and unpaid
interest to the redemption date, plus a make-whole premium. The Operating Partnership may also redeem the 2031 Notes on or after September 1, 2031, at a price equal to 100% of the principal amount, together with any accrued and unpaid interest to the redemption date.
The obligations under the 2027 Notes are fully and unconditionally guaranteed, jointly and severally, on an unsecured basis, by Sabra and one of its non-operating subsidiaries, subject to release under certain customary circumstances. The obligations under the 2029 Notes and 2031 Notes are, and the obligations under the 2026 Notes were until their redemption, fully and unconditionally guaranteed, on an unsecured basis, by Sabra; provided, however, that such guarantee is subject to release under certain customary circumstances.
The agreement governing the 2027 Notes provides for customary events of default, including, but not limited to, the failure to make payments of interest or premium, if any, on, or principal of, the 2027 Notes, the failure to comply with certain covenants and agreements specified in the agreement governing the 2027 Notes for a period of time after notice has been provided, the acceleration of other indebtedness resulting from the failure to pay principal on such other indebtedness prior to its maturity, and certain events of insolvency. In addition, certain change of control events constitute an event of default under the agreement governing the 2027 Notes. If any event of default occurs, the principal of, premium, if any, and accrued interest on all the then-outstanding 2027 Notes may become due and payable immediately.
The indenture governing the 2029 Notes and 2031 Notes contains restrictive covenants that, among other things, restrict the ability of Sabra, the Issuers and their subsidiaries to: (i) incur or guarantee additional indebtedness; (ii) incur or guarantee secured indebtedness; and (iii) merge or consolidate or sell all or substantially all of their assets. The indenture governing the 2029 Notes and 2031 Notes also provides for customary events of default, including, but not limited to, the failure to make payments of interest or premium, if any, on, or principal of, the 2029 Notes and 2031 Notes, the failure to comply with certain covenants and agreements specified in the indenture for a period of time after notice has been provided, the acceleration of other indebtedness resulting from the failure to pay principal on such other indebtedness prior to its maturity, and certain events of insolvency. If any event of default occurs, the principal of, premium, if any, and accrued interest on all the then-outstanding 2029 Notes and 2031 Notes may become due and payable immediately. The indenture governing the 2029 Notes and 2031 Notes requires Sabra, the Issuers and their subsidiaries to maintain Total Unencumbered Assets (as defined in the indentures) of at least 150% of the Company’s unsecured indebtedness.
The Company was in compliance with all applicable financial covenants under the indentures and agreements (the “Senior Notes Indentures”) governing the 2027 Notes, 2029 Notes and 2031 Notes (collectively, the “Senior Notes”) outstanding as of December 31, 2025.
Credit Agreement
On January 4, 2023, the Operating Partnership and Sabra Canadian Holdings, LLC (together, the “Borrowers”), and the other parties thereto entered into a sixth amended and restated unsecured credit agreement (the “Credit Agreement”). During the year ended December 31, 2023, the Company recognized $1.5 million of loss on extinguishment of debt related to write-offs of deferred financing costs in connection with amending and restating its prior unsecured credit agreement.
The Credit Agreement includes a $1.0 billion revolving credit facility (the “Revolving Credit Facility”), a $430.0 million U.S. dollar term loan and a CAD $150.0 million Canadian dollar term loan (collectively, the “Term Loans”). Further, up to $350.0 million of the Revolving Credit Facility may be used for borrowings in certain foreign currencies. The Credit Agreement also contains an accordion feature that can increase the total available borrowings to $2.75 billion, subject to terms and conditions.
The Revolving Credit Facility has a maturity date of January 4, 2027, and includes two six-month extension options. The Term Loans have a maturity date of January 4, 2028.
As of December 31, 2025, there was $217.6 million (including CAD $33.7 million) outstanding under the Revolving Credit Facility and $782.4 million available for borrowing.
Borrowings under the Revolving Credit Facility bear interest on the outstanding principal amount at a rate equal to a ratings-based applicable interest margin plus, Daily Simple CORRA, as defined in the Credit Agreement, for Canadian dollar borrowings, or at the Operating Partnership’s option for U.S. dollar borrowings, either (a) Daily Simple SOFR, as defined in the Credit Agreement, or (b) a base rate determined as the greater of (i) the federal funds rate plus 0.5%, (ii) the prime rate, (iii) Term SOFR, as defined in the Credit Agreement, plus 1.0% (the “Base Rate”), and (iv) 1.00%. The ratings-based applicable interest margin for borrowings will vary based on the Debt Ratings, as defined in the Credit Agreement, and will range from 0.775% to 1.450% per annum for Daily Simple SOFR-based borrowings and 0.00% to 0.450% per annum for borrowings at the Base Rate. As of December 31, 2025, the weighted average interest rate on the Revolving Credit Facility was 4.79%. In
addition, the Operating Partnership pays a facility fee ranging between 0.125% and 0.300% per annum based on the aggregate amount of commitments under the Revolving Credit Facility regardless of amounts outstanding thereunder.
The U.S. dollar Term Loan bears interest on the outstanding principal amount at a ratings-based applicable interest margin plus, at the Operating Partnership’s option, either (a) Term SOFR or (b) the Base Rate. The ratings-based applicable interest margin for borrowings will vary based on the Debt Ratings and will range from 0.850% to 1.650% per annum for Term SOFR-based borrowings and 0.00% to 0.650% per annum for borrowings at the Base Rate. As of December 31, 2025, the interest rate on the U.S. dollar Term Loan was 5.12%. The Canadian dollar Term Loan bears interest on the outstanding principal amount at a rate equal to the Term CORRA Rate, as defined in the Credit Agreement, plus an interest margin that will range from 0.850% to 1.650% depending on the Debt Ratings. As of December 31, 2025, the interest rate on the Canadian dollar Term Loan was 3.55%.
The Company has interest rate swaps that fix the Secured Overnight Financing Rate (“SOFR”) portion of the interest rate for $430.0 million of SOFR-based borrowings under its U.S. dollar Term Loan at a weighted average rate of 2.93% and interest rate swaps that fix the Canadian Overnight Repo Rate (“CORRA”) portion of the interest rate for CAD $150.0 million of CORRA-based borrowings under its Canadian dollar Term Loan at a rate of 2.59%. As of December 31, 2025, the effective interest rate on the U.S. dollar and Canadian dollar Term Loans was 4.18% and 3.84%, respectively. In addition, the Canadian dollar Term Loan and the CAD $33.7 million outstanding as of December 31, 2025 under the Revolving Credit Facility are designated as net investment hedges. See Note 10, “Derivative and Hedging Instruments,” for further information.
The obligations of the Borrowers under the Credit Agreement are guaranteed by the Company and certain of its subsidiaries.
The Credit Agreement contains customary covenants that include restrictions or limitations on the ability to pay dividends, incur additional indebtedness, engage in non-healthcare related business activities, enter into transactions with affiliates and sell or otherwise transfer certain assets as well as customary events of default. The Credit Agreement also requires Sabra, through the Operating Partnership, to comply with specified financial covenants, which include a maximum total leverage ratio, a maximum secured debt leverage ratio, a minimum fixed charge coverage ratio, a maximum unsecured leverage ratio, a minimum tangible net worth requirement and a minimum unsecured interest coverage ratio. As of December 31, 2025, the Company was in compliance with all applicable financial covenants under the Credit Agreement.
Term Loan Credit Agreement
On July 30, 2025, the Borrowers, Sabra and the other parties thereto entered into an unsecured credit agreement for a $500.0 million U.S. dollar term loan which matures on July 30, 2030 (the “Term Loan Credit Agreement”). The proceeds were used to redeem the 2026 Notes. The Term Loan Credit Agreement also contains an accordion feature that can increase the total available borrowings to $1.0 billion, subject to terms and conditions.
The term loan bears interest on the outstanding principal amount at a ratings-based applicable interest margin plus, at the Operating Partnership’s option, either (a) Daily SOFR, (b) Term SOFR or (c) the Base Rate, each as defined in the Term Loan Credit Agreement. The ratings-based applicable interest margin for borrowings will vary based on the Debt Ratings, as defined in the Term Loan Credit Agreement, and will range from 0.800% to 1.600% per annum for SOFR-based borrowings and 0.000% to 0.600% per annum for borrowings at the Base Rate. As of December 31, 2025, the interest rate on the U.S. dollar term loan under the Term Loan Credit Agreement was 5.07%.
On June 27, 2025, the Company entered into forward starting interest rate swaps with an effective date of July 30, 2025 and an aggregate notional amount of $500.0 million which fix the SOFR portion of the interest rate for SOFR-based borrowings at a weighted average rate of 3.44%. As of December 31, 2025, the effective interest rate on the $500.0 million U.S. dollar term loan under the Term Loan Credit Agreement was 4.64%.
The obligations of the Borrowers under the Term Loan Credit Agreement are guaranteed by the Company and certain of its subsidiaries.
Interest Expense
During the years ended December 31, 2025, 2024 and 2023, the Company incurred interest expense of $112.5 million, $115.3 million and $113.0 million, respectively. Interest expense includes non-cash interest expense of $8.0 million, $10.5 million and $12.3 million for the years ended December 31, 2025, 2024 and 2023, respectively. As of December 31, 2025 and 2024, the Company had $9.6 million and $16.1 million, respectively, of accrued interest included in accounts payable and accrued liabilities on the accompanying consolidated balance sheets.
Maturities
The following is a schedule of maturities for the Company’s outstanding debt as of December 31, 2025 (in thousands):
Secured
Indebtedness
Revolving
Credit Facility (1)
Term LoansSenior NotesTotal
2026$2,147 $— $— $— $2,147 
20272,206 217,584 — 100,000 319,790 
20282,266 — 539,425 — 541,691 
20292,328 — — 350,000 352,328 
20302,392 — 500,000 — 502,392 
Thereafter32,682 — — 800,000 832,682 
Total Debt44,021 217,584 1,039,425 1,250,000 2,551,030 
Discount, net— — — (6,859)(6,859)
Deferred financing costs, net(746)— (7,114)(7,415)(15,275)
Total Debt, Net$43,275 $217,584 $1,032,311 $1,235,726 $2,528,896 
(1)    Revolving Credit Facility is subject to two six-month extension options.
v3.25.4
DERIVATIVE AND HEDGING INSTRUMENTS
12 Months Ended
Dec. 31, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE AND HEDGING INSTRUMENTS DERIVATIVE AND HEDGING INSTRUMENTS
The Company is exposed to various market risks, including the potential loss arising from adverse changes in interest rates and foreign exchange rates. The Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates and foreign exchange rates. The Company’s derivative financial instruments are used to manage differences in the amount of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s investments and borrowings.
Certain of the Company’s foreign operations expose the Company to fluctuations of foreign interest rates and exchange rates. These fluctuations may impact the value in the Company’s functional currency, the U.S. dollar, of the Company’s investment in foreign operations, the cash receipts and payments related to these foreign operations and payments of interest and principal under Canadian dollar denominated debt. The Company enters into derivative financial instruments to protect the value of its foreign investments and fix a portion of the interest payments for certain debt obligations. The Company does not enter into derivatives for speculative purposes.
Cash Flow Hedges
The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish these objectives, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. During the year ended December 31, 2025, the Company reclassified $17.2 million of gain related to six previously terminated interest rate swaps from accumulated other comprehensive loss to other income as the related forecasted transactions were determined to be probable not to occur. As of December 31, 2025, approximately $0.4 million of gains, which are included in accumulated other comprehensive income, are expected to be reclassified into earnings in the next 12 months.
Net Investment Hedges
The Company is exposed to fluctuations in foreign exchange rates on investments it holds in Canada. The Company uses Canadian dollar denominated debt to hedge its exposure to changes in foreign exchange rates on these foreign investments.
Derivative Instruments
The following presents the notional amount of derivative instruments as of the dates indicated (in thousands):  
As of December 31,
20252024
Derivatives designated as cash flow hedges:
Denominated in U.S. Dollars$930,000 $430,000 
Denominated in Canadian Dollars$150,000 $150,000 
Derivatives designated as net investment hedges:
Denominated in Canadian Dollars$— $46,270 
Financial instruments designated as net investment hedges:
Denominated in Canadian Dollars$183,700 $189,600 
Derivatives not designated as net investment hedges:
Denominated in Canadian Dollars$— $10,030 
Derivative and Financial Instruments Designated as Hedging Instruments
The following is a summary of the derivative and financial instruments designated as hedging instruments held by the Company at December 31, 2025 and 2024 (dollars in thousands):    
Count as of December 31, 2025
Maturity Dates as of December 31, 2025
Fair Value as of December 31,
TypeDesignation20252024Balance Sheet Location
Assets:
Interest rate swapsCash flow$3,378 $14,085 2028Accounts receivable, prepaid expenses and other assets, net
Cross currency interest rate swapsNet investment— — 6,290 Accounts receivable, prepaid expenses and other assets, net
$3,378 $20,375 
Liabilities:
Interest rate swapsCash flow$1,281 $— 2028 - 2030Accounts payable and accrued liabilities
CAD borrowings under Revolving Credit FacilityNet investment24,584 27,554 2027Revolving credit facility
CAD Term LoanNet investment109,425 104,370 2028Term loans, net
$135,290 $131,924 
The following presents the effect of the Company’s derivative and financial instruments designated as hedging instruments on the consolidated statements of income and the consolidated statements of equity for the years ended December 31, 2025, 2024 and 2023 (in thousands):
(Loss) Gain Recognized in Other Comprehensive (Loss) IncomeGain Reclassified from Accumulated Other Comprehensive (Loss) Income
Into Income
Income Statement Location
For the year ended December 31,
202520242023202520242023
Cash Flow Hedges:
Interest rate products$(4,322)$12,549 $13,116 $6,445 $9,413 $8,332 Interest expense
Net Investment Hedges:
Foreign currency products(1,418)3,075 (664)— — — N/A
CAD borrowings under Revolving Credit Facility(417)(1,916)(3,456)— — — N/A
CAD Term Loan(5,055)8,820 (2,465)— — — N/A
$(11,212)$22,528 $6,531 $6,445 $9,413 $8,332 
During the years ended December 31, 2025, 2024 and 2023, no cash flow hedges were determined to be ineffective.
Derivatives Not Designated as Hedging Instruments
As of December 31, 2025, the Company’s derivatives were all designated as hedging instruments. During the years ended December 31, 2025, 2024 and 2023, the Company incurred $0.3 million of other expense, $0.5 million of other income and $18,000 of other expense, respectively, related to the portion of derivatives not designated as hedging instruments.
Offsetting Derivatives
The Company enters into master netting arrangements, which reduce credit risk by permitting net settlement of transactions with the same counterparty. The table below presents a gross presentation, the effects of offsetting, and a net presentation of the Company’s derivatives as of December 31, 2025 and 2024 (in thousands):
As of December 31, 2025
Gross Amounts of Recognized Assets / LiabilitiesGross Amounts Offset in the Balance SheetNet Amounts of Assets / Liabilities presented in the Balance SheetGross Amounts Not Offset in the Balance Sheet
Financial InstrumentsCash Collateral ReceivedNet Amount
Offsetting Assets:
Derivatives$3,378 $— $3,378 $(212)$— $3,166 
Offsetting Liabilities:
Derivatives$1,281 $— $1,281 $(212)$— $1,069 
As of December 31, 2024
Gross Amounts of Recognized Assets / LiabilitiesGross Amounts Offset in the Balance SheetNet Amounts of Assets / Liabilities presented in the Balance SheetGross Amounts Not Offset in the Balance Sheet
Financial InstrumentsCash Collateral ReceivedNet Amount
Offsetting Assets:
Derivatives$20,375 $— $20,375 $— $— $20,375 
Offsetting Liabilities:
Derivatives$— $— $— $— $— $— 
Credit Risk-related Contingent Features
The Company has agreements with each of its derivative counterparties that contain a provision pursuant to which the Company could be declared in default on the derivative obligation if the Company defaults on any of its indebtedness, including a default where repayment of the indebtedness has not been accelerated by the lender. As of December 31, 2025, the fair value of derivatives in a net liability position, which includes accrued interest but excludes any adjustment for nonperformance risk, related to these agreements was $1.2 million. As of December 31, 2025, the Company has not posted any collateral related to
these agreements. If the Company had breached any of these provisions at December 31, 2025, it could have been required to settle its obligations under the agreements at their termination value of $1.1 million.
v3.25.4
FAIR VALUE DISCLOSURES
12 Months Ended
Dec. 31, 2025
Fair Value Disclosures [Abstract]  
FAIR VALUE DISCLOSURES FAIR VALUE DISCLOSURES
Financial Instruments
The fair value for certain financial instruments is derived using a combination of market quotes, pricing models and other valuation techniques that involve significant management judgment. The price transparency of financial instruments is a key determinant of the degree of judgment involved in determining the fair value of the Company’s financial instruments.
Financial instruments for which actively quoted prices or pricing parameters are available and whose markets contain orderly transactions will generally have a higher degree of price transparency than financial instruments whose markets are inactive or consist of non-orderly trades. The Company evaluates several factors when determining if a market is inactive or when market transactions are not orderly. The carrying values of cash and cash equivalents, restricted cash, accounts payable, accrued liabilities and the Credit Agreement and Term Loan Credit Agreement are reasonable estimates of fair value because of the short-term maturities and/or monthly repricing of these instruments. Fair values for other financial instruments are derived as follows:
Loans receivable: These instruments are presented on the accompanying consolidated balance sheets at their amortized cost and not at fair value. The fair values of the loans receivable were estimated using an internal valuation model that considered the expected cash flows for the loans receivable, as well as the underlying collateral value and other credit enhancements as applicable. The Company utilized discount rates ranging from 5% to 13% with a weighted average rate of 6% in its fair value calculation. As such, the Company classifies these instruments as Level 3.
Preferred equity investments: These instruments are presented on the accompanying consolidated balance sheets at their cost and not at fair value. The fair values of the preferred equity investments were estimated using an internal valuation model that considered the expected future cash flows for the preferred equity investments, the underlying collateral value and other credit enhancements. The Company utilized discount rates ranging from 10% to 15% with a weighted average rate of 11% in its fair value calculation. As such, the Company classifies these instruments as Level 3.
Derivative instruments: The Company’s derivative instruments are presented at fair value on the accompanying consolidated balance sheets. The Company estimates the fair value of derivative instruments using the assistance of a third party using inputs that are observable in the market, which include forward yield curves and other relevant information. Although the Company has determined that the majority of the inputs used to value its derivative financial instruments fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with its derivative financial instruments utilize Level 3 inputs, such as estimates of current credit spreads, to evaluate the likelihood of default by itself and its counterparties. The Company has assessed the significance of the impact of the credit valuation adjustments on the overall valuation of its derivative positions and has determined that the credit valuation adjustments are not significant to the overall valuation of its derivative financial instruments. As a result, the Company has determined that its derivative financial instruments valuations in their entirety are classified in Level 2 of the fair value hierarchy.
Senior Notes: These instruments are presented on the accompanying consolidated balance sheets at their outstanding principal balance, net of unamortized deferred financing costs and premiums/discounts and not at fair value. The fair values of the Senior Notes were determined using third-party market quotes derived from orderly trades. As such, the Company classifies these instruments as Level 2.
Secured indebtedness: These instruments are presented on the accompanying consolidated balance sheets at their outstanding principal balance, net of unamortized deferred financing costs and premiums/discounts and not at fair value. The fair values of the Company’s secured debt were estimated using a discounted cash flow analysis based on management’s estimates of current market interest rates for instruments with similar characteristics, including remaining loan term, loan-to-value ratio, type of collateral and other credit enhancements. The Company utilized a rate of 6% in its fair value calculation. As such, the Company classifies these instruments as Level 3.
The following are the face values, carrying amounts and fair values of the Company’s financial instruments as of December 31, 2025 and 2024 whose carrying amounts do not approximate their fair value (in thousands):
 As of December 31, 2025As of December 31, 2024
 
Face
Value
(1)
Carrying
Amount
(2)
Fair
Value
Face
Value
(1)
Carrying
Amount
(2)
Fair
Value
Financial assets:
Loans receivable$377,249 $368,747 $381,035 $391,010 $381,468 $397,791 
Preferred equity investments65,171 65,353 66,858 60,915 61,116 62,765 
Financial liabilities:
Senior Notes1,250,000 1,235,726 1,180,495 1,750,000 1,736,025 1,617,779 
Secured indebtedness44,021 43,275 34,101 46,110 45,316 33,635 
(1)    Face value represents amounts contractually due under the terms of the respective agreements.
(2)    Carrying amount represents the book value of financial instruments, including unamortized premiums/discounts and deferred financing costs.
The Company determined the fair value of financial instruments as of December 31, 2025 whose carrying amounts do not approximate their fair value with valuation methods utilizing the following types of inputs (in thousands):
Fair Value Measurements Using
TotalQuoted Prices in
Active Markets for
Identical Assets
(Level 1)
Significant Other
Observable Inputs
(Level 2)
Significant
Unobservable Inputs
(Level 3)
Financial assets:
Loans receivable$381,035 $— $— $381,035 
Preferred equity investments66,858 — — 66,858 
Financial liabilities:
Senior Notes1,180,495 — 1,180,495 — 
Secured indebtedness34,101 — — 34,101 
Disclosure of the fair value of financial instruments is based on pertinent information available to the Company at the applicable dates and requires a significant amount of judgment. Transaction volume for certain of the Company’s financial instruments remains relatively low, which has made the estimation of fair values difficult. Therefore, both the actual results and the Company’s estimate of fair value at a future date could be materially different.
Items Measured at Fair Value on a Recurring Basis
During the year ended December 31, 2025, the Company recorded the following amounts measured at fair value (in thousands):
Fair Value Measurements Using
TotalQuoted Prices in
Active Markets for
Identical Assets
(Level 1)
Significant Other
Observable Inputs
(Level 2)
Significant
Unobservable Inputs
(Level 3)
Recurring Basis:
Financial assets:
Interest rate swaps$3,378 $— $3,378 $— 
Financial liabilities:
Interest rate swaps1,281 — 1,281 — 
v3.25.4
EQUITY
12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
EQUITY EQUITY
Common Stock
On February 23, 2023, the Company established an at-the-market equity offering program (the “Prior ATM Program”) pursuant to which shares of its common stock having an aggregate gross sales price of up to $500.0 million may be sold from time to time (i) by the Company through a consortium of banks acting as sales agents or directly to the banks acting as
principals or (ii) by a consortium of banks acting as forward sellers on behalf of any forward purchasers pursuant to a forward sale agreement. On August 5, 2025, the Company terminated the Prior ATM Program pursuant to its termination rights.
During the year ended December 31, 2025, the Company utilized the forward feature of the Prior ATM Program to allow for the sale of up to 15.3 million shares of the Company’s common stock at an initial weighted average price of $17.69 per share, net of commissions, and the Company issued 13.6 million shares in settlement of certain outstanding forward sale agreements, at a weighted average net price of $17.26 per share, after commissions and fees, resulting in net proceeds of $234.8 million.
As of December 31, 2025, 3.2 million shares remained outstanding under the Prior ATM Program’s forward sale agreements, with an initial weighted average price of $18.10 per share, net of commissions.
No other shares were sold under the Prior ATM Program during the year ended December 31, 2025.
On August 5, 2025, the Company established a new at-the-market equity offering program (the “ATM Program”) pursuant to which shares of its common stock having an aggregate gross sales price of up to $750.0 million may be sold from time to time (i) by the Company through a consortium of banks acting as sales agents or directly to the banks acting as principals or (ii) by a consortium of banks acting as forward sellers on behalf of any forward purchasers pursuant to a forward sale agreement. The use of a forward sale agreement would allow the Company to lock in a share price on the sale of shares at the time the agreement is effective, but defer receiving the proceeds from the sale of the shares until a later date. The Company may also elect to cash settle or net share settle all or a portion of its obligations under any forward sale agreement. The forward sale agreements have a one year term during which time the Company may settle the forward sales by delivery of physical shares of common stock to the forward purchasers or, at the Company’s election, in cash or net shares. The forward sale price that the Company expects to receive upon settlement will be the initial forward price established upon the effective date, subject to adjustments for (i) the forward purchasers’ stock borrowing costs and (ii) certain fixed price reductions during the term of the agreement.
During the year ended December 31, 2025, the Company utilized the forward feature of the ATM Program to allow for the sale of up to 14.1 million shares of the Company’s common stock at an initial weighted average price of $18.71 per share, net of commissions, and these shares remained outstanding as of December 31, 2025.
No other shares were sold under the ATM Program during the year ended December 31, 2025.
As of December 31, 2025, the Company had $482.9 million available under the ATM Program.
During the years ended December 31, 2025, 2024 and 2023, the Company issued 0.5 million, 0.3 million and 0.3 million shares, respectively, of common stock as a result of restricted stock unit vestings.
Upon any payment of shares to teammates as a result of restricted stock unit vestings, the teammates’ related tax withholding obligation will generally be satisfied by the Company, reducing the number of shares to be delivered by a number of shares necessary to satisfy the related applicable tax withholding obligation. During the years ended December 31, 2025, 2024 and 2023, the Company incurred $5.5 million, $2.6 million and $1.8 million, respectively, in tax withholding obligations on behalf of its teammates that were satisfied through a reduction in the number of shares delivered to those participants.
Accumulated Other Comprehensive Income
The following is a summary of the Company’s accumulated other comprehensive income (in thousands):
As of December 31,
20252024
Foreign currency translation loss$(1,371)$(4,778)
Unrealized (loss) gain on cash flow hedges(2,200)25,718 
Total accumulated other comprehensive (loss) income$(3,571)$20,940 
v3.25.4
STOCK-BASED COMPENSATION
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION STOCK-BASED COMPENSATION
All stock-based awards are subject to the terms of the 2009 Performance Incentive Plan, which was assumed by the Company effective as of November 15, 2010 in connection with the Company’s separation from Sun and was most recently amended and restated in April 2017. The 2009 Performance Incentive Plan provides for the granting of stock-based compensation, including stock options, time-based stock units, funds from operations-based stock units (“FFO Units”), relative
total stockholder return-based stock units (“TSR Units”) and performance-based restricted stock units to directors, officers and other teammates in connection with their employment with or services provided to the Company.
Restricted Stock Units and Performance-Based Restricted Stock Units
Under the 2009 Performance Incentive Plan, restricted stock units and performance-based restricted stock units generally have a contractual life or vest over a three- to five-year period. The vesting of certain restricted stock units may accelerate, as defined in the grant, upon death, disability, a change in control or involuntary termination of employment in connection with a change in control, and other events. When vested (and subject to any applicable deferral or holdback period), each performance-based restricted stock unit is convertible into one share of common stock, subject to any deferrals in issuance pursuant to the grant. The restricted stock units are valued on the grant date based on the market price of the Company’s common stock on that date. Generally, the Company recognizes the fair value of the awards over the applicable vesting period as compensation expense. In addition, since the shares to be issued may vary based on the performance of the Company, the Company must make assumptions regarding the projected performance criteria and the shares that will ultimately be issued. The amount of FFO Units that will ultimately vest is dependent on the amount by which the Company’s funds from operations as adjusted (“FFO”) differs from a target FFO amount for a period specified in each grant and will range from 0% to 200% of the FFO Units initially granted. Similarly, the amount of TSR Units that will ultimately vest is dependent on the amount by which the total shareholder return (“TSR”) of the Company’s common stock differs from a predefined peer group for a period specified in each grant and will range from 0% to 200% of the TSR Units initially granted. Upon any payment of shares as a result of restricted stock unit vestings, the related tax withholding obligation will generally be satisfied by the Company, reducing the number of shares to be delivered by a number of shares necessary to satisfy the related applicable tax withholding obligation. The value of the shares withheld is dependent on the closing price of the Company’s common stock on the date the relevant transaction occurs.
The following table summarizes additional information concerning restricted stock units at December 31, 2025:
Restricted Stock UnitsWeighted Average Grant Date Fair Value Per Unit
Unvested as of December 31, 20242,574,191 $14.94 
Granted983,708 18.76 
Vested(1,102,085)15.03 
Dividends reinvested221,574 14.71 
Cancelled/forfeited(179,133)12.58 
Unvested as of December 31, 20252,498,255 $16.56 
As of December 31, 2025, the weighted average remaining vesting period of restricted stock units was 2.6 years. The weighted average fair value per share at the date of grant for restricted stock units for the years ended December 31, 2025, 2024 and 2023 was $18.76, $17.49 and $14.73, respectively. The total fair value of units vested during the years ended December 31, 2025, 2024 and 2023 was $16.6 million, $13.2 million and $9.1 million, respectively.
The fair value of the TSR Units is estimated on the date of grant using a Monte Carlo valuation model that uses the assumptions noted in the table below. The risk-free rate is based on the U.S. Treasury yield curve in effect at the grant date for the expected performance period. Expected volatility is based on historical volatility for the most recent 3-year period ending on the grant date for the Company and the selected peer companies, and is calculated on a daily basis. The following are the key assumptions used in this valuation:
202520242023
Risk free interest rate
3.52% - 4.31%
3.98% - 4.31%
3.98% - 4.13%
Expected stock price volatility
23.43% - 28.61%
28.61% - 30.17%
30.17% - 56.11%
Expected service period
3.0 years
3.0 years
3.0 years
Expected dividend yield (assuming full reinvestment)— %— %— %
During the years ended December 31, 2025, 2024 and 2023, the Company recognized $11.4 million, $9.0 million and $7.9 million, respectively, of stock-based compensation expense included in general and administrative expense in the consolidated statements of income. As of December 31, 2025, there was $29.5 million of total unrecognized stock-based compensation expense related to unvested awards, which is expected to be recognized over a weighted average period of 2.6 years.
Employee Benefit Plan
The Company maintains a 401(k) plan that allows for eligible participants to defer compensation, subject to certain limitations imposed by the Internal Revenue Code of 1986, as amended (the “Code”). The Company provides a discretionary matching contribution of up to 4% of each participant’s eligible compensation. During the years ended December 31, 2025, 2024 and 2023, the Company’s matching contributions were $0.4 million, $0.4 million and $0.3 million, respectively.
v3.25.4
INCOME TAXES
12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
INCOME TAXES INCOME TAXES
The Company elected to be treated as a REIT with the filing of its U.S. federal income tax return for the taxable year beginning January 1, 2011. To qualify as a REIT, the Company must meet a number of organizational and operational requirements, including a requirement to distribute at least 90% of its taxable ordinary income. In addition, the Company is required to meet certain asset and income tests. As a REIT, the Company generally will not be subject to corporate level federal income tax on taxable income that it distributes to its stockholders. The Company also elected to treat certain of its consolidated subsidiaries as taxable REIT subsidiaries, which are subject to federal, state and foreign income taxes. In addition, as a result of our investments in Canada, the Company is subject to income taxes under the laws of Canada.
The following is a summary of the Company’s provision for income taxes and deferred taxes (in thousands):
Year Ended December 31,
202520242023
Provision for federal, state and local income taxes$1,726 $1,006 $2,002 
Provision for (recovery of) foreign income taxes111 (1)— 
Income tax expense$1,837 $1,005 $2,002 
As of December 31,
20252024
Deferred tax assets:
Federal$12,489 $10,597 
Valuation allowance on federal(12,489)(10,597)
Foreign3,730 4,944 
Valuation allowance on foreign(3,730)(4,944)
$— $— 
The Company classifies interest and penalties from significant uncertain tax positions as interest expense and operating expenses, respectively, in its consolidated financial statements. During the years ended December 31, 2025, 2024 and 2023, the Company did not incur any such interest or penalties. With certain exceptions, the tax years 2022 and thereafter remain open to examination by the major taxing jurisdictions with which the Company files tax returns.
v3.25.4
EARNINGS PER COMMON SHARE
12 Months Ended
Dec. 31, 2025
Earnings Per Share [Abstract]  
EARNINGS PER COMMON SHARE EARNINGS PER COMMON SHARE
The following table illustrates the computation of basic and diluted earnings per share (in thousands, except share and per share amounts):
Year Ended December 31,
202520242023
Numerator
Net income attributable to Sabra Health Care REIT, Inc.$155,609 $126,712 $13,756 
Denominator
Basic weighted average common shares and common equivalents241,312,309 233,498,736 231,203,391 
Dilutive restricted stock units2,871,902 2,446,335 1,589,387 
Dilutive forward equity sale agreements313,031 100,791 — 
Diluted weighted average common shares244,497,242 236,045,862 232,792,778 
Net income attributable to Sabra Health Care REIT, Inc., per:
Basic common share$0.64 $0.54 $0.06 
Diluted common share$0.64 $0.54 $0.06 
During the years ended December 31, 2025, 2024 and 2023, approximately 700, 1,300 and 500 restricted stock units, respectively, and during the years ended December 31, 2025 and 2024, approximately 19,400 and 8,900 shares, respectively, related to forward equity sale agreements were excluded from computing diluted earnings per share because they were considered anti-dilutive.
v3.25.4
COMMITMENTS AND CONTINGENCIES
12 Months Ended
Dec. 31, 2025
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIES
Environmental
As an owner of real estate, the Company is subject to various environmental laws of federal, state and local governments. The Company is not aware of any environmental liability that could have a material adverse effect on its financial condition or results of operations. However, changes in applicable environmental laws and regulations, the uses and conditions of properties in the vicinity of the Company’s properties, the activities of its tenants and other environmental conditions of which the Company is unaware with respect to the properties could result in future environmental liabilities. As of December 31, 2025, the Company does not expect that compliance with existing environmental laws will have a material adverse effect on the Company’s financial condition and results of operations.
Legal Matters
From time to time, the Company and its subsidiaries are party to legal proceedings that arise in the ordinary course of its business. Management is not aware of any legal proceedings where the likelihood of a loss contingency is reasonably possible and the amount or range of reasonably possible losses is material to the Company’s results of operations, financial condition or cash flows.
v3.25.4
SUBSEQUENT EVENTS
12 Months Ended
Dec. 31, 2025
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS SUBSEQUENT EVENTS
The Company evaluates subsequent events up until the date the consolidated financial statements are issued.
Dividend Declaration
On February 2, 2026, the Company’s board of directors declared a quarterly cash dividend of $0.30 per share of common stock. The dividend will be paid on February 27, 2026 to common stockholders of record as of the close of business on February 13, 2026.
v3.25.4
SCHEDULE III - REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION
12 Months Ended
Dec. 31, 2025
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation Disclosure [Abstract]  
SCHEDULE III - REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION
SCHEDULE III
REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION
As of December 31, 2025
(dollars in thousands)
Initial Cost to CompanyCost Capitalized Subsequent to AcquisitionGross Amount at which Carried at Close of Period
 Description
Encum- brances(1)
Land 
Building and Improve-
ments(2)(3)
Land 
Building and Improve-
ments(2)(3)
Total 
Accumulated Depreciation and Amortization(4)
Original Date of Construction/ Renovation 
Date Acquired
Skilled Nursing/Transitional Care Facilities        
Bedford, NH$4,588 $1,911 $12,245 $— $1,911 $10,021 $11,932 $(5,376)1992/2010, 201911/15/10
Milford, NH— 312 1,679 — 312 1,100 1,412 (1,032)1890/200511/15/10
North Conway, NH9,626 417 5,352 — 417 4,372 4,789 (2,210)1988/200911/15/10
Wolfeboro, NH8,109 454 4,531 — 454 3,745 4,199 (1,849)1984/1986, 1987, 200911/15/10
Middletown, DE— 1,650 21,730 — 1,650 21,730 23,380 (8,652)200508/01/11
Dover, DE— 4,940 15,500 — 4,940 15,500 20,440 (6,502)1996/201608/01/11
Wilmington, DE— 2,460 25,240 12,436 2,460 37,676 40,136 (12,873)2009/202208/01/11
Millsboro, DE— 1,640 22,620 — 1,632 22,620 24,252 (9,225)200808/01/11
Warrington, PA— 2,617 11,662 845 2,617 738 3,355 — 1958/2009/ 201603/30/12
Duffield, VA— 509 5,018 1,333 509 5,964 6,473 (2,887)1981/201305/10/12
Arlington, TX— 3,783 14,219 — 3,783 13,702 17,485 (4,670)2003/201211/30/12
Rockport, TX— 1,005 6,628 — 1,005 6,212 7,217 (2,153)2002/2012, 201811/30/12
Lincoln, NE— 6,368 29,919 696 6,368 29,801 36,169 (9,067)1962/1996, 201302/14/14
Fremont, NE— 615 16,176 614 615 15,643 16,258 (4,607)200802/14/14
Fremont, NE— 615 2,943 60 615 2,654 3,269 (870)1970/1979, 1983, 199402/14/14
Bartlesville, OK— 1,332 6,904 986 1,332 7,470 8,802 (2,327)1989/201910/29/14
Oklahoma City, OK— 2,189 23,567 2,534 2,189 25,033 27,222 (7,536)1963/1984, 2018, 201910/29/14
Norman, OK— 869 5,236 785 869 5,520 6,389 (1,791)2001/2013, 201910/29/14
Minneapolis, MN— 2,931 6,943 1,190 2,931 7,968 10,899 (2,406)1941/2014, 201908/17/17
Eugene, OR— 2,205 28,700 2,252 2,205 30,952 33,157 (7,741)1988/201608/17/17
Lebanon, OR— 958 14,176 — 958 14,176 15,134 (3,193)197408/17/17
Portland, OR— 1,791 12,833 2,761 1,791 15,594 17,385 (4,561)1964/201608/17/17
Tigard, OR— 2,011 11,667 — 2,011 11,667 13,678 (2,716)197508/17/17
Hillsboro, OR— 1,387 14,028 — 1,387 14,028 15,415 (3,157)197308/17/17
Junction City, OR— 584 7,901 — 584 7,901 8,485 (1,846)1966/201508/17/17
Eugene, OR— 1,380 14,921 1,791 1,380 16,712 18,092 (4,502)1966/201608/17/17
Coos Bay, OR— 829 8,518 — 829 8,518 9,347 (2,065)196808/17/17
Gladstone, OR— 792 5,000 — 792 5,000 5,792 (1,193)196108/17/17
Newport, OR— 406 5,001 — 406 5,001 5,407 (1,140)1973/201408/17/17
Initial Cost to CompanyCost Capitalized Subsequent to AcquisitionGross Amount at which Carried at Close of Period
 Description
Encum- brances(1)
Land 
Building and Improve-
ments(2)(3)
Cost Capitalized Subsequent to Acquisition
Land 
Building and Improve-
ments(2)(3)
Total 
Accumulated Depreciation and Amortization(4)
Original Date of Construction/ Renovation 
Date Acquired
Oregon City, OR— 1,496 12,142 — 1,496 12,142 13,638 (2,732)197408/17/17
Tacoma, WA— 1,771 11,595 15 1,771 11,610 13,381 (3,044)201708/17/17
Shoreline, WA— 4,703 14,444 — 4,703 14,444 19,147 (3,367)1993/201408/17/17
Sequim, WA— 427 4,450 — 427 4,450 4,877 (1,256)197408/17/17
Tacoma, WA— 2,195 1,956 — 2,195 1,956 4,151 (637)1972/201408/17/17
Vancouver, WA— 1,782 15,116 — 1,782 15,116 16,898 (3,682)199108/17/17
Lake Oswego, OR— 5,947 13,401 — 5,947 13,401 19,348 (3,151)2005/201608/17/17
Medford, OR— 2,043 38,485 2,960 2,043 41,445 43,488 (10,227)1974/201608/17/17
Seattle, WA— 2,508 6,401 — 2,508 6,401 8,909 (1,524)197008/17/17
Boise, ID— 681 9,348 627 681 9,975 10,656 (2,392)197908/17/17
Salem, OR— 2,114 15,651 — 2,114 15,651 17,765 (3,629)198108/17/17
Medford, OR— 1,375 23,808 — 1,375 23,808 25,183 (5,568)1961/201608/17/17
Northglenn, CO— 1,662 26,014 3,258 1,662 29,272 30,934 (7,784)1972/201608/17/17
Brighton, CO— 1,933 11,624 200 1,933 11,824 13,757 (2,861)197108/17/17
Santa Ana, CA— 1,889 11,682 — 1,889 11,682 13,571 (2,562)200808/17/17
La Mesa, CA— 1,276 8,177 — 1,276 8,177 9,453 (1,864)201208/17/17
Westminster, MD— 2,128 6,614 487 2,128 6,977 9,105 (2,134)1973/2010, 201908/17/17
Kansas City, MO— 1,985 2,714 303 1,714 — 1,714 — 198308/17/17
Parkersburg, WV— 697 10,688 285 697 10,911 11,608 (3,206)1974/1999, 201908/17/17
Cincinnati, OH— 2,686 10,062 700 2,686 10,762 13,448 (2,738)1989/2015, 202308/17/17
Charlottesville, VA— 2,840 8,450 1,176 2,840 9,147 11,987 (2,685)1964/2009, 201908/17/17
Annandale, VA— 7,241 17,727 3,218 7,241 20,150 27,391 (5,432)1963/2013, 201908/17/17
Petersburg, VA— 988 8,416 146 988 8,473 9,461 (2,196)1970/200908/17/17
Petersburg, VA— 1,174 8,858 151 1,174 8,942 10,116 (2,303)1976/201008/17/17
Hagerstown, MD— 1,393 13,438 150 1,393 13,477 14,870 (3,290)1971/201008/17/17
Cumberland, MD— 800 16,973 457 800 17,300 18,100 (4,261)196808/17/17
Mount Pleasant, SC— 2,689 3,942 205 2,689 4,147 6,836 (1,117)1977/201508/17/17
Harrogate, TN— 1,811 4,963 268 1,811 5,232 7,043 (1,386)1990/200508/17/17
Conway, SC— 1,408 10,784 551 1,408 11,335 12,743 (2,764)197508/17/17
Baytown, TX— 426 3,236 173 426 3,251 3,677 (896)1975/201908/17/17
Huntsville, TX— 302 3,153 75 302 3,168 3,470 (847)1968/201908/17/17
Center, TX— 231 1,335 312 231 1,477 1,708 (523)1972/201908/17/17
Humble, TX— 2,114 1,643 596 2,114 1,953 4,067 (753)1972/201908/17/17
Houston, TX— 1,019 5,734 318 1,019 5,807 6,826 (1,479)1982/201908/17/17
Linden, TX— 112 256 133 112 280 392 (128)1968/201908/17/17
Initial Cost to CompanyCost Capitalized Subsequent to AcquisitionGross Amount at which Carried at Close of Period
 Description
Encum- brances(1)
Land 
Building and Improve-
ments(2)(3)
Cost Capitalized Subsequent to Acquisition
Land 
Building and Improve-
ments(2)(3)
Total 
Accumulated Depreciation and Amortization(4)
Original Date of Construction/ Renovation 
Date Acquired
Sherman, TX— 469 6,310 255 469 6,338 6,807 (1,563)1971/201908/17/17
Mount Pleasant, TX— 250 6,913 345 250 7,160 7,410 (1,809)1970/201908/17/17
Waxahachie, TX— 416 7,259 976 416 7,968 8,384 (2,067)1976/201908/17/17
Gilmer, TX— 707 4,552 93 707 4,562 5,269 (1,198)1990/201908/17/17
Sparks, NV— 1,986 9,004 — 1,986 9,004 10,990 (2,255)198808/17/17
Richmond, IN— 259 9,819 131 259 9,819 10,078 (2,339)1975/200508/17/17
Petersburg, IN— 581 5,367 23 581 5,366 5,947 (1,369)1970/200908/17/17
Maryville, MO— 114 5,955 — 150 5,955 6,105 (1,562)197208/17/17
Doniphan, MO— 657 8,251 — 657 8,251 8,908 (2,041)199108/17/17
Dixon, MO— 521 3,358 — 75 360 435 (4)1989/201108/17/17
Forsyth, MO— 594 8,549 — 594 8,549 9,143 (2,146)1993/200708/17/17
Seymour, MO— 658 901 — 658 901 1,559 (316)199008/17/17
Silex, MO— 807 4,990 — 88 412 500 (8)199108/17/17
Columbia, MO— 2,322 6,547 — 2,322 6,547 8,869 (1,694)199408/17/17
Strafford, MO— 1,634 6,518 — 1,634 6,518 8,152 (1,648)199508/17/17
Windsor, MO— 471 6,819 — 471 6,819 7,290 (1,564)199608/17/17
Conroe, TX— 1,222 19,099 — 1,222 19,099 20,321 (4,278)200108/17/17
Houston, TX— 1,334 11,615 — 1,334 11,615 12,949 (2,711)2003/201308/17/17
Humble, TX— 1,541 12,332 645 1,541 12,806 14,347 (3,254)2003/201908/17/17
Missouri City, TX— 1,825 9,681 — 1,825 9,681 11,506 (2,347)200508/17/17
Houston, TX— 2,676 7,396 — 2,676 7,396 10,072 (1,835)200508/17/17
Houston, TX— 1,732 12,921 — 1,732 12,921 14,653 (2,992)199908/17/17
Topeka, KS— 176 2,340 — 176 2,340 2,516 (624)1973/201308/17/17
Salina, KS— 301 4,201 — 301 4,201 4,502 (1,071)198108/17/17
Terre Haute, IN— 1,067 7,061 — 1,067 7,061 8,128 (1,692)1965/198408/17/17
Gas City, IN— 345 8,852 — 345 8,852 9,197 (2,021)1974/202208/17/17
Winchester, IN— 711 5,554 — 711 5,554 6,265 (1,337)1986/1998, 202108/17/17
Columbus, IN— 1,290 10,714 — 1,290 10,714 12,004 (2,458)1988/2004, 202208/17/17
Portland, IN— 315 9,848 — 315 9,848 10,163 (2,293)1964/202208/17/17
Clinton, IN— 884 9,839 — 884 9,839 10,723 (2,406)1971/202108/17/17
Las Vegas, NV— 509 18,216 — 509 18,216 18,725 (3,995)196408/17/17
Las Vegas, NV— 3,169 7,863 — 3,169 7,863 11,032 (1,943)1972/199708/17/17
Alameda, CA— 3,078 22,328 — 3,078 22,328 25,406 (5,008)1967/202108/17/17
Dover, NH— 522 5,839 — 522 5,839 6,361 (1,822)1969/1992, 201708/17/17
Augusta, ME— 135 6,470 — 135 6,470 6,605 (1,587)196708/17/17
Bangor, ME— 302 1,811 2,211 302 3,771 4,073 (1,244)1967/1993, 201908/17/17
Initial Cost to CompanyCost Capitalized Subsequent to AcquisitionGross Amount at which Carried at Close of Period
 Description
Encum- brances(1)
Land 
Building and Improve-
ments(2)(3)
Cost Capitalized Subsequent to Acquisition
Land 
Building and Improve-
ments(2)(3)
Total 
Accumulated Depreciation and Amortization(4)
Original Date of Construction/ Renovation 
Date Acquired
Bath, ME— 250 1,934 — 250 1,934 2,184 (529)197408/17/17
Brewer, ME— 177 14,497 2,520 177 16,584 16,761 (4,192)1974/1990, 201908/17/17
Kennebunk, ME— 198 6,822 2,005 198 8,827 9,025 (2,370)1977/202208/17/17
Norway, ME— 791 3,680 — 791 3,680 4,471 (960)197608/17/17
Yarmouth, ME— 134 2,072 — 134 2,072 2,206 (581)195208/17/17
Marlborough, MA— 942 1,541 8,727 942 9,707 10,649 (4,199)1973/201808/17/17
Bangor, ME— 229 7,171 511 229 7,625 7,854 (1,897)1969/1993, 202208/17/17
Orange, CA— 4,163 14,755 — 4,163 14,755 18,918 (3,474)1987/202008/17/17
Lancaster, TX— 548 5,794 — 548 5,794 6,342 (1,500)200808/17/17
Garland, TX— 1,118 7,490 — 1,118 7,490 8,608 (1,847)200808/17/17
Clarksville, TX— 279 4,269 100 279 4,310 4,589 (1,210)1989/201908/17/17
McKinney, TX— 1,272 6,047 — 1,272 6,047 7,319 (1,601)200608/17/17
Hendersonville, NC— 1,611 3,503 1,100 1,611 4,603 6,214 (1,065)1979/202408/17/17
Baytown, TX— 579 22,317 103 579 22,403 22,982 (5,074)2000/201308/17/17
Baytown, TX— 589 20,475 362 589 20,636 21,225 (4,848)200808/17/17
Houston, TX— 1,300 13,353 31 1,300 13,372 14,672 (3,245)200608/17/17
Pasadena, TX— 1,148 23,579 47 1,148 23,595 24,743 (5,420)200408/17/17
Webster, TX— 904 10,315 24 904 10,326 11,230 (2,565)2000/200908/17/17
Beaumont, TX— 945 20,424 272 945 20,607 21,552 (4,703)200908/17/17
Orange, TX— 711 10,737 186 711 10,859 11,570 (2,594)200608/17/17
Terre Haute, IN— 644 37,451 59 644 37,511 38,155 (9,310)1996/201308/17/17
Savannah, GA— 1,235 3,765 18 1,235 3,783 5,018 (1,197)1970/201508/17/17
Bowling Green, KY— 280 13,975 32 280 14,007 14,287 (3,422)1970/201508/17/17
Calvert City, KY— 1,176 7,012 25 1,176 7,037 8,213 (1,827)1962/201508/17/17
Winchester, KY— 554 13,207 43 554 13,250 13,804 (3,306)1967/201508/17/17
Calhoun, KY— 613 7,643 30 613 7,673 8,286 (2,045)1963/201508/17/17
Bremen, IN— 173 7,393 38 173 7,431 7,604 (1,813)1982/201508/17/17
Muncie, IN— 374 27,429 38 374 27,467 27,841 (6,203)1980/201308/17/17
Lebanon, IN— 612 11,755 39 612 11,794 12,406 (2,823)1977/201208/17/17
Marietta, GA— 364 16,116 20 364 16,137 16,501 (3,956)1969/201508/17/17
Danville, KY— 790 9,356 32 790 9,388 10,178 (2,699)1962/201508/17/17
Owensboro, KY— 1,048 22,587 40 1,048 22,627 23,675 (5,310)1963/201108/17/17
Memphis, TN— 1,633 9,371 21 1,633 9,392 11,025 (2,413)1981/201508/17/17
Norfolk, VA— 705 16,451 33 705 16,485 17,190 (4,376)1969/201508/17/17
Harrodsburg, KY— 1,049 9,851 21 1,049 9,872 10,921 (2,700)1975/201608/17/17
Cookeville, TN— 1,034 15,555 32 1,034 15,586 16,620 (3,743)1979/201608/17/17
Initial Cost to CompanyCost Capitalized Subsequent to AcquisitionGross Amount at which Carried at Close of Period
 Description
Encum- brances(1)
Land 
Building and Improve-
ments(2)(3)
Cost Capitalized Subsequent to Acquisition
Land 
Building and Improve-
ments(2)(3)
Total 
Accumulated Depreciation and Amortization(4)
Original Date of Construction/ Renovation 
Date Acquired
Roanoke Rapids, NC— 373 10,308 25 373 10,334 10,707 (2,728)1967/201508/17/17
Kinston, NC— 954 7,987 73 954 8,059 9,013 (2,389)1960/201508/17/17
Chapel Hill, NC— 809 2,703 1,191 809 3,893 4,702 (1,364)1984/201508/17/17
Pine Knot, KY— 208 7,665 23 208 7,689 7,897 (1,907)199008/17/17
Bardstown, KY— 634 4,094 16 634 4,110 4,744 (1,191)1968/201008/17/17
Glasgow, KY— 83 2,057 28 83 2,086 2,169 (730)196808/17/17
Carrollton, KY— 124 1,693 21 124 1,714 1,838 (630)1978/201608/17/17
Horse Cave, KY— 208 7,070 38 208 7,108 7,316 (1,927)199308/17/17
Lawrenceburg, KY— 635 9,861 17 635 9,879 10,514 (2,485)197308/17/17
Annville, KY— 479 6,078 17 479 6,095 6,574 (1,502)198908/17/17
Louisville, KY— 3,528 4,653 24 3,528 4,677 8,205 (1,444)1982/201208/17/17
Louisville, KY— 2,207 20,733 38 2,207 20,770 22,977 (4,830)1991/201008/17/17
Tompkinsville, KY— 333 9,556 26 333 9,582 9,915 (2,384)196908/17/17
Radcliff, KY— 1,815 7,470 34 1,815 7,504 9,319 (2,364)198608/17/17
Hartford, KY— 312 8,189 21 312 8,210 8,522 (2,087)196708/17/17
Louisville, KY— 427 6,003 38 427 6,041 6,468 (1,632)1975/200508/17/17
Louisville, KY— 1,134 9,166 28 1,134 9,194 10,328 (2,554)1979/201308/17/17
Lexington, KY— 2,558 4,311 2,101 2,558 6,412 8,970 (1,321)198908/17/17
Columbia, KY— 114 11,141 28 114 11,169 11,283 (2,719)196508/17/17
Savannah, GA— 2,194 11,711 — 2,194 11,711 13,905 (2,737)197208/17/17
Durham, NC— 470 9,633 — 470 9,633 10,103 (2,230)1968/200608/17/17
Raleigh, NC— 1,155 11,749 — 1,155 11,749 12,904 (2,786)197108/17/17
Raleigh, NC— 926 17,649 — 926 17,649 18,575 (4,112)1967/200708/17/17
Wilmington, NC— 611 5,051 — 611 5,051 5,662 (1,336)1966/201308/17/17
Winston-Salem, NC— 879 3,283 — 879 3,283 4,162 (991)196508/17/17
Lincolnton, NC— — 9,967 — — 9,967 9,967 (2,372)197608/17/17
Monroe, NC— 166 5,906 — 166 5,906 6,072 (1,564)1963/200508/17/17
Zebulon, NC— 594 8,559 — 594 8,559 9,153 (1,956)1973/201008/17/17
Rocky Mount, NC— — 18,314 — — 18,314 18,314 (4,109)197508/17/17
DeSoto, TX— 942 6,033 320 942 6,353 7,295 (1,655)198708/17/17
Trinity, TX— 363 3,852 — 363 3,852 4,215 (1,081)1985/201908/17/17
Marshall, TX— 732 4,288 — 683 4,288 4,971 (1,186)200808/17/17
Warren, MI— 2,052 25,539 — 2,052 25,539 27,591 (6,591)1961/200108/17/17
Hamburg, NY— 1,026 54,086 — 1,026 54,086 55,112 (12,202)1983/201408/17/17
East Patchogue, NY— 2,181 30,373 — 2,181 30,373 32,554 (7,208)1988/201108/17/17
Williamsville, NY— 1,122 46,413 — 1,122 46,413 47,535 (10,281)1992/200708/17/17
Initial Cost to CompanyCost Capitalized Subsequent to AcquisitionGross Amount at which Carried at Close of Period
 Description
Encum- brances(1)
Land 
Building and Improve-
ments(2)(3)
Cost Capitalized Subsequent to Acquisition
Land 
Building and Improve-
ments(2)(3)
Total 
Accumulated Depreciation and Amortization(4)
Original Date of Construction/ Renovation 
Date Acquired
Cheektowaga, NY— 1,164 29,905 — 1,164 29,905 31,069 (7,020)1979/200608/17/17
North Tonawanda, NY— 830 29,488 — 830 29,488 30,318 (6,919)1982/200708/17/17
West Seneca, NY— 1,325 26,839 — 1,325 26,839 28,164 (6,181)1974/200808/17/17
Beverly, MA— 2,410 13,588 — 2,410 13,588 15,998 (4,209)1965/201508/17/17
Lancaster, MA— 343 7,733 — 343 7,733 8,076 (1,851)1970/200508/17/17
New London, CT— 505 2,248 550 505 2,798 3,303 (1,000)1967/201608/17/17
Enfield, CT— 437 16,461 231 437 16,692 17,129 (4,083)1968/201508/17/17
Fishkill, NY— 964 30,107 581 964 30,632 31,596 (7,221)199508/17/17
Highland, NY— 4,371 11,473 495 4,371 11,941 16,312 (2,994)199808/17/17
Beacon, NY— — 25,400 507 — 25,885 25,885 (6,358)200208/17/17
Sudbury, MA— 2,017 3,458 421 1,736 2,264 4,000 — 1997/202108/17/17
Long Beach, CA— 2,939 11,782 — 2,939 11,690 14,629 (2,965)1968/201109/19/17
Anaheim, CA— 2,044 14,167 121 2,044 14,288 16,332 (3,489)1968/201109/19/17
Fairfield, CA— 586 23,582 — 586 23,582 24,168 (5,406)1966/200609/19/17
Baldwin Park, CA— 2,270 17,063 262 2,270 17,325 19,595 (4,134)1970/201509/19/17
Grand Terrace, CA— 432 9,382 — 432 9,382 9,814 (2,286)1945/201709/19/17
Pacifica, CA— 1,510 27,397 — 1,510 27,397 28,907 (6,193)197509/19/17
Burien, WA— 823 17,431 204 826 17,636 18,462 (4,170)1965/201409/19/17
Seattle, WA— 4,802 7,927 70 4,802 7,997 12,799 (2,121)1963/201609/19/17
Huntington Beach, CA— 2,312 9,885 — 2,312 9,885 12,197 (2,399)1965/201009/19/17
Chatsworth, CA— 7,841 16,916 — 7,841 16,916 24,757 (4,276)197609/19/17
Woodland, CA— 504 7,369 — 504 7,369 7,873 (1,881)1975/201009/19/17
Danville, CA— 1,491 17,157 — 1,491 17,157 18,648 (4,058)196509/19/17
Van Nuys, CA— 2,456 16,462 — 2,456 16,462 18,918 (3,751)1958/201509/19/17
Lomita, CA— 2,743 14,734 — 2,743 14,734 17,477 (3,648)196909/19/17
Sacramento, CA— 2,846 17,962 — 2,846 17,962 20,808 (4,196)197209/19/17
Issaquah, WA— 10,125 7,771 10,125 7,776 17,901 (2,182)1975/201209/19/17
Long Beach, CA— 3,157 22,067 — 3,157 22,067 25,224 (5,282)1966/201409/19/17
Long Beach, CA— 2,857 5,878 — 2,857 5,878 8,735 (1,518)1952/201309/19/17
Lodi, CA— 812 21,059 — 812 21,059 21,871 (4,691)196509/19/17
Riverside, CA— 1,717 13,806 — 1,717 13,806 15,523 (3,597)196609/19/17
Woodland, CA— 278 16,729 286 278 17,015 17,293 (3,947)1930/200709/19/17
Bee Cave, TX— 2,107 10,413 — 2,107 10,413 12,520 (2,834)201412/15/17
El Monte, CA— 2,058 19,671 — 2,058 19,671 21,729 (4,535)196501/10/18
Shoreline, WA— 8,861 11,478 302 8,788 11,780 20,568 (3,201)1964/201201/19/18
Elizabethtown, KY— 729 — 19,414 729 19,414 20,143 (2,071)202105/27/21
Initial Cost to CompanyCost Capitalized Subsequent to AcquisitionGross Amount at which Carried at Close of Period
 Description
Encum- brances(1)
Land 
Building and Improve-
ments(2)(3)
Cost Capitalized Subsequent to Acquisition
Land 
Building and Improve-
ments(2)(3)
Total 
Accumulated Depreciation and Amortization(4)
Original Date of Construction/ Renovation 
Date Acquired
Crown Point, IN— 1,491 14,665 272 1,491 14,937 16,428 (1,014)2015/202411/01/23
Dyer, IN— 1,859 19,562 500 1,859 20,062 21,921 (1,336)2015/202411/01/23
22,323 298,922 2,451,080 94,563 297,114 2,505,447 2,802,561 (635,685)
Senior Housing - Leased
Exeter, NH1,407 571 7,183 — 571 5,847 6,418 (2,984)198711/15/10
Nashua, NH4,151 — 5,654 — — 4,566 4,566 (2,179)198911/15/10
Keene, NH2,759 304 3,992 — 304 3,241 3,545 (1,773)199511/15/10
Dover, NH1,747 801 10,036 — 801 8,317 9,118 (4,168)1987/2009, 201911/15/10
Green Bay, WI— 256 2,262 1,032 256 1,976 2,232 (894)2004/201111/22/11
Rockport, TX— 789 607 — 789 475 1,264 (216)1996/201811/30/12
Cadillac, MI— 217 3,000 — 217 2,920 3,137 (1,074)2001/2006, 202312/14/12
Greenville, MI— 684 5,832 372 684 5,965 6,649 (2,226)1999/2001, 2012, 2013, 201812/14/12
Manistee, MI— 952 2,578 2,547 952 5,076 6,028 (2,490)2002/201712/14/12
Mason, MI— 198 4,131 43 198 4,074 4,272 (1,564)2009/201212/14/12
Alpena, MI— 546 13,139 28 546 13,028 13,574 (4,443)2006/2008, 201012/14/12
Fremont, NE— 504 17,670 283 504 17,241 17,745 (5,191)1989/200202/14/14
Norfolk, NE— 217 9,906 4,978 217 14,231 14,448 (4,813)1989/1991, 1994, 2018, 201902/14/14
Fort Wayne, IN11,634 2,300 21,115 2,747 2,300 23,091 25,391 (8,611)2011/2016, 201804/30/14
Brandon, FL— 1,283 8,424 1,006 1,283 8,720 10,003 (2,530)1999/201610/01/14
Lecanto, FL— 1,031 5,577 805 1,023 5,681 6,704 (1,892)1997/201610/01/14
Zephyrhills, FL— 1,688 9,098 546 1,688 8,878 10,566 (2,838)2008/2016, 2025 10/01/14
Sun City West, AZ— 930 9,170 248 930 9,418 10,348 (2,779)201207/01/16
Santa Fe, NM— 1,866 19,441 — 2,157 21,736 23,893 (5,883)200609/23/16
Santa Fe, NM— 670 7,743 430 670 8,380 9,050 (1,129)202009/23/16
Franklin, NH— 292 6,889 211 292 7,110 7,402 (2,197)198811/30/16
Brenham, TX— 476 11,912 — 476 11,922 12,398 (3,530)199112/02/16
Keizer, OR— 1,220 31,783 — 1,220 31,783 33,003 (7,152)1970/202108/17/17
Lawrence, KS— 584 4,431 — 584 4,431 5,015 (1,117)1995/201408/17/17
Salina, KS— 584 3,020 — 584 3,020 3,604 (757)1989/201408/17/17
Topeka, KS— 313 5,492 — 313 5,492 5,805 (1,272)1986/201408/17/17
Lafayette, CO— 1,085 19,243 1,883 19,205 21,088 (4,465)201612/15/17
Knoxville, TN— 1,603 9,219 — 1,603 9,219 10,822 (2,270)201708/31/18
Shavano Park, TX— 2,131 11,541 — 2,131 11,541 13,672 (2,598)201508/31/18
Jasper, IN— 657 25,226 — 1,156 32,448 33,604 (3,202)201910/01/21
Initial Cost to CompanyCost Capitalized Subsequent to AcquisitionGross Amount at which Carried at Close of Period
 Description
Encum- brances(1)
Land 
Building and Improve-
ments(2)(3)
Cost Capitalized Subsequent to Acquisition
Land 
Building and Improve-
ments(2)(3)
Total 
Accumulated Depreciation and Amortization(4)
Original Date of Construction/ Renovation 
Date Acquired
Norman, OK— 557 2,663 2,533 557 5,196 5,753 (310)1999/202402/01/23
Florence, KY— 1,193 34,130 150 1,193 34,280 35,473 (1,689)202104/01/24
21,698 26,502 332,107 17,968 28,082 348,508 376,590 (90,236)
Senior Housing - Managed
Frankenmuth, MI— 5,027 20,929 2,246 5,027 25,155 30,182 (7,727)1982/200809/21/12
Gaylord, MI— 2,024 5,467 231 2,024 5,753 7,777 (2,535)200212/14/12
Tawas, MI— 258 3,713 624 258 4,475 4,733 (2,011)2005/202412/14/12
Marshfield, WI— 574 8,733 304 574 8,877 9,451 (3,120)201012/18/12
Woodstock, VA— 597 5,465 437 597 5,831 6,428 (1,965)1996/2015, 202406/28/13
Allen, TX— 2,190 45,767 2,410 2,190 52,256 54,446 (14,228)2004/2010, 202409/25/14
Gainesville, FL— 2,139 44,789 2,267 2,139 48,687 50,826 (14,173)1986/2013, 2015, 2019, 202409/25/14
McKinney, TX— 2,760 44,397 3,021 2,760 49,790 52,550 (13,654)2006/2010, 2019, 202409/25/14
Raleigh, NC— 2,344 37,506 2,010 2,344 43,549 45,893 (12,437)2002/2014, 202209/25/14
San Luis Obispo, CA— 4,992 30,909 1,382 4,992 34,478 39,470 (10,369)1987/2006, 2015, 2021, 202309/25/14
Winston-Salem, NC— 2,995 24,428 1,159 2,995 26,424 29,419 (7,705)2001/202309/25/14
Longview, TX— 805 26,498 1,605 805 27,794 28,599 (7,852)1985/201009/25/14
Kansas City, MO— 1,325 20,510 2,218 1,325 25,598 26,923 (6,849)1983/202409/25/14
Yuma, AZ— 530 21,775 1,141 530 23,205 23,735 (6,511)1996/2014, 202509/25/14
Nashville, TN— 1,996 19,368 2,396 1,996 23,882 25,878 (6,346)1986/2000, 202409/25/14
Branford, CT— 2,403 18,821 1,667 2,403 23,254 25,657 (6,439)1987/202309/25/14
Richmond, VA— 1,080 19,545 1,875 1,080 23,375 24,455 (6,948)1989/2007, 202209/25/14
Auburn, AL— 3,209 17,326 1,277 3,209 19,988 23,197 (5,670)2001/202409/25/14
Menomonee Falls, WI— 1,477 18,778 893 1,477 21,034 22,511 (5,850) 2005/2006, 2007/2011, 2019, 202509/25/14
Glenville, NY— 978 18,257 1,272 978 21,168 22,146 (6,045)2001/2014, 202409/25/14
Eustis, FL— 1,152 17,523 713 1,152 18,568 19,720 (5,451)1984/1988, 201309/25/14
Phoenix, AZ— 2,567 12,029 1,198 2,567 13,091 15,658 (3,925)198609/25/14
Jonesboro, AR— 1,782 11,244 1,195 1,782 12,916 14,698 (3,653)199909/25/14
Ogden, UT— 794 10,873 1,515 794 14,063 14,857 (3,695)1985/2016, 202409/25/14
Olympia, WA— 2,477 23,767 1,743 2,477 27,482 29,959 (7,712)1986/2016, 202410/07/14
Windsor, ON— 1,360 16,855 729 1,334 17,373 18,707 (4,780)199806/11/15
London, ON— 960 19,056 775 940 19,640 20,580 (5,238)1998/2015, 201906/11/15
Kelowna, BC— 2,321 8,308 878 2,275 9,888 12,163 (2,624)1990/2019, 202006/11/15
Waterloo, ON— 1,823 22,135 482 1,786 22,049 23,835 (6,014)2005/201506/11/15
Initial Cost to CompanyCost Capitalized Subsequent to AcquisitionGross Amount at which Carried at Close of Period
 Description
Encum- brances(1)
Land 
Building and Improve-
ments(2)(3)
Cost Capitalized Subsequent to Acquisition
Land 
Building and Improve-
ments(2)(3)
Total 
Accumulated Depreciation and Amortization(4)
Original Date of Construction/ Renovation 
Date Acquired
Sarnia, ON— 1,187 20,346 1,227 1,162 21,037 22,199 (1,890)2000/2019, 202406/11/15
Kamloops, BC— 679 8,024 300 664 8,390 9,054 (2,324)1992/201406/11/15
Vernon, BC— 843 10,724 449 264 11,177 11,441 (3,000)1990/2008, 202106/11/15
Penticton, BC— 763 6,771 436 747 7,681 8,428 (2,108)1990/1991, 2014, 201906/11/15
Calgary, AB— 3,908 20,996 1,436 3,832 21,794 25,626 (5,738)2013/202309/17/15
Lake Stevens, WA— 1,559 9,059 243 1,559 9,351 10,910 (2,508)1998/201209/17/15
Eugene, OR— 1,428 16,138 263 1,428 16,145 17,573 (4,273)1996/1997, 2011, 201909/17/15
Tualatin, OR— 527 14,659 207 527 14,723 15,250 (3,882)1995/1997, 201909/17/15
Salem, OR— 1,074 19,421 587 1,074 19,483 20,557 (5,252)1989/1995, 201809/17/15
Fredericksburg, VA— 1,379 21,209 346 1,379 21,594 22,973 (5,947)201607/14/16
Round Rock, TX— 679 13,642 58 679 13,824 14,503 (3,907)201608/01/16
Henderson, NV— 1,430 21,850 187 1,430 22,156 23,586 (5,688)201612/01/16
Cedar Park, TX— 1,035 13,127 553 1,035 14,513 15,548 (3,425)2017/202406/01/17
Ramsey, MN— 1,182 13,280 326 1,182 14,024 15,206 (3,584)201510/06/17
Marshfield, WI— 500 4,134 143 500 4,439 4,939 (1,264)201410/06/17
Dover, DE— 2,797 23,054 711 2,797 24,797 27,594 (5,648)1999/202501/02/18
Charleston, WV— 419 4,239 1,133 419 4,863 5,282 (1,552)196901/02/18
Williamsport, PA— 296 9,191 1,056 296 9,931 10,227 (2,645)1990/200901/02/18
Reading, PA— 684 12,950 412 684 13,322 14,006 (3,296)200401/02/18
Scott Depot, WV— 230 6,271 857 230 6,786 7,016 (1,894)199601/02/18
Clarks Summit, PA— 406 9,471 1,590 406 10,307 10,713 (2,692)199701/02/18
Wyncote, PA— 1,781 4,911 1,502 1,781 6,715 8,496 (1,811)1909/202401/02/18
Douglassville, PA— 611 19,083 634 611 19,562 20,173 (4,555)200801/02/18
Milford, DE— 1,199 18,786 832 1,199 20,461 21,660 (4,568)1999/202501/02/18
Oak Hill, WV— 609 2,636 1,268 609 3,842 4,451 (1,502)2001/201401/02/18
Lewisburg, WV— 355 5,055 808 355 5,503 5,858 (1,562)199501/02/18
Winnebago, IL— 263 3,743 39 263 3,835 4,098 (952)200701/31/18
Pewaukee, WI— 1,019 3,606 52 1,019 3,663 4,682 (863)201004/16/18
Pewaukee, WI— 661 5,680 41 661 5,858 6,519 (1,259)201504/16/18
Strasburg, VA— 666 5,551 417 666 6,024 6,690 (1,383)2001/202404/30/18
Sarasota, FL— 1,440 22,541 164 1,440 22,778 24,218 (4,789)201805/18/18
Beavercreek, OH— 1,622 24,215 7,823 1,622 32,076 33,698 (8,276)201611/01/18
Richardson, TX— 2,282 10,556 474 2,282 12,296 14,578 (2,593)1999/202011/01/19
Poway, CA— 3,693 14,467 1,144 3,693 16,050 19,743 (3,051)1987/2011, 202111/22/19
McCordsville, IN— 1,587 31,315 352 1,587 31,737 33,324 (5,253)201701/07/20
Initial Cost to CompanyCost Capitalized Subsequent to AcquisitionGross Amount at which Carried at Close of Period
 Description
Encum- brances(1)
Land 
Building and Improve-
ments(2)(3)
Cost Capitalized Subsequent to Acquisition
Land 
Building and Improve-
ments(2)(3)
Total 
Accumulated Depreciation and Amortization(4)
Original Date of Construction/ Renovation 
Date Acquired
New Braunfels, TX— 1,312 23,108 1,095 1,312 25,065 26,377 (4,530)2015/202501/15/20
Louisville, KY— 1,841 21,827 182 1,841 22,037 23,878 (3,574)201501/31/20
Sellersburg, IN— 1,060 28,702 5,973 1,060 34,741 35,801 (5,718)201504/01/20
Augusta, GA— 419 24,958 280 459 29,367 29,826 (4,393)201803/05/21
Anchorage, AK— 1,965 29,533 204 1,965 29,834 31,799 (3,943)201905/01/21
Loveland, OH— 3,691 21,168 179 3,691 21,466 25,157 (2,533)201702/01/22
Indianapolis, IN— 4,950 32,631 203 6,299 42,018 48,317 (4,112)201708/01/22
Saginaw, MI— 1,651 29,283 1,751 1,651 31,199 32,850 (3,305)2013/202308/01/22
Madeira, OH— 2,858 42,670 148 2,858 43,178 46,036 (3,576)201902/01/23
Columbus, IN— 2,781 36,482 197 2,781 36,740 39,521 (1,636)201907/01/24
Cincinnati, OH— 3,089 30,258 75 3,089 30,403 33,492 (1,325)202007/01/24
Fishers, IN— 2,159 20,793 72 2,159 20,945 23,104 (753)201410/01/24
Hattiesburg, MS— 2,160 46,635 71 2,160 46,788 48,948 (780)201506/01/25
Lebanon, OH— 7,435 49,870 36 7,435 49,938 57,373 (734)202107/01/25
Moline, IL— 2,049 34,854 145 2,049 35,009 37,058 (416)201808/08/25
Gainesville, FL— 4,005 14,112 99 4,005 14,252 18,257 (151)199808/28/25
St. Charles, MO— 3,179 25,312 95 3,179 25,412 28,591 (256)201808/28/25
Bethlehem, PA— 6,001 32,964 124 6,001 33,099 39,100 (329)202308/28/25
Jasper, GA— 1,554 18,818 1,399 1,554 20,228 21,782 (188)202209/01/25
Niceville, FL— 4,654 30,677 200 4,654 30,894 35,548 (149)201511/01/25
St. Clair Shores, MI— 7,291 36,675 17 7,291 36,694 43,985 (177)201811/01/25
Sparks, NV— 6,611 27,752 6,611 27,755 34,366 (136)202211/01/25
Decatur, GA— 7,911 15,914 7,911 15,918 23,829 (39)201712/01/25
— 176,358 1,720,468 80,285 176,907 1,853,360 2,030,267 (349,213)
Behavioral Health
Aurora, CO— 2,874 12,829 1,950 2,874 14,563 17,437 (4,869)2009/2018, 202109/20/12
Colorado Springs, CO— 1,210 9,490 2,765 1,210 11,815 13,025 (2,697)2013/201911/16/15
Bluffton, IN— 254 5,105 1,486 254 6,591 6,845 (1,991)1970/2015, 202108/17/17
Morrilton, AR— 508 — 3,024 508 3,024 3,532 (531)1988/2019, 202308/17/17
Glendale, AZ— 1,501 67,046 — 1,501 67,046 68,547 (14,657)1996/201308/17/17
Tempe, AZ— 3,137 50,073 — 3,137 50,073 53,210 (11,191)2001/201608/17/17
Covina, CA— 23,472 71,542 — 23,472 71,542 95,014 (16,247)1974/201108/17/17
Ventura, CA— 8,089 43,645 — 8,089 43,645 51,734 (10,776)1984/201808/17/17
San Diego, CA— 8,403 55,015 7,599 8,403 62,549 70,952 (15,924)1988/201708/17/17
New London, CT— 356 152 3,665 356 3,817 4,173 (1,319)1967/2016, 202108/17/17
Carmel, IN— 963 4,347 — 963 4,347 5,310 (988)1996/201907/24/19
Initial Cost to CompanyCost Capitalized Subsequent to AcquisitionGross Amount at which Carried at Close of Period
 Description
Encum- brances(1)
Land 
Building and Improve-
ments(2)(3)
Cost Capitalized Subsequent to Acquisition
Land 
Building and Improve-
ments(2)(3)
Total 
Accumulated Depreciation and Amortization(4)
Original Date of Construction/ Renovation 
Date Acquired
Louisville, KY— 1,078 8,305 — 1,078 8,305 9,383 (1,686)2002/201808/21/19
Monroeville, PA— 2,034 1,758 18,545 2,034 18,202 20,236 (2,599)1987/202012/18/19
Gulf Breeze, FL— 498 1,480 3,767 498 5,247 5,745 (505)2001/202103/15/21
Greenville, SC— 1,197 9,496 21,550 1,197 31,055 32,252 (2,911)1994/202212/16/21
Raytown, MO— 1,475 6,564 8,379 1,475 14,943 16,418 (1,753)1978/202210/27/22
— 57,049 346,847 72,730 57,049 416,764 473,813 (90,644)
Specialty Hospitals and Other
Sunnyvale, TX— 4,020 57,620 — 4,020 57,620 61,640 (24,973)200905/03/11
Arlington, TX— — 44,217 — — 44,217 44,217 (9,468)2009/201608/17/17
Conroe, TX— 2,935 25,003 — 2,935 25,003 27,938 (6,052)199208/17/17
Houston, TX— 3,001 14,581 — 3,001 14,581 17,582 (3,179)1999/200908/17/17
Spring, TX— 1,319 15,153 — 1,319 15,153 16,472 (3,310)1995/199808/17/17
Orange, CA— 2,060 5,538 200 2,060 5,738 7,798 (1,324)200008/17/17
Maxwell, TX— 902 2,384 902 2,384 3,286 (603)199308/17/17
Maxwell, TX— 901 1,198 — 901 1,198 2,099 (366)1994/200908/17/17
Maxwell, TX— 456 2,632 — 456 2,632 3,088 (628)199208/17/17
San Marcos, TX— 51 359 62 51 359 410 (88)186908/17/17
Seguin, TX— 539 2,627 — 539 2,627 3,166 (797)198908/17/17
Seguin, TX— 228 3,407 79 228 3,486 3,714 (881)1985/199108/17/17
Kingsbury, TX— 104 2,788 27 104 2,814 2,918 (651)1990/201208/17/17
Seguin, TX— 52 805 — 52 805 857 (203)197008/17/17
Florence, KY— 3,866 26,447 — 3,866 26,447 30,313 (5,768)200008/17/17
— 20,434 204,759 369 20,434 205,064 225,498 (58,291)
44,021 579,265 5,055,261 265,915 579,586 5,329,143 5,908,729 (1,224,069)
Corporate Assets— — 136 2,175 — 2,311 2,311 (594)
$44,021 $579,265 $5,055,397 $268,090 $579,586 $5,331,454 $5,911,040 $(1,224,663)
(1)    Encumbrances do not include deferred financing costs, net of $0.7 million as of December 31, 2025.
(2)    Building and improvements include land improvements and furniture and equipment.
(3)    The aggregate cost of real estate for federal income tax purposes was $5.0 billion.
(4)    Building and improvements are depreciated over useful lives up to 40 years.
SCHEDULE III
REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION
(dollars in thousands)

Year Ended December 31,
202520242023
Real estate:
Balance at the beginning of the year$5,615,764 $5,638,347 $5,872,688 
Acquisitions395,247 130,886 86,626 
Improvements39,004 48,810 86,073 
Impairment(10,636)(25,819)(18,853)
Sale of real estate(118,294)(115,066)(379,272)
Foreign currency translation7,172 (12,432)3,394 
Other (1)
(17,217)(48,962)(12,309)
Balance at the end of the year$5,911,040 $5,615,764 $5,638,347 
  
Accumulated depreciation:
Balance at the beginning of the year$(1,102,030)$(1,021,086)$(913,345)
Depreciation expense(167,811)(162,019)(171,278)
Impairment3,314 7,890 4,432 
Sale of real estate26,299 21,286 49,585 
Foreign currency translation(1,652)2,937 (747)
Other (1)
17,217 48,962 10,267 
Balance at the end of the year$(1,224,663)$(1,102,030)$(1,021,086)
(1)    Primarily represents real estate and accumulated depreciation related to fully-depreciated assets and reductions to net real estate due to casualty events.
v3.25.4
SCHEDULE IV - MORTGAGE LOANS ON REAL ESTATE
12 Months Ended
Dec. 31, 2025
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]  
SCHEDULE IV - MORTGAGE LOANS ON REAL ESTATE
SCHEDULE IV
MORTGAGE LOANS ON REAL ESTATE
As of December 31, 2025
(dollars in thousands)

DescriptionContractual Interest RateMaturity DatePeriodic Payment TermsPrior LiensPrincipal Balance
Book Value (1)
Principal Amount of Loans Subject to Delinquent Principal or Interest
Mortgages:
Recovery Centers of America7.5 %2026
(2)
$— $300,000 $300,000 N/A
River Vista10.0 2027
(2)
— 19,000 19,000 N/A
Symphony Chesterton9.5 2029
(2)
— 16,600 16,600 N/A
$— $335,600 $335,600 
(1)    The aggregate cost for federal income tax purposes was $337.8 million as of December 31, 2025.
(2)    Interest is due monthly, and principal is due at the maturity date.



Changes in mortgage loans are summarized as follows:
Year Ended December 31,
202520242023
Balance at the beginning of the year$335,600 $319,000 $319,000 
Additions during period:
New mortgage loans— 16,600 — 
Balance at the end of the year$335,600 $335,600 $319,000 
v3.25.4
Insider Trading Arrangements
3 Months Ended
Dec. 31, 2025
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.25.4
Insider Trading Policies and Procedures
12 Months Ended
Dec. 31, 2025
Insider Trading Policies and Procedures [Line Items]  
Insider Trading Policies and Procedures Adopted true
v3.25.4
Cybersecurity Risk Management and Strategy Disclosure
12 Months Ended
Dec. 31, 2025
Cybersecurity Risk Management, Strategy, and Governance [Line Items]  
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
We recognize the importance of assessing, identifying and managing material risks associated with cybersecurity threats. To assess and identify material risks from cybersecurity threats, our enterprise risk management (“ERM”) program considers cybersecurity threat risks alongside other Company risks as part of our overall risk assessment process. Our cybersecurity
policies, standards, processes and practices are fully integrated into Sabra’s ERM program and are evaluated annually against recognized frameworks established by the National Institute of Standards and Technology, the International Organization for Standardization and other applicable industry standards.
Our approach is focused on preserving the confidentiality, security and availability of our data and systems. We have implemented several cybersecurity processes, technologies and controls to aid in our efforts to assess, identify and manage such risks.
Risk Management and Strategy
Our cybersecurity program includes the following key elements:
Continuous monitoring of our networks, systems and cloud environments for any unusual activity by a dedicated, outsourced IT team utilizing threat detection and response capabilities.
Regular review by senior management of monitoring and logging across predefined metrics to identify suspicious activity.
Employment of technical safeguards including firewalls, managed network switches and access controls.
Implementation of a zero-trust security architecture, including preventative security measures for cloud and network security and end-user protection, incorporating Microsoft Security Framework, Multi-Factor Authentication (MFA), Intrusion Detection System (IDS), Intrusion Prevention System (IPS) and Advanced Threat Protection (ATP) functionality to protect against viruses, malware, ransomware and phishing attempts.
Review of applications from third-party service providers to ensure they meet the criteria of our security policies before implementation, and encryption of data that is transmitted over secured channels and ports from our application programming interfaces.
Education and awareness for Sabra teammates through communication of security and technology policies via the employee handbook, monthly phishing campaigns and mandatory annual training on protecting data, phishing threats, cyber trends and other security measures.
Maintenance of cyber insurance and crime insurance policies for Sabra and requirements for certain of our tenants and operators to carry a specified dollar amount of cyber insurance coverage, including coverage for third parties.
Active monitoring of emerging cybersecurity trends and developments through our network of security partners.
Establishment and maintenance of a comprehensive incident response plan that guides our response to a cybersecurity incident based on established reporting categories and that is tested and evaluated on a periodic basis.
We engage third parties to perform annual internal and external penetration testing. Additionally, our outsourced IT team conducts periodic internal vulnerability assessments. These tests and assessments of our information security control environment and operating effectiveness are performed with the intent of identifying areas for continued focus, improvement and/or compliance. The results are reported to our board of directors, and our cybersecurity policies, standards, processes and practices are adjusted as necessary based on the information provided by these audits, testing and assessments.
To date, cybersecurity incidents have not materially affected and are not reasonably likely to materially affect our Company. However, because cybersecurity incidents are sometimes difficult to detect and can remain disguised for an extended period of time or until a triggering event has occurred, we can give no assurance that we have detected all cybersecurity incidents. We describe how risks from such incidents may affect us, including our business, financial condition and results of operations in “Regulatory Risks” in Part I, Item 1A, “Risk Factors.”
Cybersecurity Risk Management Processes Integrated [Flag] true
Cybersecurity Risk Management Processes Integrated [Text Block]
We recognize the importance of assessing, identifying and managing material risks associated with cybersecurity threats. To assess and identify material risks from cybersecurity threats, our enterprise risk management (“ERM”) program considers cybersecurity threat risks alongside other Company risks as part of our overall risk assessment process. Our cybersecurity
policies, standards, processes and practices are fully integrated into Sabra’s ERM program and are evaluated annually against recognized frameworks established by the National Institute of Standards and Technology, the International Organization for Standardization and other applicable industry standards.
Cybersecurity Risk Management Third Party Engaged [Flag] true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] false
Cybersecurity Risk Board of Directors Oversight [Text Block]
Our board of directors, through direction of the Audit Committee, oversees our ERM process, including the management of risks arising from cybersecurity threats. At least annually, our board of directors receives a report on cybersecurity risks which addresses topics including current and emerging threat risks and our ability to mitigate such risks, recent developments, evolving standards, vulnerability assessments and third-party reviews.
Our cybersecurity risk management and strategy processes, which are discussed in greater detail above, are led by our Chief Executive Officer and Chief Financial Officer in conjunction with our dedicated, outsourced IT team led by our virtual Chief Information Officer who brings over 10 years of experience serving in various roles under information technology and holds a degree in computer science. These members of management are responsible for the operation of our incident response plan and, through ongoing communication with our IT team, are informed about and monitor the prevention, detection, mitigation and remediation of cybersecurity threats and incidents. Prompt and timely information regarding any cybersecurity incident that meets established reporting category designation criteria is reported to the applicable parties as identified in our
incident response plan. As discussed above, these members of management provide a report on cybersecurity risks at least annually, provide quarterly reports to the Audit Committee regarding incidents that have occurred since the prior report and report incidents immediately, when appropriate, to the board of directors.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Our board of directors, through direction of the Audit Committee, oversees our ERM process, including the management of risks arising from cybersecurity threats.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] At least annually, our board of directors receives a report on cybersecurity risks which addresses topics including current and emerging threat risks and our ability to mitigate such risks, recent developments, evolving standards, vulnerability assessments and third-party reviews.
Cybersecurity Risk Role of Management [Text Block]
Our board of directors, through direction of the Audit Committee, oversees our ERM process, including the management of risks arising from cybersecurity threats. At least annually, our board of directors receives a report on cybersecurity risks which addresses topics including current and emerging threat risks and our ability to mitigate such risks, recent developments, evolving standards, vulnerability assessments and third-party reviews.
Our cybersecurity risk management and strategy processes, which are discussed in greater detail above, are led by our Chief Executive Officer and Chief Financial Officer in conjunction with our dedicated, outsourced IT team led by our virtual Chief Information Officer who brings over 10 years of experience serving in various roles under information technology and holds a degree in computer science. These members of management are responsible for the operation of our incident response plan and, through ongoing communication with our IT team, are informed about and monitor the prevention, detection, mitigation and remediation of cybersecurity threats and incidents. Prompt and timely information regarding any cybersecurity incident that meets established reporting category designation criteria is reported to the applicable parties as identified in our
incident response plan. As discussed above, these members of management provide a report on cybersecurity risks at least annually, provide quarterly reports to the Audit Committee regarding incidents that have occurred since the prior report and report incidents immediately, when appropriate, to the board of directors.
Cybersecurity Risk Management Positions or Committees Responsible [Flag] true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]
Our cybersecurity risk management and strategy processes, which are discussed in greater detail above, are led by our Chief Executive Officer and Chief Financial Officer in conjunction with our dedicated, outsourced IT team led by our virtual Chief Information Officer who brings over 10 years of experience serving in various roles under information technology and holds a degree in computer science. These members of management are responsible for the operation of our incident response plan and, through ongoing communication with our IT team, are informed about and monitor the prevention, detection, mitigation and remediation of cybersecurity threats and incidents. Prompt and timely information regarding any cybersecurity incident that meets established reporting category designation criteria is reported to the applicable parties as identified in our
incident response plan. As discussed above, these members of management provide a report on cybersecurity risks at least annually, provide quarterly reports to the Audit Committee regarding incidents that have occurred since the prior report and report incidents immediately, when appropriate, to the board of directors.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block] Our cybersecurity risk management and strategy processes, which are discussed in greater detail above, are led by our Chief Executive Officer and Chief Financial Officer in conjunction with our dedicated, outsourced IT team led by our virtual Chief Information Officer who brings over 10 years of experience serving in various roles under information technology and holds a degree in computer science.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] At least annually, our board of directors receives a report on cybersecurity risks which addresses topics including current and emerging threat risks and our ability to mitigate such risks, recent developments, evolving standards, vulnerability assessments and third-party reviews.
Our cybersecurity risk management and strategy processes, which are discussed in greater detail above, are led by our Chief Executive Officer and Chief Financial Officer in conjunction with our dedicated, outsourced IT team led by our virtual Chief Information Officer who brings over 10 years of experience serving in various roles under information technology and holds a degree in computer science. These members of management are responsible for the operation of our incident response plan and, through ongoing communication with our IT team, are informed about and monitor the prevention, detection, mitigation and remediation of cybersecurity threats and incidents. Prompt and timely information regarding any cybersecurity incident that meets established reporting category designation criteria is reported to the applicable parties as identified in our
incident response plan. As discussed above, these members of management provide a report on cybersecurity risks at least annually, provide quarterly reports to the Audit Committee regarding incidents that have occurred since the prior report and report incidents immediately, when appropriate, to the board of directors.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] true
v3.25.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Principles of Consolidation and Basis of Presentation The accompanying consolidated financial statements include the accounts of Sabra and its wholly owned subsidiaries as of December 31, 2025 and 2024 and for the years ended December 31, 2025, 2024 and 2023. All significant intercompany transactions and balances have been eliminated in consolidation. The consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”).
Variable Interest Entities
GAAP requires the Company to identify entities for which control is achieved through voting rights or other means and to determine which business enterprise is the primary beneficiary of variable interest entities (“VIEs”). A VIE is broadly defined as an entity with one or more of the following characteristics: (a) the total equity investment at risk is insufficient to finance the entity’s activities without additional subordinated financial support; (b) as a group, the holders of the equity investment at risk lack (i) the ability to make decisions about the entity’s activities through voting or similar rights, (ii) the obligation to absorb the expected losses of the entity, or (iii) the right to receive the expected residual returns of the entity; or (c) the equity investors have voting rights that are not proportional to their economic interests, and substantially all of the entity’s activities either involve, or are conducted on behalf of, an investor that has disproportionately few voting rights. If the Company were determined to be the primary beneficiary of the VIE, the Company would consolidate investments in the VIE. The Company may change its original assessment of a VIE due to events such as modifications of contractual arrangements that affect the characteristics or adequacy of the entity’s equity investments at risk and the disposal of all or a portion of an interest held by the primary beneficiary.
The Company identifies the primary beneficiary of a VIE as the enterprise that has both: (i) the power to direct the activities of the VIE that most significantly impact the entity’s economic performance; and (ii) the obligation to absorb losses or the right to receive benefits of the VIE that could be significant to the entity. The Company performs this analysis on an ongoing basis. As of December 31, 2025, the Company determined that it was the primary beneficiary of two VIEs, a joint venture variable interest entity owning three senior housing communities and another joint venture variable interest entity under which the three senior housing communities are operated by a third-party property manager pursuant to property management agreements. The Company has consolidated these entities in the accompanying consolidated financial statements, and aggregate total assets and total liabilities of the two VIEs were $99.2 million and $2.0 million as of December 31, 2025, respectively. Assets of the consolidated VIEs can only be used to settle obligations of such VIEs, and liabilities of the consolidated VIEs represent claims against the specific assets of such VIEs. Except for capital contributions associated with the initial entity formations, the entities have been and are expected to be funded from the ongoing operations of the underlying properties.
As it relates to investments in loans, in addition to the Company’s assessment of VIEs and whether the Company is the primary beneficiary of those VIEs, the Company evaluates the loan terms and other pertinent facts to determine whether the
loan investment should be accounted for as a loan or as a real estate joint venture. If an investment has the characteristics of a real estate joint venture, including if the Company participates in the majority of the borrower’s expected residual profit, the Company would account for the investment as an investment in a real estate joint venture and not as a loan investment. Expected residual profit is defined as the amount of profit, whether called interest or another name, such as an equity kicker, above a reasonable amount of interest and fees expected to be earned by a lender. At December 31, 2025 and 2024, none of the Company’s investments in loans were accounted for as real estate joint ventures.
As it relates to investments in joint ventures, the Company assesses any partners’ rights and their impact on the presumption of control of the partnership by any single partner. The Company also applies this guidance to managing member interests in limited liability companies. The Company reassesses its determination of which entity controls the joint venture if: there is a change to the terms or in the exercisability of the rights of any partners or members, the general partner or managing member increases or decreases its ownership interests, or there is an increase or decrease in the number of outstanding ownership interests. As of December 31, 2025, the Company’s determination of which entity controls its investments in joint ventures has not changed as a result of any reassessment.
Use of Estimates The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.
Real Estate Investments
Real Estate Acquisition Valuation
All assets acquired and liabilities assumed in an acquisition of real estate accounted for as a business combination are measured at their acquisition date fair values. For acquisitions of real estate accounted for as an asset acquisition, the fair value of consideration transferred by the Company (including transaction costs) is allocated to all assets acquired and liabilities assumed on a relative fair value basis. The acquisition value of land, building and improvements are included in real estate investments on the accompanying consolidated balance sheets. The acquisition value of above market lease, tenant origination and absorption costs and tenant relationship intangible assets is included in lease intangible assets, net on the accompanying consolidated balance sheets. The acquisition value of below market lease intangible liabilities is included in lease intangible liabilities, net on the accompanying consolidated balance sheets. Acquisition costs associated with real estate acquisitions deemed asset acquisitions are capitalized, and costs associated with real estate acquisitions deemed business combinations are expensed as incurred. Restructuring costs that do not meet the definition of a liability at the acquisition date are expensed in periods subsequent to the acquisition date.
Estimates of the fair values of the tangible assets, identifiable intangibles and assumed liabilities require the Company to make significant assumptions to estimate market lease rates, property operating expenses, carrying costs during lease-up periods, discount rates, market absorption periods, and the number of years the property will be held for investment. The Company makes its best estimate based on the Company’s evaluation of the specific characteristics of each tenant’s lease. The use of inappropriate assumptions would result in an incorrect valuation of the Company’s acquired tangible assets, identifiable intangibles and assumed liabilities, which would impact the amount of the Company’s net income.
Depreciation and Amortization
Real estate costs related to the acquisition and improvement of properties are capitalized and amortized on a straight-line basis over the lesser of the expected useful life of the asset and the remaining lease term of any property subject to a ground lease. Tenant improvements are capitalized and amortized on a straight-line basis over the lesser of the expected useful life of the asset and the remaining lease term. Depreciation is discontinued when a property is identified as held for sale. Repair and maintenance costs are charged to expense as incurred and significant replacements and betterments are capitalized. Repair and maintenance costs include all costs that do not extend the useful life of the real estate asset. The Company considers the period of future benefit of an asset to determine its appropriate useful life. Depreciation of real estate assets and amortization of tenant origination and absorption costs and tenant relationship lease intangibles are included in depreciation and amortization on the accompanying consolidated statements of income. Amortization of above and below market lease intangibles is included in rental income on the accompanying consolidated statements of income. The Company anticipates the estimated useful lives of its assets by class to be generally as follows: land improvements, 15 to 20 years; buildings and building improvements, five to 40 years; and furniture and equipment, three to 10 years. Intangibles are generally amortized over the remaining noncancellable lease terms, with tenant relationship intangible amortization periods including extension periods.
Impairment of Real Estate Investments
The Company regularly monitors events and changes in circumstances, including investment operating performance and general market conditions, that could indicate that the carrying amounts of its real estate investments may not be recoverable. When indicators of potential impairment suggest that the carrying value of real estate investments may not be recoverable, the Company assesses the recoverability by estimating whether the Company will recover the carrying value of its real estate investments through the undiscounted future cash flows and the eventual disposition of the investment. In some instances, there may be various potential outcomes for an investment and its potential undiscounted future cash flows. In these instances, the undiscounted future cash flows models used to assess recoverability are based on several assumptions and are probability-weighted based on the Company’s best estimates as of the date of evaluation. These assumptions include, among others, market rent, revenue and expense growth rates, absorption period, stabilized occupancy, holding period, market capitalization rates, and estimated market values based on analysis of letters of intent, purchase and sale agreements, and comparable sales and other local and national industry market data. When discounted cash flow is used to determine fair value, a discount rate assumption is also used. The assumptions are generally based on management’s experience in its local real estate markets, and the effects of current market conditions, which are subject to economic and market uncertainties. If, based on this analysis, the Company does not believe that it will be able to recover the carrying value of its real estate investments, the Company would record an impairment loss to the extent that the carrying value exceeds the estimated fair value of its real estate investments. The Company determines estimated fair value based primarily upon (i) estimated sale prices from signed contracts or letters of intent from third-party offers, (ii) discounted cash flow models of the investment over its remaining hold period, (iii) third-party appraisals and (iv) comparable sales and other local and national industry market data.
Real Estate Investments, Inventory
Real Estate Acquisition Valuation
All assets acquired and liabilities assumed in an acquisition of real estate accounted for as a business combination are measured at their acquisition date fair values. For acquisitions of real estate accounted for as an asset acquisition, the fair value of consideration transferred by the Company (including transaction costs) is allocated to all assets acquired and liabilities assumed on a relative fair value basis. The acquisition value of land, building and improvements are included in real estate investments on the accompanying consolidated balance sheets. The acquisition value of above market lease, tenant origination and absorption costs and tenant relationship intangible assets is included in lease intangible assets, net on the accompanying consolidated balance sheets. The acquisition value of below market lease intangible liabilities is included in lease intangible liabilities, net on the accompanying consolidated balance sheets. Acquisition costs associated with real estate acquisitions deemed asset acquisitions are capitalized, and costs associated with real estate acquisitions deemed business combinations are expensed as incurred. Restructuring costs that do not meet the definition of a liability at the acquisition date are expensed in periods subsequent to the acquisition date.
Estimates of the fair values of the tangible assets, identifiable intangibles and assumed liabilities require the Company to make significant assumptions to estimate market lease rates, property operating expenses, carrying costs during lease-up periods, discount rates, market absorption periods, and the number of years the property will be held for investment. The Company makes its best estimate based on the Company’s evaluation of the specific characteristics of each tenant’s lease. The use of inappropriate assumptions would result in an incorrect valuation of the Company’s acquired tangible assets, identifiable intangibles and assumed liabilities, which would impact the amount of the Company’s net income.
Depreciation and Amortization
Real estate costs related to the acquisition and improvement of properties are capitalized and amortized on a straight-line basis over the lesser of the expected useful life of the asset and the remaining lease term of any property subject to a ground lease. Tenant improvements are capitalized and amortized on a straight-line basis over the lesser of the expected useful life of the asset and the remaining lease term. Depreciation is discontinued when a property is identified as held for sale. Repair and maintenance costs are charged to expense as incurred and significant replacements and betterments are capitalized. Repair and maintenance costs include all costs that do not extend the useful life of the real estate asset. The Company considers the period of future benefit of an asset to determine its appropriate useful life. Depreciation of real estate assets and amortization of tenant origination and absorption costs and tenant relationship lease intangibles are included in depreciation and amortization on the accompanying consolidated statements of income. Amortization of above and below market lease intangibles is included in rental income on the accompanying consolidated statements of income. The Company anticipates the estimated useful lives of its assets by class to be generally as follows: land improvements, 15 to 20 years; buildings and building improvements, five to 40 years; and furniture and equipment, three to 10 years. Intangibles are generally amortized over the remaining noncancellable lease terms, with tenant relationship intangible amortization periods including extension periods.
Impairment of Real Estate Investments
The Company regularly monitors events and changes in circumstances, including investment operating performance and general market conditions, that could indicate that the carrying amounts of its real estate investments may not be recoverable. When indicators of potential impairment suggest that the carrying value of real estate investments may not be recoverable, the Company assesses the recoverability by estimating whether the Company will recover the carrying value of its real estate investments through the undiscounted future cash flows and the eventual disposition of the investment. In some instances, there may be various potential outcomes for an investment and its potential undiscounted future cash flows. In these instances, the undiscounted future cash flows models used to assess recoverability are based on several assumptions and are probability-weighted based on the Company’s best estimates as of the date of evaluation. These assumptions include, among others, market rent, revenue and expense growth rates, absorption period, stabilized occupancy, holding period, market capitalization rates, and estimated market values based on analysis of letters of intent, purchase and sale agreements, and comparable sales and other local and national industry market data. When discounted cash flow is used to determine fair value, a discount rate assumption is also used. The assumptions are generally based on management’s experience in its local real estate markets, and the effects of current market conditions, which are subject to economic and market uncertainties. If, based on this analysis, the Company does not believe that it will be able to recover the carrying value of its real estate investments, the Company would record an impairment loss to the extent that the carrying value exceeds the estimated fair value of its real estate investments. The Company determines estimated fair value based primarily upon (i) estimated sale prices from signed contracts or letters of intent from third-party offers, (ii) discounted cash flow models of the investment over its remaining hold period, (iii) third-party appraisals and (iv) comparable sales and other local and national industry market data.
Revenue Recognition
Revenue Recognition
The Company recognizes rental revenue from tenants, including rental abatements, lease incentives and contractual fixed increases attributable to operating leases, on a straight-line basis over the term of the related leases when it is probable that substantially all rents over the life of a lease are collectible. Certain of the Company’s leases provide for contingent rents equal to a percentage of the facility’s revenue in excess of specified base amounts or other thresholds. Such revenue is recognized when actual results reported by the tenant, or estimates of tenant results, exceed the applicable base amount or other threshold.
The Company assesses the collectability of rents on a lease-by-lease basis, and in doing so, considers such things as historical bad debts, tenant creditworthiness, current economic trends, facility operating performance, lease structure, credit enhancements (including guarantees), current developments relevant to a tenant’s business specifically and to its business category generally, and changes in tenants’ payment patterns. The Company’s assessment includes an estimation of a tenant’s ability to fulfill all of its rental obligations over the remaining lease term. In addition, with respect to tenants in bankruptcy, management makes estimates of the expected recovery of pre-petition and post-petition claims in assessing the estimated collectability of the related receivable. If at any time the Company cannot determine that it is probable that substantially all rents over the life of a lease are collectible, rental revenue will be recognized only to the extent of payments received, and all receivables associated with the lease will be written off irrespective of amounts expected to be collectible. Any recoveries of these amounts will be recorded in future periods upon receipt of payment. Write-offs of receivables and any recoveries of previously written-off receivables are recorded as adjustments to rental revenue.
Revenue from resident fees and services is recorded monthly as services are provided and includes resident room and care charges, ancillary services charges and other resident charges. These charges are combined and accounted for as a single lease component.
Casualty Gains and Losses
Income resulting from insurance recoveries of property damage or business interruption losses is recognized when proceeds are received or contingencies related to the insurance recoveries are resolved.
Assets Held for Sale, Dispositions and Discontinued Operations
The Company generally considers real estate to be “held for sale” when the following criteria are met: (i) management commits to a plan to sell the property, (ii) the property is available for sale immediately, (iii) the property is actively being marketed for sale at a price that is reasonable in relation to its current fair value, (iv) the sale of the property within one year is considered probable and (v) significant changes to the plan to sell are not expected. Real estate that is held for sale and its related assets are classified as assets held for sale and are included in accounts receivable, prepaid expenses and other assets, net on the accompanying consolidated balance sheets. Secured indebtedness and other liabilities related to real estate held for sale are classified as liabilities related to assets held for sale and are included in accounts payable and accrued liabilities on the accompanying consolidated balance sheets. Real estate classified as held for sale is no longer depreciated and is reported at the
lower of its carrying value or its estimated fair value less estimated costs to sell. As of December 31, 2025 and 2024, the Company did not have any assets held for sale.
For sales of real estate where the Company has collected the consideration to which it is entitled in exchange for transferring the real estate, the related assets and liabilities are removed from the balance sheet and the resultant gain or loss is recorded in the period in which the transaction closes. Any post-sale involvement is accounted for as separate performance obligations, and when the separate performance obligations are satisfied, the portion of the sales price allocated to each such obligation is recognized.
Additionally, the Company records the operating results related to real estate that has been disposed of or classified as held for sale as discontinued operations for all periods presented if it represents a strategic shift that has or will have a major effect on the Company’s operations and financial results.
Investment in Unconsolidated Joint Ventures and Preferred Equity Investments and Preferred Return
The Company reports investments in unconsolidated entities over whose operating and financial policies it has the ability to exercise significant influence under the equity method of accounting. Under this method of accounting, the Company’s share of the investee’s earnings or losses is included in the Company’s consolidated statements of income. The initial carrying value of the investment is based on the amount paid to purchase the joint venture interest. Differences between the Company’s cost basis and the basis reflected at the joint venture level are generally amortized over the lives of the related assets and liabilities, and such amortization is included in the Company’s share of earnings of the joint venture. In addition, distributions received from unconsolidated entities are classified based on the nature of the activity or activities that generated the distribution.
The Company regularly monitors events and changes in circumstances, including investment operating performance, changes in anticipated holding period and general market conditions, that could indicate that the carrying amounts of its equity method investments may be impaired. An equity method investment's value is impaired when the fair value of the investment is less than its carrying value and the Company determines the decline in value is other-than-temporary. The fair value is estimated based on discounted cash flows models that include all estimated cash inflows and outflows and any estimated debt premiums or discounts. The discounted cash flows are based on several assumptions, including management fee, absorption period, terminal capitalization rates, revenue and expense per bed, revenue and expense growth percentage, replacement reserve per unit, stabilized occupancy, stabilized operating margin, price per bed and discount rates. The assumptions are generally based on management’s experience in its local real estate markets, and the effects of current market conditions, which are subject to economic and market uncertainties. If the Company believes that there is an other-than-temporary decline in the value of an equity method investment, the Company would record an impairment loss to the extent that the carrying value exceeds the estimated fair value of such equity method investment.
Preferred equity investments are accounted for at unreturned capital contributions, plus accrued and unpaid preferred returns. The Company recognizes preferred return income on a monthly basis based on the outstanding investment including any previously accrued and unpaid return. As a preferred member of the preferred equity joint ventures in which the Company participates, the Company is not entitled to share in the joint venture’s earnings or losses. Rather, the Company is entitled to receive a preferred return, which is deferred if the cash flow of the joint venture is insufficient to currently pay the accrued preferred return.
The Company regularly monitors events and changes in circumstances that could indicate that the carrying amounts of its preferred equity investments may not be recoverable or realized. On a quarterly basis, the Company evaluates its preferred equity investments for impairment based on a comparison of the fair value of the investment to its carrying value. The fair value is estimated based on discounted cash flows that include all estimated cash inflows and outflows over a specified holding period. If, based on this analysis, the Company does not believe that it will be able to recover the carrying value of its preferred equity investment, the Company would record an impairment loss to the extent that the carrying value exceeds the estimated fair value of its preferred equity investment.
Noncontrolling Interests
The Company presents the portion of any equity that it does not own in consolidated entities as noncontrolling interests and classifies those interests as a component of total equity, separate from total Sabra Health Care REIT, Inc. stockholders’ equity on the accompanying consolidated balance sheets. For consolidated joint ventures with pro rata distribution allocations, net income or loss and comprehensive income is allocated between the joint venture partners based on their respective stated ownership percentages. The Company includes net income or loss attributable to noncontrolling interests in net income on the accompanying consolidated statements of income and includes comprehensive income or loss attributable to noncontrolling interests in comprehensive income on the accompanying consolidated statements of comprehensive income.
Loans Receivable
Loans Receivable
The Company’s loans receivable are reflected at amortized cost on the accompanying consolidated balance sheets. The amortized cost of a loan receivable is the outstanding unpaid principal balance, net of unamortized discounts, costs and fees directly associated with the origination of the loan.
Loans acquired in connection with a business combination are recorded at their acquisition date fair value. The Company determines the fair value of loans receivable based on estimates of expected discounted cash flows, collateral, credit risk and other factors. The Company does not establish a valuation allowance at the acquisition date, as the amount of estimated future cash flows reflects its judgment regarding their uncertainty. The Company recognizes the difference between the acquisition date fair value and the total expected cash flows as interest income using the effective interest method over the life of the applicable loan. The Company immediately recognizes in income any unamortized balances if the loan is repaid before its contractual maturity.
Interest income on the Company’s loans receivable is recognized on an accrual basis over the life of the investment using the interest method. Direct loan origination costs are amortized over the term of the loan as an adjustment to interest income. When concerns exist as to the ultimate collection of principal or interest due under a loan, the loan is placed on nonaccrual status, and the Company will not recognize interest income until the cash is received, or the loan returns to accrual status. If the Company determines that the collection of interest according to the contractual terms of the loan or through the receipts of assets in satisfaction of contractual amounts due is probable, the Company will resume the accrual of interest. In instances where borrowers are in default under the terms of their loans, the Company may continue recognizing interest income provided that all amounts owed under the contractual terms of the loan, including accrued and unpaid interest, do not exceed the estimated fair value of the collateral, less costs to sell.
On a quarterly basis, the Company evaluates the collectability of its interest income receivable and establishes a reserve for amounts not expected to be collected. The Company’s evaluation includes reviewing credit quality indicators such as payment status, changes affecting the operations of the facilities securing the loans, and national and regional economic factors. The reserve is a valuation allowance that reflects management’s estimate of losses inherent in the interest income receivable balance as of the balance sheet date. The reserve is adjusted through provision for loan losses and other reserves on the Company’s consolidated statements of income and is decreased by charge-offs to specific receivables.
Credit Losses
Credit Losses
On a quarterly basis, the Company evaluates the collectability of its loan portfolio, including the portion of unfunded loan commitments expected to be funded, and establishes an allowance for credit losses. The allowance for credit losses is calculated using the related amortization schedules, payment histories and loan-to-value ratios. The following rates are applied to determine the aggregate expected losses, which is recorded as the allowance for credit losses: (i) a default rate, (ii) a liquidation cost rate and (iii) a distressed property reduction rate. If no loan-to-value ratio is available, a loss severity rate is applied in place of the liquidation cost rate and the distressed property reduction rate. The default rate is based on average charge-off and delinquency rates from the Federal Reserve, and the other rates are based on industry research and historical performance of a similar portfolio of financial assets. The allowance for credit losses is a valuation allowance that reflects management’s estimate of losses inherent in the loan portfolio as of the balance sheet date. The reserve is adjusted through provision for loan losses and other reserves on the Company’s consolidated statements of income and is decreased by charge-offs to specific loans.
Cash and Cash Equivalents
The Company considers all short-term (with an original maturity of three months or less), highly-liquid investments utilized as part of the Company’s cash-management activities to be cash equivalents. Cash equivalents may include cash and short-term investments. Short-term investments are stated at cost, which approximates fair value.
The Company’s cash and cash equivalents balance exceeded federally insurable limits as of December 31, 2025. To date, the Company has experienced no loss or lack of access to cash in its operating accounts. The Company has a corporate banking relationship with Bank of America, N.A. in which it deposits the majority of its cash.
Restricted Cash Restricted cash primarily consists of amounts held by an exchange accommodation titleholder or by secured debt lenders to provide for future real estate tax expenditures, tenant improvements and capital expenditures. Pursuant to the terms of the Company’s leases with certain tenants, the Company has assigned its interests in certain of these restricted cash accounts with secured debt lenders to the tenants, and this amount is included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets.
Stock-Based Compensation
Stock-based compensation expense for stock-based awards granted to Sabra’s employees (teammates) and its non-employee directors is recognized in the consolidated statements of income based on the estimated grant date fair value, as adjusted. Compensation expense for awards with graded vesting schedules is generally recognized ratably over the period from the grant date to the date when the award is no longer contingent on the recipient providing additional services. Compensation expense for awards with performance-based vesting conditions is recognized based on the Company’s estimate of the ultimate value of such award after considering the Company’s expectations of future performance. Forfeitures of stock-based awards are recognized as they occur.
Deferred Financing Costs
Deferred financing costs representing fees paid to third parties are amortized over the terms of the respective financing agreements using the interest method. Deferred financing costs related to secured debt, term loans and senior unsecured notes are recorded as a reduction of the related debt liability, and deferred financing costs related to the revolving credit facility are recorded in accounts receivable, prepaid expenses and other assets, net. Unamortized deferred financing costs are generally expensed when the associated debt is refinanced or repaid before maturity. Costs incurred in seeking financings that do not close are expensed in the period in which it is determined that the financing will not close.
Income Taxes
The Company elected to be treated as a REIT with the filing of its U.S. federal income tax return for the taxable year beginning January 1, 2011. The Company believes that it has been organized and operated, and it intends to continue to operate, in a manner to qualify as a REIT. To qualify as a REIT, the Company must meet certain organizational and operational requirements, including a requirement to distribute at least 90% of the Company’s annual REIT taxable income to stockholders (which is computed without regard to the dividends-paid deduction or net capital gains and which does not necessarily equal net income as calculated in accordance with GAAP). As a REIT, the Company generally will not be subject to federal income tax on income that it distributes as dividends to its stockholders. If the Company fails to qualify as a REIT in any taxable year, it will be subject to U.S. federal income tax on its taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost, unless the Internal Revenue Service grants the Company relief under certain statutory provisions. Such an event could materially and adversely affect the Company’s net income and net cash available for distribution to stockholders. However, the Company believes that it is organized and operates in such a manner as to qualify for treatment as a REIT.
As a result of certain investments, the Company now records income tax expense or benefit with respect to certain of its entities that are taxed as taxable REIT subsidiaries under provisions similar to those applicable to regular corporations and not under the REIT provisions.
The Company accounts for deferred income taxes using the asset and liability method and recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the Company’s financial statements or tax returns. Under this method, the Company determines deferred tax assets and liabilities based on the differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Any increase or decrease in the deferred tax liability that results from a change in circumstances, and that causes a change in the Company’s judgment about expected future tax consequences of events, is included in the tax provision when such changes occur. Deferred income taxes also reflect the impact of operating loss and tax credit carryforwards. A valuation allowance is provided if the Company believes it is more likely than not that all or some portion of the deferred tax asset will not be realized. Any increase or decrease in the valuation allowance that results from a change in circumstances, and that causes a change in the Company’s judgment about the realizability of the related deferred tax asset, is included in the tax provision when such changes occur. 
The Company evaluates its tax positions using a two-step approach: step one (recognition) occurs when the Company concludes that a tax position, based solely on its technical merits, is more likely than not to be sustained upon examination, and step two (measurement) is only addressed if step one has been satisfied (i.e., the position is more likely than not to be sustained). Under step two, the tax benefit is measured as the largest amount of benefit (determined on a cumulative probability basis) that is more likely than not to be realized upon ultimate settlement. The Company will recognize tax penalties relating to unrecognized tax benefits as additional tax expense.
Foreign Currency
Certain of the Company’s subsidiaries’ functional currencies are the local currencies of their respective foreign jurisdictions. The Company translates the results of operations of its foreign subsidiaries into U.S. dollars using average rates of exchange in effect during the period presented, and it translates balance sheet accounts using exchange rates in effect at the end of the period presented. The Company records resulting currency translation adjustments in accumulated other comprehensive loss, a component of stockholders’ equity, on its consolidated balance sheets, and it records foreign currency transaction gains and losses as a component of other income (expense) on its consolidated statements of income.
Derivative Instruments
The Company uses certain types of derivative instruments for the purpose of managing interest rate and currency risk. To qualify for hedge accounting, derivative instruments used for risk management purposes must effectively reduce the risk exposure that they are designed to hedge. In addition, at inception, the Company must make an assessment that the transaction that the Company intends to hedge is probable of occurring, and this assessment must be updated each reporting period.
The Company recognizes all derivative instruments as assets or liabilities on the consolidated balance sheets at their fair value. For derivatives designated and qualified as a hedge, the change in fair value of the effective portion of the derivatives is recognized in accumulated other comprehensive (loss) income. Changes in the fair value of derivative instruments that are not designated in hedging relationships or that do not meet the criteria for hedge accounting would be recognized in earnings. In addition, the Company classifies cash flows from qualifying cash flow hedging relationships in the same category as the cash flows from the hedged items.
The Company formally documents all relationships between hedging instruments and hedged items, as well as its risk-management objectives and strategy for undertaking various hedge transactions. This process includes designating all derivatives that are part of a hedging relationship to specific transactions, as well as recognizing obligations or assets on the consolidated balance sheets. The Company also assesses and documents, both at inception of the hedging relationship and on a quarterly basis thereafter, whether the derivatives are highly effective in offsetting the designated risks associated with the respective hedged items. If it is determined that a derivative ceases to be highly effective as a hedge, or that it is probable the underlying transaction will not occur, the Company would discontinue hedge accounting prospectively and record the appropriate adjustment to earnings based on the then-current fair value of the derivative.
Fair Value Measurements
Under GAAP, the Company is required to measure certain financial instruments at fair value on a recurring basis. In addition, the Company is required to measure other financial instruments and balances at fair value on a non-recurring basis (e.g., carrying value of impaired loans receivable and long-lived assets). Fair value is defined as the price that would be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The GAAP fair value framework uses a three-tiered approach. Fair value measurements are classified and disclosed in one of the following three categories:
Level 1: unadjusted quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities;
Level 2: quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and
Level 3: prices or valuation techniques where little or no market data is available that requires inputs that are both significant to the fair value measurement and unobservable.
When available, the Company utilizes quoted market prices from an independent third-party source to determine fair value and classifies such items as Level 1 or Level 2. In instances where the market for a financial instrument is not active, regardless of the availability of a nonbinding quoted market price, observable inputs might not be relevant and could require the Company to make a significant adjustment to derive a fair value measurement. Additionally, in an inactive market, a market price quoted from an independent third party may rely more on models with inputs based on information available only to that
independent third party. When the Company determines the market for a financial instrument owned by the Company to be illiquid or when market transactions for similar instruments do not appear orderly, the Company may use several valuation sources (including internal valuations, discounted cash flow analysis and quoted market prices) to establish a fair value. If more than one valuation source is used, the Company will assign weights to the various valuation sources. Additionally, when determining the fair value of liabilities in circumstances in which a quoted price in an active market for an identical liability is not available, the Company measures fair value using (i) a valuation technique that uses the quoted price of the identical liability when traded as an asset or quoted prices for similar liabilities or similar liabilities when traded as assets or (ii) another valuation technique that is consistent with the principles of fair value measurement, such as the income approach or the market approach.
Changes in assumptions or estimation methodologies can have a material effect on these estimated fair values. In this regard, the derived fair value estimates cannot be substantiated by comparison to independent markets and, in many cases, may not be realized in an immediate settlement of the instrument.
The Company considers the following factors to be indicators of an inactive market: (i) there are few recent transactions, (ii) price quotations are not based on current information, (iii) price quotations vary substantially either over time or among market makers (for example, some brokered markets), (iv) indexes that previously were highly correlated with the fair values of the asset or liability are demonstrably uncorrelated with recent indications of fair value for that asset or liability, (v) there is a significant increase in implied liquidity risk premiums, yields, or performance indicators (such as delinquency rates or loss severities) for observed transactions or quoted prices when compared with the Company’s estimate of expected cash flows, considering all available market data about credit and other nonperformance risk for the asset or liability, (vi) there is a wide bid-ask spread or significant increase in the bid-ask spread, (vii) there is a significant decline or absence of a market for new issuances (that is, a primary market) for the asset or liability or similar assets or liabilities, and (viii) little information is released publicly (for example, a principal-to-principal market).
The Company considers the following factors to be indicators of non-orderly transactions: (i) there was not adequate exposure to the market for a period before the measurement date to allow for marketing activities that are usual and customary for transactions involving such assets or liabilities under current market conditions, (ii) there was a usual and customary marketing period, but the seller marketed the asset or liability to a single market participant, (iii) the seller is in or near bankruptcy or receivership (that is, distressed), or the seller was required to sell to meet regulatory or legal requirements (that is, forced), and (iv) the transaction price is an outlier when compared with other recent transactions for the same or similar assets or liabilities.
Per Share Data Basic earnings per common share is computed by dividing net income applicable to common stockholders by the weighted average number of shares of common stock and common equivalents outstanding during the period. Diluted earnings per common share is calculated by including the effect of dilutive securities, such as the impact of forward equity sales agreements using the treasury stock method and common shares issuable from certain performance restricted stock units and unvested restricted stock units.
Segment
The Company conducts and manages its business of investing in the healthcare sector as one reportable segment for internal reporting and internal decision-making purposes. The presentation of financial results as one reportable segment is consistent with the manner in which the Company’s Chief Operating Decision Maker (“CODM”), Sabra’s Chief Executive Officer, evaluates performance and makes resource allocation and operating decisions for the Company. The CODM reviews assets as shown on the accompanying consolidated balance sheets and evaluates performance and makes resource allocation and operating decisions based on net income. Expenses that are significant are the same as shown on the accompanying consolidated statements of income.
Recently Issued Accounting Standards Updates
Adopted
In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 is intended to
improve income tax disclosures, primarily through enhanced rate reconciliation disclosures, including specified categories, and enhanced income taxes paid disclosures, including disaggregation by federal, state and foreign jurisdictions. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. The additional disclosures related to ASU 2023-09 do not apply to the Company as the related amounts are immaterial.
Issued but Not Yet Adopted
In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40), and in January 2025, the FASB issued ASU 2025-01 to clarify the effective date (together, herein referred to as “ASU 2024-03”). ASU 2024-03 is intended to improve expense disclosures, primarily through disaggregated disclosures of specified information about certain costs and expenses included in relevant expense captions on the statement of income. ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026 and interim reporting periods within annual reporting periods beginning after December 15, 2027. The Company is currently evaluating the impact this guidance will have on its consolidated financial statements when adopted.
Fair Value of Financial Instruments
The fair value for certain financial instruments is derived using a combination of market quotes, pricing models and other valuation techniques that involve significant management judgment. The price transparency of financial instruments is a key determinant of the degree of judgment involved in determining the fair value of the Company’s financial instruments.
Financial instruments for which actively quoted prices or pricing parameters are available and whose markets contain orderly transactions will generally have a higher degree of price transparency than financial instruments whose markets are inactive or consist of non-orderly trades. The Company evaluates several factors when determining if a market is inactive or when market transactions are not orderly. The carrying values of cash and cash equivalents, restricted cash, accounts payable, accrued liabilities and the Credit Agreement and Term Loan Credit Agreement are reasonable estimates of fair value because of the short-term maturities and/or monthly repricing of these instruments. Fair values for other financial instruments are derived as follows:
Loans receivable: These instruments are presented on the accompanying consolidated balance sheets at their amortized cost and not at fair value. The fair values of the loans receivable were estimated using an internal valuation model that considered the expected cash flows for the loans receivable, as well as the underlying collateral value and other credit enhancements as applicable. The Company utilized discount rates ranging from 5% to 13% with a weighted average rate of 6% in its fair value calculation. As such, the Company classifies these instruments as Level 3.
Preferred equity investments: These instruments are presented on the accompanying consolidated balance sheets at their cost and not at fair value. The fair values of the preferred equity investments were estimated using an internal valuation model that considered the expected future cash flows for the preferred equity investments, the underlying collateral value and other credit enhancements. The Company utilized discount rates ranging from 10% to 15% with a weighted average rate of 11% in its fair value calculation. As such, the Company classifies these instruments as Level 3.
Derivative instruments: The Company’s derivative instruments are presented at fair value on the accompanying consolidated balance sheets. The Company estimates the fair value of derivative instruments using the assistance of a third party using inputs that are observable in the market, which include forward yield curves and other relevant information. Although the Company has determined that the majority of the inputs used to value its derivative financial instruments fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with its derivative financial instruments utilize Level 3 inputs, such as estimates of current credit spreads, to evaluate the likelihood of default by itself and its counterparties. The Company has assessed the significance of the impact of the credit valuation adjustments on the overall valuation of its derivative positions and has determined that the credit valuation adjustments are not significant to the overall valuation of its derivative financial instruments. As a result, the Company has determined that its derivative financial instruments valuations in their entirety are classified in Level 2 of the fair value hierarchy.
Senior Notes: These instruments are presented on the accompanying consolidated balance sheets at their outstanding principal balance, net of unamortized deferred financing costs and premiums/discounts and not at fair value. The fair values of the Senior Notes were determined using third-party market quotes derived from orderly trades. As such, the Company classifies these instruments as Level 2.
Secured indebtedness: These instruments are presented on the accompanying consolidated balance sheets at their outstanding principal balance, net of unamortized deferred financing costs and premiums/discounts and not at fair value. The fair values of the Company’s secured debt were estimated using a discounted cash flow analysis based on management’s estimates of current market interest rates for instruments with similar characteristics, including remaining loan term, loan-to-value ratio, type of collateral and other credit enhancements. The Company utilized a rate of 6% in its fair value calculation. As such, the Company classifies these instruments as Level 3.
v3.25.4
RECENT REAL ESTATE ACQUISITIONS (CONSOLIDATED) (Tables)
12 Months Ended
Dec. 31, 2025
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Schedule of Purchase Price Allocation The consideration was allocated as follows (in thousands):
Year Ended December 31,
20252024
Land$53,350 $9,222 
Building and improvements340,806 121,664 
Tenant origination and absorption costs intangible assets40,274 5,338 
Tenant relationship intangible assets30 206 
Total consideration$434,460 $136,430 
v3.25.4
INVESTMENT IN REAL ESTATE PROPERTIES (Tables)
12 Months Ended
Dec. 31, 2025
Real Estate [Abstract]  
Schedule of Real Estate Properties Held for Investment
The Company’s real estate properties held for investment consisted of the following (dollars in thousands):
As of December 31, 2025  
Property TypeNumber of
Properties
Number of
Beds/Units
Total
Real Estate
at Cost
Accumulated
Depreciation
Total
Real Estate
Investments, Net
Skilled Nursing/Transitional Care210 23,537 $2,802,561 $(635,685)$2,166,876 
Senior Housing - Leased32 2,668 376,590 (90,236)286,354 
Senior Housing - Managed87 8,677 2,030,267 (349,213)1,681,054 
Behavioral Health16 1,138 473,813 (90,644)383,169 
Specialty Hospitals and Other15 392 225,498 (58,291)167,207 
360 36,412 5,908,729 (1,224,069)4,684,660 
Corporate Level2,311 (594)1,717 
$5,911,040 $(1,224,663)$4,686,377 
As of December 31, 2024
Property TypeNumber of
Properties
Number of
Beds/Units
Total
Real Estate
at Cost
Accumulated
Depreciation
Total
Real Estate
Investments, Net
Skilled Nursing/Transitional Care224 25,492 $2,926,349 $(588,107)$2,338,242 
Senior Housing - Leased39 3,319 508,586 (102,111)406,475 
Senior Housing - Managed69 6,680 1,474,267 (278,328)1,195,939 
Behavioral Health17 1,164 478,318 (79,819)398,499 
Specialty Hospitals and Other15 392 225,498 (52,872)172,626 
364 37,047 5,613,018 (1,101,237)4,511,781 
Corporate Level2,746 (793)1,953 
$5,615,764 $(1,102,030)$4,513,734 
As of December 31,
20252024
Building and improvements$5,115,662 $4,853,151 
Furniture and equipment203,721 207,265 
Land improvements12,071 11,813 
Land579,586 543,535 
Total real estate at cost5,911,040 5,615,764 
Accumulated depreciation(1,224,663)(1,102,030)
Total real estate investments, net$4,686,377 $4,513,734 
Schedule of Investment in Joint Ventures
The following is a summary of the Company’s investment in unconsolidated joint ventures (dollars in thousands):
Property Type
Number of
Properties as of
December 31, 2025
Ownership as of
December 31, 2025 (1)
Book Value as of December 31,
20252024
Sienna Joint VentureSenior Housing - Managed12 50 %$110,283 $107,732 
Marlin Spring Joint VentureSenior Housing - Managed85 %7,883 14,071 
$118,166 $121,803 
(1)    These investments are not consolidated because the Company does not control, through voting rights or other means, the joint ventures.
v3.25.4
IMPAIRMENT OF REAL ESTATE AND DISPOSITIONS (Tables)
12 Months Ended
Dec. 31, 2025
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of Dispositions
The following table summarizes the Company’s dispositions for the periods presented (dollars in millions):
Year Ended December 31,
202520242023
Number of facilities151828
Consideration, net of closing costs$88.5 $96.0 $255.6 
Net carrying value92.0 93.9 332.2 
Net (loss) gain on sale$(3.5)$2.1 $(76.6)
v3.25.4
OPERATING LEASES (Tables)
12 Months Ended
Dec. 31, 2025
Leases [Abstract]  
Schedule of Future Minimum Rental Payments from Non-Cancelable Operating Leases
As of December 31, 2025, the future minimum rental payments from the Company’s properties held for investment under non-cancelable operating leases were as follows and may materially differ from actual future rental payments received (in thousands):
2026$355,230 
2027343,478 
2028323,161 
2029273,867 
2030246,425 
Thereafter909,657 
$2,451,818 
Schedule of Future Minimum Lease Payments As of December 31, 2025, the weighted average remaining lease term and discount rate were 12 years and 8%, respectively, and the future minimum lease payments under the operating leases included in the Company’s lease liability were as follows (in thousands):
2026$1,032 
20271,047 
20281,021 
20291,050 
20301,069 
Thereafter6,819 
Undiscounted minimum lease payments included in the lease liability12,038 
Less: imputed interest(4,659)
Present value of lease liability$7,379 
v3.25.4
INTANGIBLE ASSETS AND LIABILITIES (Tables)
12 Months Ended
Dec. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Intangible Assets and Liabilities
The following table summarizes the Company’s intangible assets and liabilities as of December 31, 2025 and 2024 (in thousands):
As of December 31,
20252024
Lease Intangible Assets:
Above market leases$5,606 $5,606 
Tenant origination and absorption costs90,430 40,544 
Tenant relationship14,595 15,914 
Gross lease intangible assets110,631 62,064 
Accumulated amortization(45,310)(34,600)
Lease intangible assets, net$65,321 $27,464 
Lease Intangible Liabilities:
Below market leases$61,537 $64,538 
Accumulated amortization(40,154)(37,691)
Lease intangible liabilities, net$21,383 $26,847 
Schedule of Real Estate Intangible Amortization Income (Expense)
The following is a summary of real estate intangible amortization income (expense) for the years ended December 31, 2025, 2024 and 2023 (in thousands): 
Year Ended December 31,
202520242023
Increase to rental income related to above/below market leases, net$4,880 $4,867 $5,821 
Depreciation and amortization related to tenant origination and absorption costs and tenant relationship(19,085)(7,501)(11,616)
Schedule of Remaining Unamortized Balance for Outstanding Intangible Assets
The remaining unamortized balance for these outstanding intangible assets and liabilities as of December 31, 2025 will be amortized for the years ending December 31 as follows (dollars in thousands):
Lease Intangible
Assets
 Lease Intangible
Liabilities
2026$34,296 $4,564 
202717,521 4,438 
20284,274 4,296 
20291,997 4,190 
20301,767 3,895 
Thereafter5,466 — 
$65,321 $21,383 
  
Weighted-average remaining amortization period3.5 years4.8 years
Schedule of Remaining Unamortized Balance for Outstanding Intangible Liabilities
The remaining unamortized balance for these outstanding intangible assets and liabilities as of December 31, 2025 will be amortized for the years ending December 31 as follows (dollars in thousands):
Lease Intangible
Assets
 Lease Intangible
Liabilities
2026$34,296 $4,564 
202717,521 4,438 
20284,274 4,296 
20291,997 4,190 
20301,767 3,895 
Thereafter5,466 — 
$65,321 $21,383 
  
Weighted-average remaining amortization period3.5 years4.8 years
v3.25.4
LOANS RECEIVABLE AND OTHER INVESTMENTS (Tables)
12 Months Ended
Dec. 31, 2025
Receivables [Abstract]  
Schedule of Loans Receivable and Other Investments
As of December 31, 2025 and 2024, the Company’s loans receivable and other investments consisted of the following (dollars in thousands):
As of December 31, 2025
Investment
Quantity
as of
December 31, 2025
Property Type
Principal Balance as of December 31, 2025 (1)
Book Value
as of
December 31, 2025
Book Value
as of
December 31, 2024
Weighted Average Contractual Interest Rate / Rate of ReturnWeighted Average Annualized Effective Interest Rate / Rate of ReturnMaturity Date
Loans Receivable:
MortgageBehavioral Health /
Skilled Nursing
$335,600 $335,600 $335,600 7.7 %7.7 %11/01/26 - 06/01/29
Other10 Multiple41,649 38,194 51,962 7.4 %6.9 %02/28/26 - 08/31/33
13 377,249 373,794 387,562 7.7 %7.6 %
Allowance for loan losses— (5,047)(6,094)
$377,249 $368,747 $381,468 
Other Investments:
Preferred EquitySkilled Nursing / Senior Housing65,171 65,353 61,116 11.0 %11.0 %N/A
Total17 $442,420 $434,100 $442,584 8.2 %8.1 %
(1)    Principal balance includes amounts funded and accrued but unpaid interest / preferred return and excludes capitalizable fees.
Schedule of Additional Information Regarding the Company's Loans Receivable
Additional information regarding the Company’s loans receivable is as follows (dollars in thousands):
Year Ended December 31,
202520242023
Allowance for loan losses:
Balance at the beginning of the year$6,094 $6,665 $6,611 
(Recovery of) provision for loan losses(1,047)(571)191 
Write-off of uncollectible balances— — (137)
Balance at the end of the year$5,047 $6,094 $6,665 
v3.25.4
DEBT (Tables)
12 Months Ended
Dec. 31, 2025
Debt Disclosure [Abstract]  
Schedule of Debt
The Company’s secured debt consists of the following (dollars in thousands):
Principal Balance as of December 31, (1)
As of December 31, 2025
Weighted Average Interest Rate
Weighted Average Effective Interest Rate (2)
Interest Rate Type
2025
2024
Maturity Date
Fixed Rate$44,021 $46,110 2.86 %3.36 %May 2031 - 
August 2051
(1)    Principal balance does not include deferred financing costs, net of $0.7 million and $0.8 million as of December 31, 2025 and 2024, respectively.
(2)    Weighted average effective interest rate includes private mortgage insurance.
The Company’s senior unsecured notes consist of the following (dollars in thousands):
Principal Balance as of December 31, (1)
TitleMaturity Date
2025
2024
5.125% senior unsecured notes due 2026 (“2026 Notes”)
August 15, 2026$— $500,000 
5.38% senior unsecured notes due 2027 (“2027 Notes”)
May 17, 2027100,000 100,000 
3.90% senior unsecured notes due 2029 (“2029 Notes”)
October 15, 2029350,000 350,000 
3.20% senior unsecured notes due 2031 (“2031 Notes”)
December 1, 2031800,000 800,000 
$1,250,000 $1,750,000 
(1)    Principal balance does not include discount, net of $6.9 million and deferred financing costs, net of $7.4 million as of December 31, 2025 and does not include discount, net of $5.0 million and deferred financing costs, net of $9.0 million as of December 31, 2024. In addition, the weighted average effective interest rate as of December 31, 2025 was 3.66%.
Schedule of Maturities for Outstanding Debt
The following is a schedule of maturities for the Company’s outstanding debt as of December 31, 2025 (in thousands):
Secured
Indebtedness
Revolving
Credit Facility (1)
Term LoansSenior NotesTotal
2026$2,147 $— $— $— $2,147 
20272,206 217,584 — 100,000 319,790 
20282,266 — 539,425 — 541,691 
20292,328 — — 350,000 352,328 
20302,392 — 500,000 — 502,392 
Thereafter32,682 — — 800,000 832,682 
Total Debt44,021 217,584 1,039,425 1,250,000 2,551,030 
Discount, net— — — (6,859)(6,859)
Deferred financing costs, net(746)— (7,114)(7,415)(15,275)
Total Debt, Net$43,275 $217,584 $1,032,311 $1,235,726 $2,528,896 
(1)    Revolving Credit Facility is subject to two six-month extension options.
v3.25.4
DERIVATIVE AND HEDGING INSTRUMENTS (Tables)
12 Months Ended
Dec. 31, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Notional Amount of Derivatives Instruments
The following presents the notional amount of derivative instruments as of the dates indicated (in thousands):  
As of December 31,
20252024
Derivatives designated as cash flow hedges:
Denominated in U.S. Dollars$930,000 $430,000 
Denominated in Canadian Dollars$150,000 $150,000 
Derivatives designated as net investment hedges:
Denominated in Canadian Dollars$— $46,270 
Financial instruments designated as net investment hedges:
Denominated in Canadian Dollars$183,700 $189,600 
Derivatives not designated as net investment hedges:
Denominated in Canadian Dollars$— $10,030 
Schedule of Derivative and Financial Instruments Designated as Hedging Instruments
The following is a summary of the derivative and financial instruments designated as hedging instruments held by the Company at December 31, 2025 and 2024 (dollars in thousands):    
Count as of December 31, 2025
Maturity Dates as of December 31, 2025
Fair Value as of December 31,
TypeDesignation20252024Balance Sheet Location
Assets:
Interest rate swapsCash flow$3,378 $14,085 2028Accounts receivable, prepaid expenses and other assets, net
Cross currency interest rate swapsNet investment— — 6,290 Accounts receivable, prepaid expenses and other assets, net
$3,378 $20,375 
Liabilities:
Interest rate swapsCash flow$1,281 $— 2028 - 2030Accounts payable and accrued liabilities
CAD borrowings under Revolving Credit FacilityNet investment24,584 27,554 2027Revolving credit facility
CAD Term LoanNet investment109,425 104,370 2028Term loans, net
$135,290 $131,924 
Schedule of Effect of Derivatives and Financial Instruments Designated as Hedging Instruments on Income and Equity
The following presents the effect of the Company’s derivative and financial instruments designated as hedging instruments on the consolidated statements of income and the consolidated statements of equity for the years ended December 31, 2025, 2024 and 2023 (in thousands):
(Loss) Gain Recognized in Other Comprehensive (Loss) IncomeGain Reclassified from Accumulated Other Comprehensive (Loss) Income
Into Income
Income Statement Location
For the year ended December 31,
202520242023202520242023
Cash Flow Hedges:
Interest rate products$(4,322)$12,549 $13,116 $6,445 $9,413 $8,332 Interest expense
Net Investment Hedges:
Foreign currency products(1,418)3,075 (664)— — — N/A
CAD borrowings under Revolving Credit Facility(417)(1,916)(3,456)— — — N/A
CAD Term Loan(5,055)8,820 (2,465)— — — N/A
$(11,212)$22,528 $6,531 $6,445 $9,413 $8,332 
Schedule of Gross Presentation, Effects of Offsetting, and a Net Presentation of Derivatives, Assets The table below presents a gross presentation, the effects of offsetting, and a net presentation of the Company’s derivatives as of December 31, 2025 and 2024 (in thousands):
As of December 31, 2025
Gross Amounts of Recognized Assets / LiabilitiesGross Amounts Offset in the Balance SheetNet Amounts of Assets / Liabilities presented in the Balance SheetGross Amounts Not Offset in the Balance Sheet
Financial InstrumentsCash Collateral ReceivedNet Amount
Offsetting Assets:
Derivatives$3,378 $— $3,378 $(212)$— $3,166 
Offsetting Liabilities:
Derivatives$1,281 $— $1,281 $(212)$— $1,069 
As of December 31, 2024
Gross Amounts of Recognized Assets / LiabilitiesGross Amounts Offset in the Balance SheetNet Amounts of Assets / Liabilities presented in the Balance SheetGross Amounts Not Offset in the Balance Sheet
Financial InstrumentsCash Collateral ReceivedNet Amount
Offsetting Assets:
Derivatives$20,375 $— $20,375 $— $— $20,375 
Offsetting Liabilities:
Derivatives$— $— $— $— $— $— 
Schedule of Gross Presentation, Effects of Offsetting, and a Net Presentation of Derivatives, Liabilities The table below presents a gross presentation, the effects of offsetting, and a net presentation of the Company’s derivatives as of December 31, 2025 and 2024 (in thousands):
As of December 31, 2025
Gross Amounts of Recognized Assets / LiabilitiesGross Amounts Offset in the Balance SheetNet Amounts of Assets / Liabilities presented in the Balance SheetGross Amounts Not Offset in the Balance Sheet
Financial InstrumentsCash Collateral ReceivedNet Amount
Offsetting Assets:
Derivatives$3,378 $— $3,378 $(212)$— $3,166 
Offsetting Liabilities:
Derivatives$1,281 $— $1,281 $(212)$— $1,069 
As of December 31, 2024
Gross Amounts of Recognized Assets / LiabilitiesGross Amounts Offset in the Balance SheetNet Amounts of Assets / Liabilities presented in the Balance SheetGross Amounts Not Offset in the Balance Sheet
Financial InstrumentsCash Collateral ReceivedNet Amount
Offsetting Assets:
Derivatives$20,375 $— $20,375 $— $— $20,375 
Offsetting Liabilities:
Derivatives$— $— $— $— $— $— 
v3.25.4
FAIR VALUE DISCLOSURES (Tables)
12 Months Ended
Dec. 31, 2025
Fair Value Disclosures [Abstract]  
Schedule of Face Values, Carrying Amounts and Fair Values of Financial Instruments
The following are the face values, carrying amounts and fair values of the Company’s financial instruments as of December 31, 2025 and 2024 whose carrying amounts do not approximate their fair value (in thousands):
 As of December 31, 2025As of December 31, 2024
 
Face
Value
(1)
Carrying
Amount
(2)
Fair
Value
Face
Value
(1)
Carrying
Amount
(2)
Fair
Value
Financial assets:
Loans receivable$377,249 $368,747 $381,035 $391,010 $381,468 $397,791 
Preferred equity investments65,171 65,353 66,858 60,915 61,116 62,765 
Financial liabilities:
Senior Notes1,250,000 1,235,726 1,180,495 1,750,000 1,736,025 1,617,779 
Secured indebtedness44,021 43,275 34,101 46,110 45,316 33,635 
(1)    Face value represents amounts contractually due under the terms of the respective agreements.
(2)    Carrying amount represents the book value of financial instruments, including unamortized premiums/discounts and deferred financing costs.
Schedule of Fair Value of Financial Instruments
The Company determined the fair value of financial instruments as of December 31, 2025 whose carrying amounts do not approximate their fair value with valuation methods utilizing the following types of inputs (in thousands):
Fair Value Measurements Using
TotalQuoted Prices in
Active Markets for
Identical Assets
(Level 1)
Significant Other
Observable Inputs
(Level 2)
Significant
Unobservable Inputs
(Level 3)
Financial assets:
Loans receivable$381,035 $— $— $381,035 
Preferred equity investments66,858 — — 66,858 
Financial liabilities:
Senior Notes1,180,495 — 1,180,495 — 
Secured indebtedness34,101 — — 34,101 
Schedule of Items Measured at Fair Value on a Recurring Basis
During the year ended December 31, 2025, the Company recorded the following amounts measured at fair value (in thousands):
Fair Value Measurements Using
TotalQuoted Prices in
Active Markets for
Identical Assets
(Level 1)
Significant Other
Observable Inputs
(Level 2)
Significant
Unobservable Inputs
(Level 3)
Recurring Basis:
Financial assets:
Interest rate swaps$3,378 $— $3,378 $— 
Financial liabilities:
Interest rate swaps1,281 — 1,281 — 
v3.25.4
EQUITY (Tables)
12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Schedule of Accumulated Other Comprehensive Income
The following is a summary of the Company’s accumulated other comprehensive income (in thousands):
As of December 31,
20252024
Foreign currency translation loss$(1,371)$(4,778)
Unrealized (loss) gain on cash flow hedges(2,200)25,718 
Total accumulated other comprehensive (loss) income$(3,571)$20,940 
v3.25.4
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Additional Information Concerning Restricted Stock Units
The following table summarizes additional information concerning restricted stock units at December 31, 2025:
Restricted Stock UnitsWeighted Average Grant Date Fair Value Per Unit
Unvested as of December 31, 20242,574,191 $14.94 
Granted983,708 18.76 
Vested(1,102,085)15.03 
Dividends reinvested221,574 14.71 
Cancelled/forfeited(179,133)12.58 
Unvested as of December 31, 20252,498,255 $16.56 
Schedule of Assumptions Used in Total Stockholder Return-Based Stock Units Valuation The following are the key assumptions used in this valuation:
202520242023
Risk free interest rate
3.52% - 4.31%
3.98% - 4.31%
3.98% - 4.13%
Expected stock price volatility
23.43% - 28.61%
28.61% - 30.17%
30.17% - 56.11%
Expected service period
3.0 years
3.0 years
3.0 years
Expected dividend yield (assuming full reinvestment)— %— %— %
v3.25.4
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Schedule of Provision for Income Tax Expense
The following is a summary of the Company’s provision for income taxes and deferred taxes (in thousands):
Year Ended December 31,
202520242023
Provision for federal, state and local income taxes$1,726 $1,006 $2,002 
Provision for (recovery of) foreign income taxes111 (1)— 
Income tax expense$1,837 $1,005 $2,002 
As of December 31,
20252024
Deferred tax assets:
Federal$12,489 $10,597 
Valuation allowance on federal(12,489)(10,597)
Foreign3,730 4,944 
Valuation allowance on foreign(3,730)(4,944)
$— $— 
Schedule of Deferred Taxes
The following is a summary of the Company’s provision for income taxes and deferred taxes (in thousands):
Year Ended December 31,
202520242023
Provision for federal, state and local income taxes$1,726 $1,006 $2,002 
Provision for (recovery of) foreign income taxes111 (1)— 
Income tax expense$1,837 $1,005 $2,002 
As of December 31,
20252024
Deferred tax assets:
Federal$12,489 $10,597 
Valuation allowance on federal(12,489)(10,597)
Foreign3,730 4,944 
Valuation allowance on foreign(3,730)(4,944)
$— $— 
v3.25.4
EARNINGS PER COMMON SHARE (Tables)
12 Months Ended
Dec. 31, 2025
Earnings Per Share [Abstract]  
Schedule of Computation of Basic and Diluted Earnings Per Share
The following table illustrates the computation of basic and diluted earnings per share (in thousands, except share and per share amounts):
Year Ended December 31,
202520242023
Numerator
Net income attributable to Sabra Health Care REIT, Inc.$155,609 $126,712 $13,756 
Denominator
Basic weighted average common shares and common equivalents241,312,309 233,498,736 231,203,391 
Dilutive restricted stock units2,871,902 2,446,335 1,589,387 
Dilutive forward equity sale agreements313,031 100,791 — 
Diluted weighted average common shares244,497,242 236,045,862 232,792,778 
Net income attributable to Sabra Health Care REIT, Inc., per:
Basic common share$0.64 $0.54 $0.06 
Diluted common share$0.64 $0.54 $0.06 
v3.25.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)
12 Months Ended
Dec. 31, 2025
USD ($)
variableInterestEntity
property
segment
investment
Dec. 31, 2024
USD ($)
investment
Accounting Policies [Line Items]    
Assets $ 5,493,396,000 $ 5,303,679,000
Liabilities $ 2,669,608,000 $ 2,562,391,000
Number of investments in loans accounted for as real estate joint ventures | investment 0 0
Assets held for sale $ 0 $ 0
Restricted cash 6,603,000 5,871,000
Restricted cash obligations $ 1,200,000 $ 5,500,000
Number of reportable segments | segment 1  
Minimum | Land improvements    
Accounting Policies [Line Items]    
Estimated useful lives of assets 15 years  
Minimum | Buildings and building improvements    
Accounting Policies [Line Items]    
Estimated useful lives of assets 5 years  
Minimum | Furniture and equipment    
Accounting Policies [Line Items]    
Estimated useful lives of assets 3 years  
Maximum | Land improvements    
Accounting Policies [Line Items]    
Estimated useful lives of assets 20 years  
Maximum | Buildings and building improvements    
Accounting Policies [Line Items]    
Estimated useful lives of assets 40 years  
Maximum | Furniture and equipment    
Accounting Policies [Line Items]    
Estimated useful lives of assets 10 years  
Primary beneficiary    
Accounting Policies [Line Items]    
Number of variable interest entities | variableInterestEntity 2  
Assets $ 99,200,000  
Liabilities $ 2,000,000  
Variable Interest Entity, Primary Beneficiary One    
Accounting Policies [Line Items]    
Number of properties | property 3  
Variable Interest Entity, Primary Beneficiary Two | Third-Party Property Manager    
Accounting Policies [Line Items]    
Number of properties | property 3  
v3.25.4
RECENT REAL ESTATE ACQUISITIONS (CONSOLIDATED) - Narrative (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2025
USD ($)
property
unit
Dec. 31, 2024
USD ($)
property
Dec. 31, 2023
USD ($)
Asset Acquisition [Line Items]      
Revenues $ 774,632 $ 703,235 $ 647,514
Net income 155,510 126,712 $ 13,756
Senior Housing      
Asset Acquisition [Line Items]      
Revenues 31,900 12,500  
Net income $ 2,400 $ 2,500  
Senior Housing | Tenant origination and absorption costs      
Asset Acquisition [Line Items]      
Weighted-average amortization period of intangible assets 2 years 3 years  
Tenant intangible assets $ 40,274 $ 5,338  
Senior Housing | Tenant relationship      
Asset Acquisition [Line Items]      
Weighted-average amortization period of intangible assets   25 years  
Tenant intangible assets $ 30 $ 206  
Senior housing - managed portfolio      
Asset Acquisition [Line Items]      
Number of acquired properties | property 11 3  
Senior housing - managed portfolio | Joint venture entity | Consolidated Joint Venture      
Asset Acquisition [Line Items]      
Number of acquired properties | property 3    
Equity interest percent 95.00%    
Senior Housing - Leased      
Asset Acquisition [Line Items]      
Number of acquired properties | property 1 1  
Number of units acquired | unit 24    
Senior Housing Operations - Managed Portfolio      
Asset Acquisition [Line Items]      
Number of properties | property 4    
Consideration transferred $ 19,700    
Furniture and equipment 1,100    
Lease termination expense 1,200    
Senior Housing Operations - Managed Portfolio | Tenant origination and absorption costs      
Asset Acquisition [Line Items]      
Tenant intangible assets $ 17,400    
v3.25.4
RECENT REAL ESTATE ACQUISITIONS (CONSOLIDATED) - Purchase Price Allocation for Recent Real Estate Acquisitions (Details) - Senior Housing - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Asset Acquisition [Line Items]    
Land $ 53,350 $ 9,222
Building and improvements 340,806 121,664
Total consideration 434,460 136,430
Tenant origination and absorption costs intangible assets    
Asset Acquisition [Line Items]    
Tenant intangible assets 40,274 5,338
Tenant relationship intangible assets    
Asset Acquisition [Line Items]    
Tenant intangible assets $ 30 $ 206
v3.25.4
INVESTMENT IN REAL ESTATE PROPERTIES - Real Estate Properties Held for Investment (Details)
$ in Thousands
Dec. 31, 2025
USD ($)
property
bed
Dec. 31, 2024
USD ($)
bed
property
Real Estate Properties [Line Items]    
Total Real Estate at Cost $ 5,911,040 $ 5,615,764
Accumulated Depreciation (1,224,663) (1,102,030)
Total Real Estate Investments, Net 4,686,377 4,513,734
Building and improvements 5,115,662 4,853,151
Furniture and equipment 203,721 207,265
Land improvements 12,071 11,813
Land $ 579,586 $ 543,535
Real Estate Properties, Excluding Corporate Level    
Real Estate Properties [Line Items]    
Number of Properties | property 360 364
Number of Beds/Units | bed 36,412 37,047
Total Real Estate at Cost $ 5,908,729 $ 5,613,018
Accumulated Depreciation (1,224,069) (1,101,237)
Total Real Estate Investments, Net $ 4,684,660 $ 4,511,781
Skilled Nursing/Transitional Care    
Real Estate Properties [Line Items]    
Number of Properties | property 210 224
Number of Beds/Units | bed 23,537 25,492
Total Real Estate at Cost $ 2,802,561 $ 2,926,349
Accumulated Depreciation (635,685) (588,107)
Total Real Estate Investments, Net $ 2,166,876 $ 2,338,242
Senior Housing - Leased    
Real Estate Properties [Line Items]    
Number of Properties | property 32 39
Number of Beds/Units | bed 2,668 3,319
Total Real Estate at Cost $ 376,590 $ 508,586
Accumulated Depreciation (90,236) (102,111)
Total Real Estate Investments, Net $ 286,354 $ 406,475
Senior Housing - Managed    
Real Estate Properties [Line Items]    
Number of Properties | property 87 69
Number of Beds/Units | bed 8,677 6,680
Total Real Estate at Cost $ 2,030,267 $ 1,474,267
Accumulated Depreciation (349,213) (278,328)
Total Real Estate Investments, Net $ 1,681,054 $ 1,195,939
Behavioral Health    
Real Estate Properties [Line Items]    
Number of Properties | property 16 17
Number of Beds/Units | bed 1,138 1,164
Total Real Estate at Cost $ 473,813 $ 478,318
Accumulated Depreciation (90,644) (79,819)
Total Real Estate Investments, Net $ 383,169 $ 398,499
Specialty Hospitals and Other    
Real Estate Properties [Line Items]    
Number of Properties | property 15 15
Number of Beds/Units | bed 392 392
Total Real Estate at Cost $ 225,498 $ 225,498
Accumulated Depreciation (58,291) (52,872)
Total Real Estate Investments, Net 167,207 172,626
Corporate Level    
Real Estate Properties [Line Items]    
Total Real Estate at Cost 2,311 2,746
Accumulated Depreciation (594) (793)
Total Real Estate Investments, Net $ 1,717 $ 1,953
v3.25.4
INVESTMENT IN REAL ESTATE PROPERTIES - Real Estate Properties Held for Investment Narrative (Details) - Vandalism And Theft
$ in Millions
12 Months Ended
Dec. 31, 2023
USD ($)
Schedule of Equity Method Investments [Line Items]  
Proceeds of insurance $ 6.2
Gain of unusual amount $ 3.7
Gain on business interruption insurance recovery, statement of income or comprehensive income Other income
v3.25.4
INVESTMENT IN REAL ESTATE PROPERTIES - Capital and Other Expenditures Narrative (Details)
$ in Millions
12 Months Ended
Dec. 31, 2025
USD ($)
Real Estate [Abstract]  
Future capital expenditures $ 17
v3.25.4
INVESTMENT IN REAL ESTATE PROPERTIES - Senior Housing - Managed Communities Narrative (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Disaggregation of Revenue [Line Items]      
Resident fees and services $ 356,883 $ 284,581 $ 236,153
Fire      
Disaggregation of Revenue [Line Items]      
Gain of unusual amount 400 1,700 500
Fire | Senior Housing - Managed      
Disaggregation of Revenue [Line Items]      
Proceeds of insurance 400 2,100 1,100
Property Damage      
Disaggregation of Revenue [Line Items]      
Gain of unusual amount 1,300 500  
Property Damage | Senior Housing - Managed      
Disaggregation of Revenue [Line Items]      
Proceeds of insurance 1,300 2,400  
Ancillary services      
Disaggregation of Revenue [Line Items]      
Resident fees and services $ 4,900 $ 3,900 $ 2,000
v3.25.4
INVESTMENT IN REAL ESTATE PROPERTIES - Schedule of Investment in Joint Ventures (Details)
$ in Thousands
Dec. 31, 2025
USD ($)
property
Dec. 31, 2024
USD ($)
Schedule of Equity Method Investments [Line Items]    
Book value $ 118,166 $ 121,803
Sienna Joint Venture    
Schedule of Equity Method Investments [Line Items]    
Ownership 50.00%  
Book value $ 110,283 107,732
Marlin Spring Joint Venture    
Schedule of Equity Method Investments [Line Items]    
Ownership 85.00%  
Book value $ 7,883 $ 14,071
Senior Housing - Managed | Sienna Joint Venture    
Schedule of Equity Method Investments [Line Items]    
Number of properties | property 12  
Senior Housing - Managed | Marlin Spring Joint Venture    
Schedule of Equity Method Investments [Line Items]    
Number of properties | property 4  
v3.25.4
IMPAIRMENT OF REAL ESTATE AND DISPOSITIONS - Narrative (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2025
USD ($)
facility
Dec. 31, 2024
USD ($)
facility
property
uSDollarPerSquareFoot
Dec. 31, 2023
USD ($)
facility
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Impairment of real estate $ 7,322 $ 18,472 $ 14,332
Sold | Real Estate Dispositions      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Net income (loss) (3,900) (11,600) (81,000)
Impairment upon disposal   18,000 14,300
Skilled Nursing/Transitional Care | Sold | Real Estate Dispositions      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Impairment of real estate $ 7,300 $ 18,500 $ 14,300
Number of real estate properties impaired | facility 3 6 3
Non-Operational Facilities | Sold | Real Estate Dispositions      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Number of real estate properties impaired | property   2  
Non-Operational Facilities | Sold | Real Estate Dispositions | Minimum      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Sales price per square foot (in dollars per sq ft) | uSDollarPerSquareFoot   4  
Non-Operational Facilities | Sold | Real Estate Dispositions | Maximum      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Sales price per square foot (in dollars per sq ft) | uSDollarPerSquareFoot   73  
v3.25.4
IMPAIRMENT OF REAL ESTATE AND DISPOSITIONS - Dispositions (Details)
$ in Millions
12 Months Ended
Dec. 31, 2025
USD ($)
property
Dec. 31, 2024
USD ($)
property
Dec. 31, 2023
USD ($)
property
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Disposal group, not discontinued operations, gain (loss) on disposal, statement of income Net (loss) gain on sale    
Dispositions | Real Estate Dispositions      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Number of facilities | property 15 18 28
Consideration, net of closing costs $ 88.5 $ 96.0 $ 255.6
Net carrying value 92.0 93.9 332.2
Net (loss) gain on sale $ (3.5) $ 2.1 $ (76.6)
v3.25.4
OPERATING LEASES - Lessor Narrative (Details)
$ in Millions
12 Months Ended
Dec. 31, 2025
USD ($)
property
Dec. 31, 2024
USD ($)
property
Dec. 31, 2023
USD ($)
Lessor, Lease, Description [Line Items]      
Security deposit liability $ 10.5 $ 9.0  
Letters of credit deposited 63.0 64.0  
Tenant deposits for future real estate taxes, insurance expenditures, and tenant improvements 10.8 10.8  
Variable lease revenue $ 14.2 $ 14.5 $ 15.3
Senior Housing - Managed      
Lessor, Lease, Description [Line Items]      
Number of properties | property 87 69  
Minimum | Senior Housing - Managed      
Lessor, Lease, Description [Line Items]      
Operating lease expiration period 1 year    
Maximum | Senior Housing - Managed      
Lessor, Lease, Description [Line Items]      
Operating lease expiration period 18 years    
Weighted Average      
Lessor, Lease, Description [Line Items]      
Operating lease expiration period 7 years    
v3.25.4
OPERATING LEASES - Future Minimum Rental Payments (Details)
$ in Thousands
Dec. 31, 2025
USD ($)
Leases [Abstract]  
2026 $ 355,230
2027 343,478
2028 323,161
2029 273,867
2030 246,425
Thereafter 909,657
Total $ 2,451,818
v3.25.4
OPERATING LEASES - Lessee Narrative (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Leases [Abstract]      
Operating lease right-of-use asset $ 6,500 $ 7,000  
Operating lease, right-of-use asset, statement of financial position Accounts receivable, prepaid expenses and other assets, net Accounts receivable, prepaid expenses and other assets, net  
Present value of lease liability $ 7,379 $ 8,300  
Operating lease, liability, statement of financial position Accounts payable and accrued liabilities Accounts payable and accrued liabilities  
Operating lease, expense $ 1,000 $ 1,300 $ 1,400
Weighted-average remaining term of operating leases 12 years    
Weighted average discount rate 8.00%    
v3.25.4
OPERATING LEASES - Future Minimum Lease Payments (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Leases [Abstract]    
2026 $ 1,032  
2027 1,047  
2028 1,021  
2029 1,050  
2030 1,069  
Thereafter 6,819  
Undiscounted minimum lease payments included in the lease liability 12,038  
Less: imputed interest (4,659)  
Present value of lease liability $ 7,379 $ 8,300
v3.25.4
INTANGIBLE ASSETS AND LIABILITIES - Intangible Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Lease Intangible Assets:    
Gross lease intangible assets $ 110,631 $ 62,064
Accumulated amortization (45,310) (34,600)
Lease intangible assets, net 65,321 27,464
Lease Intangible Liabilities:    
Below market leases 61,537 64,538
Accumulated amortization (40,154) (37,691)
Lease intangible liabilities, net 21,383 26,847
Above market leases    
Lease Intangible Assets:    
Gross lease intangible assets 5,606 5,606
Tenant origination and absorption costs    
Lease Intangible Assets:    
Gross lease intangible assets 90,430 40,544
Tenant relationship    
Lease Intangible Assets:    
Gross lease intangible assets $ 14,595 $ 15,914
v3.25.4
INTANGIBLE ASSETS AND LIABILITIES - Real Estate Intangible Amortization (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]      
Increase to rental income related to above/below market leases, net $ 4,880 $ 4,867 $ 5,821
Depreciation and amortization related to tenant origination and absorption costs and tenant relationship $ (19,085) $ (7,501) $ (11,616)
v3.25.4
INTANGIBLE ASSETS AND LIABILITIES - Remaining Unamortized Balance for Outstanding Intangible Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Lease Intangible Assets    
2026 $ 34,296  
2027 17,521  
2028 4,274  
2029 1,997  
2030 1,767  
Thereafter 5,466  
Lease intangible assets, net $ 65,321 $ 27,464
Weighted-average remaining amortization period 3 years 6 months  
Lease Intangible Liabilities    
2026 $ 4,564  
2027 4,438  
2028 4,296  
2029 4,190  
2030 3,895  
Thereafter 0  
Lease intangible liabilities, net $ 21,383 $ 26,847
Weighted-average remaining amortization period 4 years 9 months 18 days  
v3.25.4
LOANS RECEIVABLE AND OTHER INVESTMENTS - Composition of Loans Receivable and Other Investments (Details)
$ in Thousands
Dec. 31, 2025
USD ($)
preferredEquityInvestment
loan
investment
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Loans Receivable:        
Quantity | loan 13      
Principal balance $ 377,249 $ 391,010    
Book Value 373,794 387,562    
Allowance for loan losses (5,047) (6,094) $ (6,665) $ (6,611)
Book Value $ 368,747 381,468    
Weighted Average Contractual Interest Rate / Rate of Return 7.70%      
Weighted Average Annualized Effective Interest Rate / Rate of Return 7.60%      
Other Investments:        
Quantity | preferredEquityInvestment 4      
Principal Balance $ 65,171 60,915    
Book Value $ 65,353 61,116    
Weighted Average Contractual Interest Rate / Rate of Return 11.00%      
Weighted Average Annualized Effective Interest Rate / Rate of Return 11.00%      
Total Quantity | investment 17      
Total Principal Balance $ 442,420      
Total Book Value $ 434,100 442,584    
Total weighted average contractual interest rate / rate of return 8.20%      
Total weighted average annualized effective interest rate / rate of return 8.10%      
Mortgage        
Loans Receivable:        
Quantity | loan 3      
Principal balance $ 335,600      
Book Value $ 335,600 335,600    
Weighted Average Contractual Interest Rate / Rate of Return 7.70%      
Weighted Average Annualized Effective Interest Rate / Rate of Return 7.70%      
Other        
Loans Receivable:        
Quantity | loan 10      
Principal balance $ 41,649      
Book Value $ 38,194 $ 51,962    
Weighted Average Contractual Interest Rate / Rate of Return 7.40%      
Weighted Average Annualized Effective Interest Rate / Rate of Return 6.90%      
v3.25.4
LOANS RECEIVABLE AND OTHER INVESTMENTS - Narrative (Details)
$ in Thousands
Dec. 31, 2025
USD ($)
loan
investment
Dec. 31, 2024
USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Principal balance $ 377,249 $ 391,010
Book value $ 368,747 $ 381,468
Nonaccrual status    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Number of loans receivable investments | loan 3  
Book value $ 0  
Deteriorated credit quality    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Number of loans receivable investments | loan 1  
Principal balance $ 1,200  
Book value 0  
Future funding on investment    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Future funding commitment $ 500  
Number of preferred equity investments for funding commitment | investment 2  
v3.25.4
LOANS RECEIVABLE AND OTHER INVESTMENTS - Schedule of Additional Information Regarding the Company's Loans Receivable (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Financing Receivable, Allowance for Credit Loss [Roll Forward]      
Balance at the beginning of the year $ 6,094 $ 6,665 $ 6,611
(Recovery of) provision for loan losses (1,047) (571) 191
Write-off of uncollectible balances 0 0 (137)
Balance at the end of the year $ 5,047 $ 6,094 $ 6,665
v3.25.4
DEBT - Secured Indebtedness (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Debt Instrument [Line Items]    
Deferred financing costs $ 15,275  
Secured Debt    
Debt Instrument [Line Items]    
Deferred financing costs 746 $ 800
Secured Debt | Fixed Rate    
Debt Instrument [Line Items]    
Principal balance $ 44,021 $ 46,110
Weighted average interest rate (percent) 2.86%  
Weighted average effective interest rate (percent) 3.36%  
v3.25.4
DEBT - Senior Unsecured Notes (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Sep. 30, 2025
Dec. 31, 2024
Debt Instrument [Line Items]      
Discount, net $ 6,859    
Deferred financing costs 15,275    
Senior Notes      
Debt Instrument [Line Items]      
Principal balance 1,250,000   $ 1,750,000
Discount, net 6,859   5,000
Deferred financing costs $ 7,415   $ 9,000
Weighted average effective interest rate (percent) 3.66%    
Senior Notes | 5.125% senior unsecured notes due 2026 (“2026 Notes”)      
Debt Instrument [Line Items]      
Interest rate 5.125%   5.125%
Principal balance $ 0 $ 500,000 $ 500,000
Senior Notes | 5.38% senior unsecured notes due 2027 (“2027 Notes”)      
Debt Instrument [Line Items]      
Interest rate 5.38%   5.38%
Principal balance $ 100,000   $ 100,000
Senior Notes | 3.90% senior unsecured notes due 2029 (“2029 Notes”)      
Debt Instrument [Line Items]      
Interest rate 3.90%   3.90%
Principal balance $ 350,000   $ 350,000
Senior Notes | 3.20% senior unsecured notes due 2031 (“2031 Notes”)      
Debt Instrument [Line Items]      
Interest rate 3.20%   3.20%
Principal balance $ 800,000   $ 800,000
v3.25.4
DEBT - Senior Unsecured Notes Narrative (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Jul. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Sep. 30, 2025
Debt Instrument [Line Items]          
Loss on extinguishment of debt   $ 1,154 $ 0 $ 1,541  
Payments made to noteholders and legal fees for early redemption   2,884 0 $ 0  
Senior Notes          
Debt Instrument [Line Items]          
Senior notes   $ 1,250,000 $ 1,750,000    
5.125% senior unsecured notes due 2026 (“2026 Notes”) | Senior Notes          
Debt Instrument [Line Items]          
Interest rate   5.125% 5.125%    
Senior notes   $ 0 $ 500,000   $ 500,000
Redemption price (percent) 100.575%        
Loss on extinguishment of debt $ 1,200        
Payments made to noteholders and legal fees for early redemption 2,900        
Write-offs associated with unamortized premium $ 1,700        
5.38% senior unsecured notes due 2027 (“2027 Notes”) | Senior Notes          
Debt Instrument [Line Items]          
Interest rate   5.38% 5.38%    
Senior notes   $ 100,000 $ 100,000    
Redemption price (percent)   100.00%      
5.375% Senior Unsecured Notes Due 2023 | Senior Notes          
Debt Instrument [Line Items]          
Interest rate   5.375%      
3.90% senior unsecured notes due 2029 (“2029 Notes”) | Senior Notes          
Debt Instrument [Line Items]          
Interest rate   3.90% 3.90%    
Senior notes   $ 350,000 $ 350,000    
Debt covenant, consolidated unencumbered total asset value to aggregate principal of unsecured debt   150.00%      
3.90% senior unsecured notes due 2029 (“2029 Notes”) | Senior Notes | Redemption Period One          
Debt Instrument [Line Items]          
Redemption price (percent)   100.00%      
3.90% senior unsecured notes due 2029 (“2029 Notes”) | Senior Notes | Redemption Period Two          
Debt Instrument [Line Items]          
Redemption price (percent)   100.00%      
3.20% senior unsecured notes due 2031 (“2031 Notes”) | Senior Notes          
Debt Instrument [Line Items]          
Interest rate   3.20% 3.20%    
Senior notes   $ 800,000 $ 800,000    
Debt covenant, consolidated unencumbered total asset value to aggregate principal of unsecured debt   150.00%      
3.20% senior unsecured notes due 2031 (“2031 Notes”) | Senior Notes | Redemption Period One          
Debt Instrument [Line Items]          
Redemption price (percent)   100.00%      
3.20% senior unsecured notes due 2031 (“2031 Notes”) | Senior Notes | Redemption Period Two          
Debt Instrument [Line Items]          
Redemption price (percent)   100.00%      
v3.25.4
DEBT - Credit Agreement Narrative (Details)
12 Months Ended
Jan. 04, 2023
USD ($)
extensionOption
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2025
CAD ($)
Jan. 04, 2023
CAD ($)
extensionOption
Debt Instrument [Line Items]            
Loss on extinguishment of debt   $ 1,154,000 $ 0 $ 1,541,000    
Revolving credit facility   217,584,000 $ 106,554,000      
Fifth Amended and Restated Credit Agreement | Revolving Credit Facility            
Debt Instrument [Line Items]            
Borrowing capacity $ 1,000,000,000          
Borrowing capacity in certain foreign currencies $ 350,000,000          
Number of extension options | extensionOption 2         2
Extension period 6 months          
Revolving credit facility   217,600,000     $ 33,700,000  
Available borrowing capacity   $ 782,400,000        
Basis spread on variable rate 1.00%          
Interest rate   4.79%     4.79%  
Fifth Amended and Restated Credit Agreement | Revolving Credit Facility | Minimum            
Debt Instrument [Line Items]            
Annum percent unused borrowing fee 0.125%          
Fifth Amended and Restated Credit Agreement | Revolving Credit Facility | Maximum            
Debt Instrument [Line Items]            
Annum percent unused borrowing fee 0.30%          
Fifth Amended and Restated Credit Agreement | Revolving Credit Facility | Prime Rate            
Debt Instrument [Line Items]            
Basis spread on variable rate 0.50%          
Fifth Amended and Restated Credit Agreement | Revolving Credit Facility | Base Rate            
Debt Instrument [Line Items]            
Basis spread on variable rate 1.00%          
Fifth Amended and Restated Credit Agreement | Revolving Credit Facility | Base Rate | Minimum            
Debt Instrument [Line Items]            
Basis spread on variable rate 0.00%          
Fifth Amended and Restated Credit Agreement | Revolving Credit Facility | Base Rate | Maximum            
Debt Instrument [Line Items]            
Basis spread on variable rate 0.45%          
Fifth Amended and Restated Credit Agreement | Revolving Credit Facility | SOFR | Minimum            
Debt Instrument [Line Items]            
Basis spread on variable rate 0.775%          
Fifth Amended and Restated Credit Agreement | Revolving Credit Facility | SOFR | Maximum            
Debt Instrument [Line Items]            
Basis spread on variable rate 1.45%          
Fifth Amended and Restated Credit Agreement | Line of Credit            
Debt Instrument [Line Items]            
Increase the total available borrowings $ 2,750,000,000          
Fifth Amended and Restated Credit Agreement | U.S. dollar Term Loans            
Debt Instrument [Line Items]            
Loss on extinguishment of debt       $ 1,500,000    
Financial liabilities $ 430,000,000          
Interest rate   5.12%     5.12%  
Weighted average effective interest rate (percent)   4.18%     4.18%  
Fifth Amended and Restated Credit Agreement | U.S. dollar Term Loans | Interest rate swaps            
Debt Instrument [Line Items]            
Financial liabilities   $ 430,000,000        
Fixed interest rate under swap   2.93%     2.93%  
Fifth Amended and Restated Credit Agreement | U.S. dollar Term Loans | Base Rate | Minimum            
Debt Instrument [Line Items]            
Basis spread on variable rate 0.00%          
Fifth Amended and Restated Credit Agreement | U.S. dollar Term Loans | Base Rate | Maximum            
Debt Instrument [Line Items]            
Basis spread on variable rate 0.65%          
Fifth Amended and Restated Credit Agreement | U.S. dollar Term Loans | SOFR | Minimum            
Debt Instrument [Line Items]            
Basis spread on variable rate 0.85%          
Fifth Amended and Restated Credit Agreement | U.S. dollar Term Loans | SOFR | Maximum            
Debt Instrument [Line Items]            
Basis spread on variable rate 1.65%          
Fifth Amended and Restated Credit Agreement | Canadian dollar Term Loan            
Debt Instrument [Line Items]            
Financial liabilities           $ 150,000,000
Interest rate   3.55%     3.55%  
Weighted average effective interest rate (percent)   3.84%     3.84%  
Fifth Amended and Restated Credit Agreement | Canadian dollar Term Loan | Interest rate swaps            
Debt Instrument [Line Items]            
Financial liabilities         $ 150,000,000.0  
Fixed interest rate under swap   2.59%     2.59%  
Fifth Amended and Restated Credit Agreement | Canadian dollar Term Loan | CDOR | Minimum            
Debt Instrument [Line Items]            
Basis spread on variable rate 0.85%          
Fifth Amended and Restated Credit Agreement | Canadian dollar Term Loan | CDOR | Maximum            
Debt Instrument [Line Items]            
Basis spread on variable rate 1.65%          
v3.25.4
Debt - Term Loan Credit Agreement Narrative (Details) - Line of Credit - USD ($)
Jul. 30, 2025
Dec. 31, 2025
Jun. 27, 2025
Interest rate swaps      
Debt Instrument [Line Items]      
Notional amount     $ 500,000,000
Weighted average rate     3.44%
Term Loan Credit Agreement      
Debt Instrument [Line Items]      
Financial liabilities $ 500,000,000 $ 500,000,000  
Increase the total available borrowings $ 1,000,000,000    
Interest rate   5.07%  
Weighted average effective interest rate (percent)   4.64%  
Term Loan Credit Agreement | Minimum | SOFR      
Debt Instrument [Line Items]      
Basis spread on variable rate 0.80%    
Term Loan Credit Agreement | Minimum | Base Rate      
Debt Instrument [Line Items]      
Basis spread on variable rate 0.00%    
Term Loan Credit Agreement | Maximum | SOFR      
Debt Instrument [Line Items]      
Basis spread on variable rate 1.60%    
Term Loan Credit Agreement | Maximum | Base Rate      
Debt Instrument [Line Items]      
Basis spread on variable rate 0.60%    
v3.25.4
DEBT - Interest Expense Narrative (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Debt Disclosure [Abstract]      
Interest expense $ 112,489 $ 115,272 $ 112,964
Non-cash interest expense 7,970 10,479 $ 12,265
Accrued interest $ 9,600 $ 16,100  
v3.25.4
DEBT - Maturities for Outstanding Debt (Details)
$ in Thousands
Jan. 04, 2023
extensionOption
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Debt Instrument [Line Items]      
2026   $ 2,147  
2027   319,790  
2028   541,691  
2029   352,328  
2030   502,392  
Thereafter   832,682  
Total Debt   2,551,030  
Discount, net   (6,859)  
Deferred financing costs, net   (15,275)  
Total Debt, Net   2,528,896  
Revolving Credit Facility | Fifth Amended and Restated Credit Agreement      
Debt Instrument [Line Items]      
Number of extension options | extensionOption 2    
Extension period 6 months    
Secured Indebtedness      
Debt Instrument [Line Items]      
2026   2,147  
2027   2,206  
2028   2,266  
2029   2,328  
2030   2,392  
Thereafter   32,682  
Total Debt   44,021  
Discount, net   0  
Deferred financing costs, net   (746) $ (800)
Total Debt, Net   43,275  
Line of Credit      
Debt Instrument [Line Items]      
2026   0  
2027   217,584  
2028   0  
2029   0  
2030   0  
Thereafter   0  
Total Debt   217,584  
Discount, net   0  
Deferred financing costs, net   0  
Total Debt, Net   217,584  
Term Loans      
Debt Instrument [Line Items]      
2026   0  
2027   0  
2028   539,425  
2029   0  
2030   500,000  
Thereafter   0  
Total Debt   1,039,425  
Discount, net   0  
Deferred financing costs, net   (7,114)  
Total Debt, Net   1,032,311  
Senior Notes      
Debt Instrument [Line Items]      
2026   0  
2027   100,000  
2028   0  
2029   350,000  
2030   0  
Thereafter   800,000  
Total Debt   1,250,000  
Discount, net   (6,859) (5,000)
Deferred financing costs, net   (7,415) $ (9,000)
Total Debt, Net   $ 1,235,726  
v3.25.4
DERIVATIVE AND HEDGING INSTRUMENTS - Narrative (Details)
12 Months Ended
Dec. 31, 2025
USD ($)
instrument
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Designated as Hedging Instrument      
Derivative [Line Items]      
Financial liabilities $ 135,290,000 $ 131,924,000  
Cash Flow Hedges | Designated as Hedging Instrument      
Derivative [Line Items]      
Gains included in accumulated other comprehensive income expected to be reclassified into retained earnings in the next 12 months 400,000    
Terminated Interest Rate Swaps      
Derivative [Line Items]      
Gain on previously terminated swaps that were determined to be probable to not occur $ 17,200,000    
Number of derivative instruments held | instrument 6    
Interest rate swaps | Cash Flow Hedges      
Derivative [Line Items]      
Ineffectiveness on cash flow hedges $ 0 0 $ 0
Interest rate swaps | Cash Flow Hedges | Designated as Hedging Instrument      
Derivative [Line Items]      
Financial liabilities 1,281,000 0  
Cross currency interest rate swaps | Not Designated as Hedging Instrument      
Derivative [Line Items]      
Other income (expense) related to derivatives 300,000 $ (500,000) $ (18,000)
Credit risk-related contingent features      
Derivative [Line Items]      
Financial liabilities 1,200,000    
Aggregate termination value $ 1,100,000    
v3.25.4
DERIVATIVE AND HEDGING INSTRUMENTS - Notional Amounts of Derivative Instruments (Details)
Dec. 31, 2025
USD ($)
Dec. 31, 2025
CAD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2024
CAD ($)
Cash Flow Hedges | Designated as Hedging Instrument        
Derivative [Line Items]        
Notional amount $ 930,000,000   $ 430,000,000  
Cash Flow Hedges | Designated as Hedging Instrument | Cross currency interest rate swaps        
Derivative [Line Items]        
Notional amount   $ 150,000,000   $ 150,000,000
Net Investment Hedges | Designated as Hedging Instrument        
Derivative [Line Items]        
Notional amount   183,700,000   189,600,000
Net Investment Hedges | Designated as Hedging Instrument | Cross currency interest rate swaps        
Derivative [Line Items]        
Notional amount   0   46,270,000
Net Investment Hedges | Not Designated as Hedging Instrument | Cross currency interest rate swaps        
Derivative [Line Items]        
Notional amount   $ 0   $ 10,030,000
v3.25.4
DERIVATIVE AND HEDGING INSTRUMENTS - Derivative and Financial Instruments Designated as Hedging Instruments (Details)
$ in Thousands
Dec. 31, 2025
USD ($)
instrument
Dec. 31, 2024
USD ($)
Liabilities:    
Derivative liability, statement of financial position Revolving credit facility, Term loans, net Revolving credit facility, Term loans, net
Derivative asset, statement of financial position Accounts receivable, prepaid expenses and other assets, net Accounts receivable, prepaid expenses and other assets, net
Designated as Hedging Instrument    
Assets:    
Fair Value $ 3,378 $ 20,375
Liabilities:    
Fair value $ 135,290 131,924
Designated as Hedging Instrument | Interest rate swaps | Cash flow    
Assets:    
Count | instrument 4  
Fair Value $ 3,378 14,085
Liabilities:    
Count | instrument 7  
Fair value $ 1,281 0
Designated as Hedging Instrument | Cross currency interest rate swaps | Net investment    
Assets:    
Count | instrument 0  
Fair Value $ 0 6,290
Designated as Hedging Instrument | Currency Swap | Net investment | Revolving credit facility    
Liabilities:    
Count | instrument 1  
Fair value $ 24,584 27,554
Designated as Hedging Instrument | Currency Swap | Net investment | Term loans, net    
Liabilities:    
Count | instrument 1  
Fair value $ 109,425 $ 104,370
v3.25.4
DERIVATIVE AND HEDGING INSTRUMENTS - Effect of Derivative Financial Instruments on the Condensed Consolidated Statements of Income and Condensed Consolidated Statements of Equity (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Derivative Instruments, Gain (Loss) [Line Items]      
(Loss) gain recognized in other comprehensive income (loss) $ (11,212) $ 22,528 $ 6,531
Gain reclassified accumulated other comprehensive income (loss) into income 6,445 9,413 8,332
Interest rate products      
Derivative Instruments, Gain (Loss) [Line Items]      
(Loss) gain recognized in other comprehensive income (loss), cash flow hedges (4,322) 12,549 13,116
Gain reclassified accumulated other comprehensive income (loss) into income, cash flow hedge 6,445 9,413 8,332
Foreign currency products      
Derivative Instruments, Gain (Loss) [Line Items]      
(Loss) gain recognized in other comprehensive income (loss), net investment hedges (1,418) 3,075 (664)
Gain reclassified accumulated other comprehensive income (loss) into income, net investment hedges 0 0 0
Currency Swap      
Derivative Instruments, Gain (Loss) [Line Items]      
(Loss) gain recognized in other comprehensive income (loss), net investment hedges (5,055) 8,820 (2,465)
Gain reclassified accumulated other comprehensive income (loss) into income, net investment hedges 0 0 0
Currency Swap | Revolving Credit Facility      
Derivative Instruments, Gain (Loss) [Line Items]      
(Loss) gain recognized in other comprehensive income (loss), net investment hedges (417) (1,916) (3,456)
Gain reclassified accumulated other comprehensive income (loss) into income, net investment hedges $ 0 $ 0 $ 0
v3.25.4
DERIVATIVE AND HEDGING INSTRUMENTS - Gross Presentation, Effects of Offsetting, and a Net Presentation of Derivatives (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Offsetting Assets:    
Gross Amounts of Recognized Assets $ 3,378 $ 20,375
Gross Amounts Offset in the Balance Sheet 0 0
Net Amounts of Assets presented in the Balance Sheet 3,378 20,375
Financial Instruments (212) 0
Cash Collateral Received 0 0
Net Amount 3,166 20,375
Offsetting Liabilities:    
Gross Amounts of Recognized Liabilities 1,281 0
Gross Amounts Offset in the Balance Sheet 0 0
Net Amounts of Liabilities presented in the Balance Sheet 1,281 0
Financial Instruments (212) 0
Cash Collateral Received 0 0
Net Amount $ 1,069 $ 0
v3.25.4
FAIR VALUE DISCLOSURES - Narrative (Details) - Discount Rate
Dec. 31, 2025
Minimum  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Loans receivable, measurement input 0.05
Preferred equity investments, measurement input 0.10
Maximum  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Loans receivable, measurement input 0.13
Preferred equity investments, measurement input 0.15
Weighted Average  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Loans receivable, measurement input 0.06
Preferred equity investments, measurement input 0.11
Secured Indebtedness | Weighted Average  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Debt, measurement input 0.06
v3.25.4
FAIR VALUE DISCLOSURES - Face Values, Carrying Amounts and Fair Values of Financial Instruments (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Financial assets:    
Loans receivable $ 377,249 $ 391,010
Loans receivable 381,035  
Preferred equity investments 65,171 60,915
Preferred equity investments 66,858  
Senior Notes    
Financial liabilities:    
Financial liabilities 1,250,000 1,750,000
Financial liabilities 1,180,495  
Secured Indebtedness    
Financial liabilities:    
Financial liabilities 44,021 46,110
Financial liabilities 34,101  
Carrying Amount    
Financial assets:    
Loans receivable 368,747 381,468
Preferred equity investments 65,353 61,116
Carrying Amount | Senior Notes    
Financial liabilities:    
Financial liabilities 1,235,726 1,736,025
Carrying Amount | Secured Indebtedness    
Financial liabilities:    
Financial liabilities 43,275 45,316
Fair Value    
Financial assets:    
Loans receivable 381,035 397,791
Preferred equity investments 66,858 62,765
Fair Value | Senior Notes    
Financial liabilities:    
Financial liabilities 1,180,495 1,617,779
Fair Value | Secured Indebtedness    
Financial liabilities:    
Financial liabilities $ 34,101 $ 33,635
v3.25.4
FAIR VALUE DISCLOSURES - Fair Value of Financial Instruments (Details)
$ in Thousands
Dec. 31, 2025
USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Loans receivable $ 381,035
Preferred equity investments 66,858
Senior Notes  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Financial liabilities 1,180,495
Secured Indebtedness  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Financial liabilities 34,101
Quoted Prices in Active Markets for Identical Assets (Level 1)  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Loans receivable 0
Preferred equity investments 0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Senior Notes  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Financial liabilities 0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Secured Indebtedness  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Financial liabilities 0
Significant Other Observable Inputs (Level 2)  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Loans receivable 0
Preferred equity investments 0
Significant Other Observable Inputs (Level 2) | Senior Notes  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Financial liabilities 1,180,495
Significant Other Observable Inputs (Level 2) | Secured Indebtedness  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Financial liabilities 0
Significant Unobservable Inputs (Level 3)  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Loans receivable 381,035
Preferred equity investments 66,858
Significant Unobservable Inputs (Level 3) | Senior Notes  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Financial liabilities 0
Significant Unobservable Inputs (Level 3) | Secured Indebtedness  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Financial liabilities $ 34,101
v3.25.4
FAIR VALUE DISCLOSURES - Items Measured at Fair Value on a Recurring Basis (Details) - Recurring - Interest rate swaps
$ in Thousands
Dec. 31, 2025
USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Financial assets $ 3,378
Financial liabilities 1,281
Quoted Prices in Active Markets for Identical Assets (Level 1)  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Financial assets 0
Financial liabilities 0
Significant Other Observable Inputs (Level 2)  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Financial assets 3,378
Financial liabilities 1,281
Significant Unobservable Inputs (Level 3)  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Financial assets 0
Financial liabilities $ 0
v3.25.4
EQUITY - Narrative (Details) - USD ($)
12 Months Ended
Aug. 05, 2025
Feb. 23, 2023
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Class of Stock [Line Items]          
Tax withholding obligations incurred on behalf of employees     $ 5,500,000 $ 2,600,000 $ 1,800,000
Restricted Stock Units          
Class of Stock [Line Items]          
Shares issued upon vesting (in shares)     500,000 300,000 300,000
Equity Distribution Agreement, Prior ATM Program          
Class of Stock [Line Items]          
Aggregate gross proceeds possible from sales of common stock under equity offering program   $ 500,000,000      
Shares allowed for forward feature of ATM Program (in shares)     15,300,000    
Initial weighted average price (in dollars per share)     $ 17.69    
Shares issued (in shares)     13,600,000    
Average price per share (in dollars per share)     $ 17.26    
Proceeds from issuance of common stock     $ 234,800,000    
Shares outstanding (in shares)     3,200,000    
Price per share (in dollars per share)     $ 18.10    
Number of additional shares sold (in shares)     0    
Equity Distribution Agreement, ATM Program          
Class of Stock [Line Items]          
Aggregate gross proceeds possible from sales of common stock under equity offering program $ 750,000,000        
Shares allowed for forward feature of ATM Program (in shares)     14,100,000    
Price per share (in dollars per share)     $ 18.71    
Number of additional shares sold (in shares)     0    
Forward sale agreement term 1 year        
Amount available for issuance     $ 482,900,000    
v3.25.4
EQUITY - Accumulated Other Comprehensive Income (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Total accumulated other comprehensive (loss) income $ 2,823,788 $ 2,741,288 $ 2,802,534 $ 3,056,395
Total accumulated other comprehensive (loss) income        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Total accumulated other comprehensive (loss) income (3,571) 20,940 $ 23,745 $ 19,063
Foreign currency translation loss        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Total accumulated other comprehensive (loss) income (1,371) (4,778)    
Unrealized (loss) gain on cash flow hedges        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Total accumulated other comprehensive (loss) income $ (2,200) $ 25,718    
v3.25.4
STOCK-BASED COMPENSATION - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total fair value of units vested $ 16,600 $ 13,200 $ 9,100
Stock-based compensation expense 11,360 8,987 7,917
Total unrecognized stock-based compensation expense $ 29,500    
Weighted average period for recognition of stock-based compensation expense 2 years 7 months 6 days    
Discretionary matching contribution (percent) 4.00%    
Matching contributions $ 400 $ 400 $ 300
Restricted Stock Units      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of shares of common stock convertible upon each performance-based restricted stock unit vesting (in shares) 1    
Weighted average remaining vesting period 2 years 7 months 6 days    
Weighted average fair value per share at grant date (in dollars per share) $ 18.76 $ 17.49 $ 14.73
Restricted Stock Units | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period 3 years    
Restricted Stock Units | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period 5 years    
FFO Units | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting percentage 0.00%    
FFO Units | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting percentage 200.00%    
TSR Units      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Historical volatility rate period 3 years    
TSR Units | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting percentage 0.00%    
TSR Units | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting percentage 200.00%    
v3.25.4
STOCK-BASED COMPENSATION - Restricted Stock Units Activity (Details) - Restricted Stock Units - $ / shares
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Restricted Stock Units      
Unvested, beginning (in shares) 2,574,191    
Granted (in shares) 983,708    
Vested (in shares) (1,102,085)    
Dividends reinvested (in shares) 221,574    
Cancelled/forfeited (in shares) (179,133)    
Unvested, ending (in shares) 2,498,255 2,574,191  
Weighted Average Grant Date Fair Value Per Unit      
Unvested, beginning (in dollars per share) $ 14.94    
Granted (in dollars per share) 18.76 $ 17.49 $ 14.73
Vested (in dollars per share) 15.03    
Dividends reinvested (in dollars per share) 14.71    
Cancelled/forfeited (in dollars per share) 12.58    
Unvested, ending (in dollars per share) $ 16.56 $ 14.94  
v3.25.4
STOCK-BASED COMPENSATION - Assumptions Used in Total Stockholder Return-Based Stock Units Valuation (Details) - TSR Units
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Assumptions used in valuation      
Risk free interest rate, minimum 3.52% 3.98% 3.98%
Risk free interest rate, maximum 4.31% 4.31% 4.13%
Expected stock price volatility, minimum 23.43% 28.61% 30.17%
Expected stock price volatility, maximum 28.61% 30.17% 56.11%
Expected service period 3 years 3 years 3 years
Expected dividend yield (assuming full reinvestment) 0.00% 0.00% 0.00%
v3.25.4
INCOME TAXES - Provision for Income Tax Expense (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Tax Disclosure [Abstract]      
Provision for federal, state and local income taxes $ 1,726 $ 1,006 $ 2,002
Provision for (recovery of) foreign income taxes 111 (1) 0
Income tax expense $ 1,837 $ 1,005 $ 2,002
v3.25.4
INCOME TAXES - Deferred Taxes (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Deferred tax assets:    
Deferred taxes, net $ 0 $ 0
Federal    
Deferred tax assets:    
Deferred tax assets 12,489 10,597
Valuation allowance (12,489) (10,597)
Foreign    
Deferred tax assets:    
Deferred tax assets 3,730 4,944
Valuation allowance $ (3,730) $ (4,944)
v3.25.4
INCOME TAXES - Narrative (Details) - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Tax Disclosure [Abstract]      
Interest and penalties from significant uncertain tax positions $ 0 $ 0 $ 0
v3.25.4
EARNINGS PER COMMON SHARE - Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Numerator      
Net income attributable to Sabra Health Care REIT, Inc. $ 155,609 $ 126,712 $ 13,756
Denominator      
Basic weighted average common shares and common equivalents (in shares) 241,312,309 233,498,736 231,203,391
Dilutive restricted stock units (in shares) 2,871,902 2,446,335 1,589,387
Dilutive forward equity sale agreements (in shares) 313,031 100,791 0
Diluted weighted average common shares (in shares) 244,497,242 236,045,862 232,792,778
Net income attributable to Sabra Health Care REIT, Inc., per:      
Basic common share (in dollars per share) $ 0.64 $ 0.54 $ 0.06
Diluted common share (in dollars per share) $ 0.64 $ 0.54 $ 0.06
v3.25.4
EARNINGS PER COMMON SHARE - Narrative (Details) - shares
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Restricted Stock Units      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Anti-dilutive securities not included in computation of diluted earnings per share (in shares) 700 1,300 500
Forward Equity Sale Agreements      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Anti-dilutive securities not included in computation of diluted earnings per share (in shares) 19,400 8,900  
v3.25.4
SUBSEQUENT EVENTS (Details) - $ / shares
12 Months Ended
Feb. 02, 2026
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Subsequent Event        
Quarterly cash dividend declared on common stock (in dollars per share)   $ 1.20 $ 1.20 $ 1.20
Subsequent event        
Subsequent Event        
Quarterly cash dividend declared on common stock (in dollars per share) $ 0.30      
v3.25.4
SCHEDULE III - REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION - Summary of Real Estate Properties (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Real Estate and Accumulated Depreciation        
Encumbrances $ 44,021      
Initial Cost to Company        
Land  579,265      
Buildings and Improvements 5,055,397      
Cost Capitalized Subsequent to Acquisition 268,090      
Gross Amount at which Carried at Close of Period        
Land  579,586      
Building and Improvements 5,331,454      
Total  5,911,040 $ 5,615,764 $ 5,638,347 $ 5,872,688
Accumulated Depreciation and Amortization (1,224,663) (1,102,030) $ (1,021,086) $ (913,345)
Aggregate cost of real estate for federal income tax purposes $ 5,000,000      
Depreciated over useful lives (in years) 40 years      
Deferred financing costs, net $ (15,275)      
Secured Indebtedness        
Gross Amount at which Carried at Close of Period        
Deferred financing costs, net (746) $ (800)    
Operating Segments        
Real Estate and Accumulated Depreciation        
Encumbrances 44,021      
Initial Cost to Company        
Land  579,265      
Buildings and Improvements 5,055,261      
Cost Capitalized Subsequent to Acquisition 265,915      
Gross Amount at which Carried at Close of Period        
Land  579,586      
Building and Improvements 5,329,143      
Total  5,908,729      
Accumulated Depreciation and Amortization (1,224,069)      
Corporate Assets        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  0      
Buildings and Improvements 136      
Cost Capitalized Subsequent to Acquisition 2,175      
Gross Amount at which Carried at Close of Period        
Land  0      
Building and Improvements 2,311      
Total  2,311      
Accumulated Depreciation and Amortization (594)      
Skilled Nursing/Transitional Care        
Real Estate and Accumulated Depreciation        
Encumbrances 22,323      
Initial Cost to Company        
Land  298,922      
Buildings and Improvements 2,451,080      
Cost Capitalized Subsequent to Acquisition 94,563      
Gross Amount at which Carried at Close of Period        
Land  297,114      
Building and Improvements 2,505,447      
Total  2,802,561      
Accumulated Depreciation and Amortization (635,685)      
Skilled Nursing/Transitional Care | Bedford, NH        
Real Estate and Accumulated Depreciation        
Encumbrances 4,588      
Initial Cost to Company        
Land  1,911      
Buildings and Improvements 12,245      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,911      
Building and Improvements 10,021      
Total  11,932      
Accumulated Depreciation and Amortization (5,376)      
Skilled Nursing/Transitional Care | Milford, NH        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  312      
Buildings and Improvements 1,679      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  312      
Building and Improvements 1,100      
Total  1,412      
Accumulated Depreciation and Amortization (1,032)      
Skilled Nursing/Transitional Care | North Conway, NH        
Real Estate and Accumulated Depreciation        
Encumbrances 9,626      
Initial Cost to Company        
Land  417      
Buildings and Improvements 5,352      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  417      
Building and Improvements 4,372      
Total  4,789      
Accumulated Depreciation and Amortization (2,210)      
Skilled Nursing/Transitional Care | Wolfeboro, NH        
Real Estate and Accumulated Depreciation        
Encumbrances 8,109      
Initial Cost to Company        
Land  454      
Buildings and Improvements 4,531      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  454      
Building and Improvements 3,745      
Total  4,199      
Accumulated Depreciation and Amortization (1,849)      
Skilled Nursing/Transitional Care | Middletown, DE        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,650      
Buildings and Improvements 21,730      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,650      
Building and Improvements 21,730      
Total  23,380      
Accumulated Depreciation and Amortization (8,652)      
Skilled Nursing/Transitional Care | Dover, DE        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  4,940      
Buildings and Improvements 15,500      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  4,940      
Building and Improvements 15,500      
Total  20,440      
Accumulated Depreciation and Amortization (6,502)      
Skilled Nursing/Transitional Care | Wilmington, DE        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,460      
Buildings and Improvements 25,240      
Cost Capitalized Subsequent to Acquisition 12,436      
Gross Amount at which Carried at Close of Period        
Land  2,460      
Building and Improvements 37,676      
Total  40,136      
Accumulated Depreciation and Amortization (12,873)      
Skilled Nursing/Transitional Care | Millsboro, DE        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,640      
Buildings and Improvements 22,620      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,632      
Building and Improvements 22,620      
Total  24,252      
Accumulated Depreciation and Amortization (9,225)      
Skilled Nursing/Transitional Care | Warrington, PA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,617      
Buildings and Improvements 11,662      
Cost Capitalized Subsequent to Acquisition 845      
Gross Amount at which Carried at Close of Period        
Land  2,617      
Building and Improvements 738      
Total  3,355      
Accumulated Depreciation and Amortization 0      
Skilled Nursing/Transitional Care | Duffield, VA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  509      
Buildings and Improvements 5,018      
Cost Capitalized Subsequent to Acquisition 1,333      
Gross Amount at which Carried at Close of Period        
Land  509      
Building and Improvements 5,964      
Total  6,473      
Accumulated Depreciation and Amortization (2,887)      
Skilled Nursing/Transitional Care | Arlington, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  3,783      
Buildings and Improvements 14,219      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  3,783      
Building and Improvements 13,702      
Total  17,485      
Accumulated Depreciation and Amortization (4,670)      
Skilled Nursing/Transitional Care | Rockport, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,005      
Buildings and Improvements 6,628      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,005      
Building and Improvements 6,212      
Total  7,217      
Accumulated Depreciation and Amortization (2,153)      
Skilled Nursing/Transitional Care | Lincoln, NE        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  6,368      
Buildings and Improvements 29,919      
Cost Capitalized Subsequent to Acquisition 696      
Gross Amount at which Carried at Close of Period        
Land  6,368      
Building and Improvements 29,801      
Total  36,169      
Accumulated Depreciation and Amortization (9,067)      
Skilled Nursing/Transitional Care | Fremont, NE 1        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  615      
Buildings and Improvements 16,176      
Cost Capitalized Subsequent to Acquisition 614      
Gross Amount at which Carried at Close of Period        
Land  615      
Building and Improvements 15,643      
Total  16,258      
Accumulated Depreciation and Amortization (4,607)      
Skilled Nursing/Transitional Care | Fremont, NE 2        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  615      
Buildings and Improvements 2,943      
Cost Capitalized Subsequent to Acquisition 60      
Gross Amount at which Carried at Close of Period        
Land  615      
Building and Improvements 2,654      
Total  3,269      
Accumulated Depreciation and Amortization (870)      
Skilled Nursing/Transitional Care | Bartlesville, OK        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,332      
Buildings and Improvements 6,904      
Cost Capitalized Subsequent to Acquisition 986      
Gross Amount at which Carried at Close of Period        
Land  1,332      
Building and Improvements 7,470      
Total  8,802      
Accumulated Depreciation and Amortization (2,327)      
Skilled Nursing/Transitional Care | Oklahoma City, OK        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,189      
Buildings and Improvements 23,567      
Cost Capitalized Subsequent to Acquisition 2,534      
Gross Amount at which Carried at Close of Period        
Land  2,189      
Building and Improvements 25,033      
Total  27,222      
Accumulated Depreciation and Amortization (7,536)      
Skilled Nursing/Transitional Care | Norman, OK        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  869      
Buildings and Improvements 5,236      
Cost Capitalized Subsequent to Acquisition 785      
Gross Amount at which Carried at Close of Period        
Land  869      
Building and Improvements 5,520      
Total  6,389      
Accumulated Depreciation and Amortization (1,791)      
Skilled Nursing/Transitional Care | Minneapolis, MN        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,931      
Buildings and Improvements 6,943      
Cost Capitalized Subsequent to Acquisition 1,190      
Gross Amount at which Carried at Close of Period        
Land  2,931      
Building and Improvements 7,968      
Total  10,899      
Accumulated Depreciation and Amortization (2,406)      
Skilled Nursing/Transitional Care | Eugene, OR 1        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,205      
Buildings and Improvements 28,700      
Cost Capitalized Subsequent to Acquisition 2,252      
Gross Amount at which Carried at Close of Period        
Land  2,205      
Building and Improvements 30,952      
Total  33,157      
Accumulated Depreciation and Amortization (7,741)      
Skilled Nursing/Transitional Care | Lebanon, OR        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  958      
Buildings and Improvements 14,176      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  958      
Building and Improvements 14,176      
Total  15,134      
Accumulated Depreciation and Amortization (3,193)      
Skilled Nursing/Transitional Care | Portland, OR        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,791      
Buildings and Improvements 12,833      
Cost Capitalized Subsequent to Acquisition 2,761      
Gross Amount at which Carried at Close of Period        
Land  1,791      
Building and Improvements 15,594      
Total  17,385      
Accumulated Depreciation and Amortization (4,561)      
Skilled Nursing/Transitional Care | Tigard, OR        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,011      
Buildings and Improvements 11,667      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  2,011      
Building and Improvements 11,667      
Total  13,678      
Accumulated Depreciation and Amortization (2,716)      
Skilled Nursing/Transitional Care | Hillsboro, OR        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,387      
Buildings and Improvements 14,028      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,387      
Building and Improvements 14,028      
Total  15,415      
Accumulated Depreciation and Amortization (3,157)      
Skilled Nursing/Transitional Care | Junction City, OR        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  584      
Buildings and Improvements 7,901      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  584      
Building and Improvements 7,901      
Total  8,485      
Accumulated Depreciation and Amortization (1,846)      
Skilled Nursing/Transitional Care | Eugene, OR 2        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,380      
Buildings and Improvements 14,921      
Cost Capitalized Subsequent to Acquisition 1,791      
Gross Amount at which Carried at Close of Period        
Land  1,380      
Building and Improvements 16,712      
Total  18,092      
Accumulated Depreciation and Amortization (4,502)      
Skilled Nursing/Transitional Care | Coos Bay, OR        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  829      
Buildings and Improvements 8,518      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  829      
Building and Improvements 8,518      
Total  9,347      
Accumulated Depreciation and Amortization (2,065)      
Skilled Nursing/Transitional Care | Gladstone, OR        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  792      
Buildings and Improvements 5,000      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  792      
Building and Improvements 5,000      
Total  5,792      
Accumulated Depreciation and Amortization (1,193)      
Skilled Nursing/Transitional Care | Newport, OR        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  406      
Buildings and Improvements 5,001      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  406      
Building and Improvements 5,001      
Total  5,407      
Accumulated Depreciation and Amortization (1,140)      
Skilled Nursing/Transitional Care | Oregon City, OR        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,496      
Buildings and Improvements 12,142      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,496      
Building and Improvements 12,142      
Total  13,638      
Accumulated Depreciation and Amortization (2,732)      
Skilled Nursing/Transitional Care | Tacoma, WA 1        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,771      
Buildings and Improvements 11,595      
Cost Capitalized Subsequent to Acquisition 15      
Gross Amount at which Carried at Close of Period        
Land  1,771      
Building and Improvements 11,610      
Total  13,381      
Accumulated Depreciation and Amortization (3,044)      
Skilled Nursing/Transitional Care | Shoreline, WA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  4,703      
Buildings and Improvements 14,444      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  4,703      
Building and Improvements 14,444      
Total  19,147      
Accumulated Depreciation and Amortization (3,367)      
Skilled Nursing/Transitional Care | Sequim, WA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  427      
Buildings and Improvements 4,450      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  427      
Building and Improvements 4,450      
Total  4,877      
Accumulated Depreciation and Amortization (1,256)      
Skilled Nursing/Transitional Care | Tacoma, WA 2        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,195      
Buildings and Improvements 1,956      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  2,195      
Building and Improvements 1,956      
Total  4,151      
Accumulated Depreciation and Amortization (637)      
Skilled Nursing/Transitional Care | Vancouver, WA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,782      
Buildings and Improvements 15,116      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,782      
Building and Improvements 15,116      
Total  16,898      
Accumulated Depreciation and Amortization (3,682)      
Skilled Nursing/Transitional Care | Lake Oswego, OR        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  5,947      
Buildings and Improvements 13,401      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  5,947      
Building and Improvements 13,401      
Total  19,348      
Accumulated Depreciation and Amortization (3,151)      
Skilled Nursing/Transitional Care | Medford, OR 1        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,043      
Buildings and Improvements 38,485      
Cost Capitalized Subsequent to Acquisition 2,960      
Gross Amount at which Carried at Close of Period        
Land  2,043      
Building and Improvements 41,445      
Total  43,488      
Accumulated Depreciation and Amortization (10,227)      
Skilled Nursing/Transitional Care | Seattle, WA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,508      
Buildings and Improvements 6,401      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  2,508      
Building and Improvements 6,401      
Total  8,909      
Accumulated Depreciation and Amortization (1,524)      
Skilled Nursing/Transitional Care | Boise, ID        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  681      
Buildings and Improvements 9,348      
Cost Capitalized Subsequent to Acquisition 627      
Gross Amount at which Carried at Close of Period        
Land  681      
Building and Improvements 9,975      
Total  10,656      
Accumulated Depreciation and Amortization (2,392)      
Skilled Nursing/Transitional Care | Salem, OR        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,114      
Buildings and Improvements 15,651      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  2,114      
Building and Improvements 15,651      
Total  17,765      
Accumulated Depreciation and Amortization (3,629)      
Skilled Nursing/Transitional Care | Medford, OR 2        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,375      
Buildings and Improvements 23,808      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,375      
Building and Improvements 23,808      
Total  25,183      
Accumulated Depreciation and Amortization (5,568)      
Skilled Nursing/Transitional Care | Northglenn, CO        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,662      
Buildings and Improvements 26,014      
Cost Capitalized Subsequent to Acquisition 3,258      
Gross Amount at which Carried at Close of Period        
Land  1,662      
Building and Improvements 29,272      
Total  30,934      
Accumulated Depreciation and Amortization (7,784)      
Skilled Nursing/Transitional Care | Brighton, CO        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,933      
Buildings and Improvements 11,624      
Cost Capitalized Subsequent to Acquisition 200      
Gross Amount at which Carried at Close of Period        
Land  1,933      
Building and Improvements 11,824      
Total  13,757      
Accumulated Depreciation and Amortization (2,861)      
Skilled Nursing/Transitional Care | Santa Ana, CA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,889      
Buildings and Improvements 11,682      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,889      
Building and Improvements 11,682      
Total  13,571      
Accumulated Depreciation and Amortization (2,562)      
Skilled Nursing/Transitional Care | La Mesa, CA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,276      
Buildings and Improvements 8,177      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,276      
Building and Improvements 8,177      
Total  9,453      
Accumulated Depreciation and Amortization (1,864)      
Skilled Nursing/Transitional Care | Westminster, MD        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,128      
Buildings and Improvements 6,614      
Cost Capitalized Subsequent to Acquisition 487      
Gross Amount at which Carried at Close of Period        
Land  2,128      
Building and Improvements 6,977      
Total  9,105      
Accumulated Depreciation and Amortization (2,134)      
Skilled Nursing/Transitional Care | Kansas City, MO        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,985      
Buildings and Improvements 2,714      
Cost Capitalized Subsequent to Acquisition 303      
Gross Amount at which Carried at Close of Period        
Land  1,714      
Building and Improvements 0      
Total  1,714      
Accumulated Depreciation and Amortization 0      
Skilled Nursing/Transitional Care | Parkersburg, WV        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  697      
Buildings and Improvements 10,688      
Cost Capitalized Subsequent to Acquisition 285      
Gross Amount at which Carried at Close of Period        
Land  697      
Building and Improvements 10,911      
Total  11,608      
Accumulated Depreciation and Amortization (3,206)      
Skilled Nursing/Transitional Care | Cincinnati, OH        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,686      
Buildings and Improvements 10,062      
Cost Capitalized Subsequent to Acquisition 700      
Gross Amount at which Carried at Close of Period        
Land  2,686      
Building and Improvements 10,762      
Total  13,448      
Accumulated Depreciation and Amortization (2,738)      
Skilled Nursing/Transitional Care | Charlottesville, VA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,840      
Buildings and Improvements 8,450      
Cost Capitalized Subsequent to Acquisition 1,176      
Gross Amount at which Carried at Close of Period        
Land  2,840      
Building and Improvements 9,147      
Total  11,987      
Accumulated Depreciation and Amortization (2,685)      
Skilled Nursing/Transitional Care | Annandale, VA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  7,241      
Buildings and Improvements 17,727      
Cost Capitalized Subsequent to Acquisition 3,218      
Gross Amount at which Carried at Close of Period        
Land  7,241      
Building and Improvements 20,150      
Total  27,391      
Accumulated Depreciation and Amortization (5,432)      
Skilled Nursing/Transitional Care | Petersburg, VA 1        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  988      
Buildings and Improvements 8,416      
Cost Capitalized Subsequent to Acquisition 146      
Gross Amount at which Carried at Close of Period        
Land  988      
Building and Improvements 8,473      
Total  9,461      
Accumulated Depreciation and Amortization (2,196)      
Skilled Nursing/Transitional Care | Petersburg, VA 2        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,174      
Buildings and Improvements 8,858      
Cost Capitalized Subsequent to Acquisition 151      
Gross Amount at which Carried at Close of Period        
Land  1,174      
Building and Improvements 8,942      
Total  10,116      
Accumulated Depreciation and Amortization (2,303)      
Skilled Nursing/Transitional Care | Hagerstown, MD        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,393      
Buildings and Improvements 13,438      
Cost Capitalized Subsequent to Acquisition 150      
Gross Amount at which Carried at Close of Period        
Land  1,393      
Building and Improvements 13,477      
Total  14,870      
Accumulated Depreciation and Amortization (3,290)      
Skilled Nursing/Transitional Care | Cumberland, MD        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  800      
Buildings and Improvements 16,973      
Cost Capitalized Subsequent to Acquisition 457      
Gross Amount at which Carried at Close of Period        
Land  800      
Building and Improvements 17,300      
Total  18,100      
Accumulated Depreciation and Amortization (4,261)      
Skilled Nursing/Transitional Care | Mount Pleasant, SC        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,689      
Buildings and Improvements 3,942      
Cost Capitalized Subsequent to Acquisition 205      
Gross Amount at which Carried at Close of Period        
Land  2,689      
Building and Improvements 4,147      
Total  6,836      
Accumulated Depreciation and Amortization (1,117)      
Skilled Nursing/Transitional Care | Harrogate, TN        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,811      
Buildings and Improvements 4,963      
Cost Capitalized Subsequent to Acquisition 268      
Gross Amount at which Carried at Close of Period        
Land  1,811      
Building and Improvements 5,232      
Total  7,043      
Accumulated Depreciation and Amortization (1,386)      
Skilled Nursing/Transitional Care | Conway, SC        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,408      
Buildings and Improvements 10,784      
Cost Capitalized Subsequent to Acquisition 551      
Gross Amount at which Carried at Close of Period        
Land  1,408      
Building and Improvements 11,335      
Total  12,743      
Accumulated Depreciation and Amortization (2,764)      
Skilled Nursing/Transitional Care | Baytown, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  426      
Buildings and Improvements 3,236      
Cost Capitalized Subsequent to Acquisition 173      
Gross Amount at which Carried at Close of Period        
Land  426      
Building and Improvements 3,251      
Total  3,677      
Accumulated Depreciation and Amortization (896)      
Skilled Nursing/Transitional Care | Huntsville, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  302      
Buildings and Improvements 3,153      
Cost Capitalized Subsequent to Acquisition 75      
Gross Amount at which Carried at Close of Period        
Land  302      
Building and Improvements 3,168      
Total  3,470      
Accumulated Depreciation and Amortization (847)      
Skilled Nursing/Transitional Care | Center, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  231      
Buildings and Improvements 1,335      
Cost Capitalized Subsequent to Acquisition 312      
Gross Amount at which Carried at Close of Period        
Land  231      
Building and Improvements 1,477      
Total  1,708      
Accumulated Depreciation and Amortization (523)      
Skilled Nursing/Transitional Care | Humble, TX 1        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,114      
Buildings and Improvements 1,643      
Cost Capitalized Subsequent to Acquisition 596      
Gross Amount at which Carried at Close of Period        
Land  2,114      
Building and Improvements 1,953      
Total  4,067      
Accumulated Depreciation and Amortization (753)      
Skilled Nursing/Transitional Care | Houston, TX 1        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,019      
Buildings and Improvements 5,734      
Cost Capitalized Subsequent to Acquisition 318      
Gross Amount at which Carried at Close of Period        
Land  1,019      
Building and Improvements 5,807      
Total  6,826      
Accumulated Depreciation and Amortization (1,479)      
Skilled Nursing/Transitional Care | Linden, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  112      
Buildings and Improvements 256      
Cost Capitalized Subsequent to Acquisition 133      
Gross Amount at which Carried at Close of Period        
Land  112      
Building and Improvements 280      
Total  392      
Accumulated Depreciation and Amortization (128)      
Skilled Nursing/Transitional Care | Sherman, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  469      
Buildings and Improvements 6,310      
Cost Capitalized Subsequent to Acquisition 255      
Gross Amount at which Carried at Close of Period        
Land  469      
Building and Improvements 6,338      
Total  6,807      
Accumulated Depreciation and Amortization (1,563)      
Skilled Nursing/Transitional Care | Mount Pleasant, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  250      
Buildings and Improvements 6,913      
Cost Capitalized Subsequent to Acquisition 345      
Gross Amount at which Carried at Close of Period        
Land  250      
Building and Improvements 7,160      
Total  7,410      
Accumulated Depreciation and Amortization (1,809)      
Skilled Nursing/Transitional Care | Waxahachie, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  416      
Buildings and Improvements 7,259      
Cost Capitalized Subsequent to Acquisition 976      
Gross Amount at which Carried at Close of Period        
Land  416      
Building and Improvements 7,968      
Total  8,384      
Accumulated Depreciation and Amortization (2,067)      
Skilled Nursing/Transitional Care | Gilmer, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  707      
Buildings and Improvements 4,552      
Cost Capitalized Subsequent to Acquisition 93      
Gross Amount at which Carried at Close of Period        
Land  707      
Building and Improvements 4,562      
Total  5,269      
Accumulated Depreciation and Amortization (1,198)      
Skilled Nursing/Transitional Care | Sparks, NV 1        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,986      
Buildings and Improvements 9,004      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,986      
Building and Improvements 9,004      
Total  10,990      
Accumulated Depreciation and Amortization (2,255)      
Skilled Nursing/Transitional Care | Richmond, IN        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  259      
Buildings and Improvements 9,819      
Cost Capitalized Subsequent to Acquisition 131      
Gross Amount at which Carried at Close of Period        
Land  259      
Building and Improvements 9,819      
Total  10,078      
Accumulated Depreciation and Amortization (2,339)      
Skilled Nursing/Transitional Care | Petersburg, IN        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  581      
Buildings and Improvements 5,367      
Cost Capitalized Subsequent to Acquisition 23      
Gross Amount at which Carried at Close of Period        
Land  581      
Building and Improvements 5,366      
Total  5,947      
Accumulated Depreciation and Amortization (1,369)      
Skilled Nursing/Transitional Care | Maryville, MO        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  114      
Buildings and Improvements 5,955      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  150      
Building and Improvements 5,955      
Total  6,105      
Accumulated Depreciation and Amortization (1,562)      
Skilled Nursing/Transitional Care | Doniphan, MO        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  657      
Buildings and Improvements 8,251      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  657      
Building and Improvements 8,251      
Total  8,908      
Accumulated Depreciation and Amortization (2,041)      
Skilled Nursing/Transitional Care | Dixon, MO        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  521      
Buildings and Improvements 3,358      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  75      
Building and Improvements 360      
Total  435      
Accumulated Depreciation and Amortization (4)      
Skilled Nursing/Transitional Care | Forsyth, MO        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  594      
Buildings and Improvements 8,549      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  594      
Building and Improvements 8,549      
Total  9,143      
Accumulated Depreciation and Amortization (2,146)      
Skilled Nursing/Transitional Care | Seymour, MO        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  658      
Buildings and Improvements 901      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  658      
Building and Improvements 901      
Total  1,559      
Accumulated Depreciation and Amortization (316)      
Skilled Nursing/Transitional Care | Silex, MO        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  807      
Buildings and Improvements 4,990      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  88      
Building and Improvements 412      
Total  500      
Accumulated Depreciation and Amortization (8)      
Skilled Nursing/Transitional Care | Columbia, MO        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,322      
Buildings and Improvements 6,547      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  2,322      
Building and Improvements 6,547      
Total  8,869      
Accumulated Depreciation and Amortization (1,694)      
Skilled Nursing/Transitional Care | Strafford, MO        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,634      
Buildings and Improvements 6,518      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,634      
Building and Improvements 6,518      
Total  8,152      
Accumulated Depreciation and Amortization (1,648)      
Skilled Nursing/Transitional Care | Windsor, MO        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  471      
Buildings and Improvements 6,819      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  471      
Building and Improvements 6,819      
Total  7,290      
Accumulated Depreciation and Amortization (1,564)      
Skilled Nursing/Transitional Care | Conroe, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,222      
Buildings and Improvements 19,099      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,222      
Building and Improvements 19,099      
Total  20,321      
Accumulated Depreciation and Amortization (4,278)      
Skilled Nursing/Transitional Care | Houston, TX 2        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,334      
Buildings and Improvements 11,615      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,334      
Building and Improvements 11,615      
Total  12,949      
Accumulated Depreciation and Amortization (2,711)      
Skilled Nursing/Transitional Care | Humble, TX 2        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,541      
Buildings and Improvements 12,332      
Cost Capitalized Subsequent to Acquisition 645      
Gross Amount at which Carried at Close of Period        
Land  1,541      
Building and Improvements 12,806      
Total  14,347      
Accumulated Depreciation and Amortization (3,254)      
Skilled Nursing/Transitional Care | Missouri City, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,825      
Buildings and Improvements 9,681      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,825      
Building and Improvements 9,681      
Total  11,506      
Accumulated Depreciation and Amortization (2,347)      
Skilled Nursing/Transitional Care | Houston, TX 3        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,676      
Buildings and Improvements 7,396      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  2,676      
Building and Improvements 7,396      
Total  10,072      
Accumulated Depreciation and Amortization (1,835)      
Skilled Nursing/Transitional Care | Houston, TX 4        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,732      
Buildings and Improvements 12,921      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,732      
Building and Improvements 12,921      
Total  14,653      
Accumulated Depreciation and Amortization (2,992)      
Skilled Nursing/Transitional Care | Topeka, KS        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  176      
Buildings and Improvements 2,340      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  176      
Building and Improvements 2,340      
Total  2,516      
Accumulated Depreciation and Amortization (624)      
Skilled Nursing/Transitional Care | Salina, KS        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  301      
Buildings and Improvements 4,201      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  301      
Building and Improvements 4,201      
Total  4,502      
Accumulated Depreciation and Amortization (1,071)      
Skilled Nursing/Transitional Care | Terre Haute, IN        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,067      
Buildings and Improvements 7,061      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,067      
Building and Improvements 7,061      
Total  8,128      
Accumulated Depreciation and Amortization (1,692)      
Skilled Nursing/Transitional Care | Gas City, IN        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  345      
Buildings and Improvements 8,852      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  345      
Building and Improvements 8,852      
Total  9,197      
Accumulated Depreciation and Amortization (2,021)      
Skilled Nursing/Transitional Care | Winchester, IN        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  711      
Buildings and Improvements 5,554      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  711      
Building and Improvements 5,554      
Total  6,265      
Accumulated Depreciation and Amortization (1,337)      
Skilled Nursing/Transitional Care | Columbus, IN        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,290      
Buildings and Improvements 10,714      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,290      
Building and Improvements 10,714      
Total  12,004      
Accumulated Depreciation and Amortization (2,458)      
Skilled Nursing/Transitional Care | Portland, IN        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  315      
Buildings and Improvements 9,848      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  315      
Building and Improvements 9,848      
Total  10,163      
Accumulated Depreciation and Amortization (2,293)      
Skilled Nursing/Transitional Care | Clinton, IN        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  884      
Buildings and Improvements 9,839      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  884      
Building and Improvements 9,839      
Total  10,723      
Accumulated Depreciation and Amortization (2,406)      
Skilled Nursing/Transitional Care | Las Vegas, NV 1        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  509      
Buildings and Improvements 18,216      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  509      
Building and Improvements 18,216      
Total  18,725      
Accumulated Depreciation and Amortization (3,995)      
Skilled Nursing/Transitional Care | Las Vegas, NV 2        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  3,169      
Buildings and Improvements 7,863      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  3,169      
Building and Improvements 7,863      
Total  11,032      
Accumulated Depreciation and Amortization (1,943)      
Skilled Nursing/Transitional Care | Alameda, CA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  3,078      
Buildings and Improvements 22,328      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  3,078      
Building and Improvements 22,328      
Total  25,406      
Accumulated Depreciation and Amortization (5,008)      
Skilled Nursing/Transitional Care | Dover, NH        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  522      
Buildings and Improvements 5,839      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  522      
Building and Improvements 5,839      
Total  6,361      
Accumulated Depreciation and Amortization (1,822)      
Skilled Nursing/Transitional Care | Augusta, ME        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  135      
Buildings and Improvements 6,470      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  135      
Building and Improvements 6,470      
Total  6,605      
Accumulated Depreciation and Amortization (1,587)      
Skilled Nursing/Transitional Care | Bangor, ME 1        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  302      
Buildings and Improvements 1,811      
Cost Capitalized Subsequent to Acquisition 2,211      
Gross Amount at which Carried at Close of Period        
Land  302      
Building and Improvements 3,771      
Total  4,073      
Accumulated Depreciation and Amortization (1,244)      
Skilled Nursing/Transitional Care | Bath, ME        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  250      
Buildings and Improvements 1,934      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  250      
Building and Improvements 1,934      
Total  2,184      
Accumulated Depreciation and Amortization (529)      
Skilled Nursing/Transitional Care | Brewer, ME        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  177      
Buildings and Improvements 14,497      
Cost Capitalized Subsequent to Acquisition 2,520      
Gross Amount at which Carried at Close of Period        
Land  177      
Building and Improvements 16,584      
Total  16,761      
Accumulated Depreciation and Amortization (4,192)      
Skilled Nursing/Transitional Care | Kennebunk, ME        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  198      
Buildings and Improvements 6,822      
Cost Capitalized Subsequent to Acquisition 2,005      
Gross Amount at which Carried at Close of Period        
Land  198      
Building and Improvements 8,827      
Total  9,025      
Accumulated Depreciation and Amortization (2,370)      
Skilled Nursing/Transitional Care | Norway, ME        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  791      
Buildings and Improvements 3,680      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  791      
Building and Improvements 3,680      
Total  4,471      
Accumulated Depreciation and Amortization (960)      
Skilled Nursing/Transitional Care | Yarmouth, ME        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  134      
Buildings and Improvements 2,072      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  134      
Building and Improvements 2,072      
Total  2,206      
Accumulated Depreciation and Amortization (581)      
Skilled Nursing/Transitional Care | Marlborough, MA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  942      
Buildings and Improvements 1,541      
Cost Capitalized Subsequent to Acquisition 8,727      
Gross Amount at which Carried at Close of Period        
Land  942      
Building and Improvements 9,707      
Total  10,649      
Accumulated Depreciation and Amortization (4,199)      
Skilled Nursing/Transitional Care | Bangor, ME 2        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  229      
Buildings and Improvements 7,171      
Cost Capitalized Subsequent to Acquisition 511      
Gross Amount at which Carried at Close of Period        
Land  229      
Building and Improvements 7,625      
Total  7,854      
Accumulated Depreciation and Amortization (1,897)      
Skilled Nursing/Transitional Care | Orange, CA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  4,163      
Buildings and Improvements 14,755      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  4,163      
Building and Improvements 14,755      
Total  18,918      
Accumulated Depreciation and Amortization (3,474)      
Skilled Nursing/Transitional Care | Lancaster, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  548      
Buildings and Improvements 5,794      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  548      
Building and Improvements 5,794      
Total  6,342      
Accumulated Depreciation and Amortization (1,500)      
Skilled Nursing/Transitional Care | Garland, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,118      
Buildings and Improvements 7,490      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,118      
Building and Improvements 7,490      
Total  8,608      
Accumulated Depreciation and Amortization (1,847)      
Skilled Nursing/Transitional Care | Clarksville, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  279      
Buildings and Improvements 4,269      
Cost Capitalized Subsequent to Acquisition 100      
Gross Amount at which Carried at Close of Period        
Land  279      
Building and Improvements 4,310      
Total  4,589      
Accumulated Depreciation and Amortization (1,210)      
Skilled Nursing/Transitional Care | McKinney, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,272      
Buildings and Improvements 6,047      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,272      
Building and Improvements 6,047      
Total  7,319      
Accumulated Depreciation and Amortization (1,601)      
Skilled Nursing/Transitional Care | Hendersonville, NC        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,611      
Buildings and Improvements 3,503      
Cost Capitalized Subsequent to Acquisition 1,100      
Gross Amount at which Carried at Close of Period        
Land  1,611      
Building and Improvements 4,603      
Total  6,214      
Accumulated Depreciation and Amortization (1,065)      
Skilled Nursing/Transitional Care | Baytown, TX 1        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  579      
Buildings and Improvements 22,317      
Cost Capitalized Subsequent to Acquisition 103      
Gross Amount at which Carried at Close of Period        
Land  579      
Building and Improvements 22,403      
Total  22,982      
Accumulated Depreciation and Amortization (5,074)      
Skilled Nursing/Transitional Care | Baytown, TX 2        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  589      
Buildings and Improvements 20,475      
Cost Capitalized Subsequent to Acquisition 362      
Gross Amount at which Carried at Close of Period        
Land  589      
Building and Improvements 20,636      
Total  21,225      
Accumulated Depreciation and Amortization (4,848)      
Skilled Nursing/Transitional Care | Houston, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,300      
Buildings and Improvements 13,353      
Cost Capitalized Subsequent to Acquisition 31      
Gross Amount at which Carried at Close of Period        
Land  1,300      
Building and Improvements 13,372      
Total  14,672      
Accumulated Depreciation and Amortization (3,245)      
Skilled Nursing/Transitional Care | Pasadena, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,148      
Buildings and Improvements 23,579      
Cost Capitalized Subsequent to Acquisition 47      
Gross Amount at which Carried at Close of Period        
Land  1,148      
Building and Improvements 23,595      
Total  24,743      
Accumulated Depreciation and Amortization (5,420)      
Skilled Nursing/Transitional Care | Webster, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  904      
Buildings and Improvements 10,315      
Cost Capitalized Subsequent to Acquisition 24      
Gross Amount at which Carried at Close of Period        
Land  904      
Building and Improvements 10,326      
Total  11,230      
Accumulated Depreciation and Amortization (2,565)      
Skilled Nursing/Transitional Care | Beaumont, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  945      
Buildings and Improvements 20,424      
Cost Capitalized Subsequent to Acquisition 272      
Gross Amount at which Carried at Close of Period        
Land  945      
Building and Improvements 20,607      
Total  21,552      
Accumulated Depreciation and Amortization (4,703)      
Skilled Nursing/Transitional Care | Orange, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  711      
Buildings and Improvements 10,737      
Cost Capitalized Subsequent to Acquisition 186      
Gross Amount at which Carried at Close of Period        
Land  711      
Building and Improvements 10,859      
Total  11,570      
Accumulated Depreciation and Amortization (2,594)      
Skilled Nursing/Transitional Care | Terre Haute, IN 1        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  644      
Buildings and Improvements 37,451      
Cost Capitalized Subsequent to Acquisition 59      
Gross Amount at which Carried at Close of Period        
Land  644      
Building and Improvements 37,511      
Total  38,155      
Accumulated Depreciation and Amortization (9,310)      
Skilled Nursing/Transitional Care | Savannah, GA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,235      
Buildings and Improvements 3,765      
Cost Capitalized Subsequent to Acquisition 18      
Gross Amount at which Carried at Close of Period        
Land  1,235      
Building and Improvements 3,783      
Total  5,018      
Accumulated Depreciation and Amortization (1,197)      
Skilled Nursing/Transitional Care | Bowling Green, KY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  280      
Buildings and Improvements 13,975      
Cost Capitalized Subsequent to Acquisition 32      
Gross Amount at which Carried at Close of Period        
Land  280      
Building and Improvements 14,007      
Total  14,287      
Accumulated Depreciation and Amortization (3,422)      
Skilled Nursing/Transitional Care | Calvert City, KY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,176      
Buildings and Improvements 7,012      
Cost Capitalized Subsequent to Acquisition 25      
Gross Amount at which Carried at Close of Period        
Land  1,176      
Building and Improvements 7,037      
Total  8,213      
Accumulated Depreciation and Amortization (1,827)      
Skilled Nursing/Transitional Care | Winchester, KY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  554      
Buildings and Improvements 13,207      
Cost Capitalized Subsequent to Acquisition 43      
Gross Amount at which Carried at Close of Period        
Land  554      
Building and Improvements 13,250      
Total  13,804      
Accumulated Depreciation and Amortization (3,306)      
Skilled Nursing/Transitional Care | Calhoun, KY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  613      
Buildings and Improvements 7,643      
Cost Capitalized Subsequent to Acquisition 30      
Gross Amount at which Carried at Close of Period        
Land  613      
Building and Improvements 7,673      
Total  8,286      
Accumulated Depreciation and Amortization (2,045)      
Skilled Nursing/Transitional Care | Bremen, IN        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  173      
Buildings and Improvements 7,393      
Cost Capitalized Subsequent to Acquisition 38      
Gross Amount at which Carried at Close of Period        
Land  173      
Building and Improvements 7,431      
Total  7,604      
Accumulated Depreciation and Amortization (1,813)      
Skilled Nursing/Transitional Care | Muncie, IN        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  374      
Buildings and Improvements 27,429      
Cost Capitalized Subsequent to Acquisition 38      
Gross Amount at which Carried at Close of Period        
Land  374      
Building and Improvements 27,467      
Total  27,841      
Accumulated Depreciation and Amortization (6,203)      
Skilled Nursing/Transitional Care | Lebanon, IN        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  612      
Buildings and Improvements 11,755      
Cost Capitalized Subsequent to Acquisition 39      
Gross Amount at which Carried at Close of Period        
Land  612      
Building and Improvements 11,794      
Total  12,406      
Accumulated Depreciation and Amortization (2,823)      
Skilled Nursing/Transitional Care | Marietta, GA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  364      
Buildings and Improvements 16,116      
Cost Capitalized Subsequent to Acquisition 20      
Gross Amount at which Carried at Close of Period        
Land  364      
Building and Improvements 16,137      
Total  16,501      
Accumulated Depreciation and Amortization (3,956)      
Skilled Nursing/Transitional Care | Danville, KY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  790      
Buildings and Improvements 9,356      
Cost Capitalized Subsequent to Acquisition 32      
Gross Amount at which Carried at Close of Period        
Land  790      
Building and Improvements 9,388      
Total  10,178      
Accumulated Depreciation and Amortization (2,699)      
Skilled Nursing/Transitional Care | Owensboro, KY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,048      
Buildings and Improvements 22,587      
Cost Capitalized Subsequent to Acquisition 40      
Gross Amount at which Carried at Close of Period        
Land  1,048      
Building and Improvements 22,627      
Total  23,675      
Accumulated Depreciation and Amortization (5,310)      
Skilled Nursing/Transitional Care | Memphis, TN        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,633      
Buildings and Improvements 9,371      
Cost Capitalized Subsequent to Acquisition 21      
Gross Amount at which Carried at Close of Period        
Land  1,633      
Building and Improvements 9,392      
Total  11,025      
Accumulated Depreciation and Amortization (2,413)      
Skilled Nursing/Transitional Care | Norfolk, VA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  705      
Buildings and Improvements 16,451      
Cost Capitalized Subsequent to Acquisition 33      
Gross Amount at which Carried at Close of Period        
Land  705      
Building and Improvements 16,485      
Total  17,190      
Accumulated Depreciation and Amortization (4,376)      
Skilled Nursing/Transitional Care | Harrodsburg, KY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,049      
Buildings and Improvements 9,851      
Cost Capitalized Subsequent to Acquisition 21      
Gross Amount at which Carried at Close of Period        
Land  1,049      
Building and Improvements 9,872      
Total  10,921      
Accumulated Depreciation and Amortization (2,700)      
Skilled Nursing/Transitional Care | Cookeville, TN        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,034      
Buildings and Improvements 15,555      
Cost Capitalized Subsequent to Acquisition 32      
Gross Amount at which Carried at Close of Period        
Land  1,034      
Building and Improvements 15,586      
Total  16,620      
Accumulated Depreciation and Amortization (3,743)      
Skilled Nursing/Transitional Care | Roanoke Rapids, NC        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  373      
Buildings and Improvements 10,308      
Cost Capitalized Subsequent to Acquisition 25      
Gross Amount at which Carried at Close of Period        
Land  373      
Building and Improvements 10,334      
Total  10,707      
Accumulated Depreciation and Amortization (2,728)      
Skilled Nursing/Transitional Care | Kinston, NC        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  954      
Buildings and Improvements 7,987      
Cost Capitalized Subsequent to Acquisition 73      
Gross Amount at which Carried at Close of Period        
Land  954      
Building and Improvements 8,059      
Total  9,013      
Accumulated Depreciation and Amortization (2,389)      
Skilled Nursing/Transitional Care | Chapel Hill, NC        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  809      
Buildings and Improvements 2,703      
Cost Capitalized Subsequent to Acquisition 1,191      
Gross Amount at which Carried at Close of Period        
Land  809      
Building and Improvements 3,893      
Total  4,702      
Accumulated Depreciation and Amortization (1,364)      
Skilled Nursing/Transitional Care | Pine Knot, KY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  208      
Buildings and Improvements 7,665      
Cost Capitalized Subsequent to Acquisition 23      
Gross Amount at which Carried at Close of Period        
Land  208      
Building and Improvements 7,689      
Total  7,897      
Accumulated Depreciation and Amortization (1,907)      
Skilled Nursing/Transitional Care | Bardstown, KY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  634      
Buildings and Improvements 4,094      
Cost Capitalized Subsequent to Acquisition 16      
Gross Amount at which Carried at Close of Period        
Land  634      
Building and Improvements 4,110      
Total  4,744      
Accumulated Depreciation and Amortization (1,191)      
Skilled Nursing/Transitional Care | Glasgow, KY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  83      
Buildings and Improvements 2,057      
Cost Capitalized Subsequent to Acquisition 28      
Gross Amount at which Carried at Close of Period        
Land  83      
Building and Improvements 2,086      
Total  2,169      
Accumulated Depreciation and Amortization (730)      
Skilled Nursing/Transitional Care | Carrollton, KY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  124      
Buildings and Improvements 1,693      
Cost Capitalized Subsequent to Acquisition 21      
Gross Amount at which Carried at Close of Period        
Land  124      
Building and Improvements 1,714      
Total  1,838      
Accumulated Depreciation and Amortization (630)      
Skilled Nursing/Transitional Care | Horse Cave, KY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  208      
Buildings and Improvements 7,070      
Cost Capitalized Subsequent to Acquisition 38      
Gross Amount at which Carried at Close of Period        
Land  208      
Building and Improvements 7,108      
Total  7,316      
Accumulated Depreciation and Amortization (1,927)      
Skilled Nursing/Transitional Care | Lawrenceburg, KY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  635      
Buildings and Improvements 9,861      
Cost Capitalized Subsequent to Acquisition 17      
Gross Amount at which Carried at Close of Period        
Land  635      
Building and Improvements 9,879      
Total  10,514      
Accumulated Depreciation and Amortization (2,485)      
Skilled Nursing/Transitional Care | Annville, KY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  479      
Buildings and Improvements 6,078      
Cost Capitalized Subsequent to Acquisition 17      
Gross Amount at which Carried at Close of Period        
Land  479      
Building and Improvements 6,095      
Total  6,574      
Accumulated Depreciation and Amortization (1,502)      
Skilled Nursing/Transitional Care | Louisville, KY 1        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  3,528      
Buildings and Improvements 4,653      
Cost Capitalized Subsequent to Acquisition 24      
Gross Amount at which Carried at Close of Period        
Land  3,528      
Building and Improvements 4,677      
Total  8,205      
Accumulated Depreciation and Amortization (1,444)      
Skilled Nursing/Transitional Care | Louisville, KY 2        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,207      
Buildings and Improvements 20,733      
Cost Capitalized Subsequent to Acquisition 38      
Gross Amount at which Carried at Close of Period        
Land  2,207      
Building and Improvements 20,770      
Total  22,977      
Accumulated Depreciation and Amortization (4,830)      
Skilled Nursing/Transitional Care | Tompkinsville, KY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  333      
Buildings and Improvements 9,556      
Cost Capitalized Subsequent to Acquisition 26      
Gross Amount at which Carried at Close of Period        
Land  333      
Building and Improvements 9,582      
Total  9,915      
Accumulated Depreciation and Amortization (2,384)      
Skilled Nursing/Transitional Care | Radcliff, KY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,815      
Buildings and Improvements 7,470      
Cost Capitalized Subsequent to Acquisition 34      
Gross Amount at which Carried at Close of Period        
Land  1,815      
Building and Improvements 7,504      
Total  9,319      
Accumulated Depreciation and Amortization (2,364)      
Skilled Nursing/Transitional Care | Hartford, KY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  312      
Buildings and Improvements 8,189      
Cost Capitalized Subsequent to Acquisition 21      
Gross Amount at which Carried at Close of Period        
Land  312      
Building and Improvements 8,210      
Total  8,522      
Accumulated Depreciation and Amortization (2,087)      
Skilled Nursing/Transitional Care | Louisville, KY 3        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  427      
Buildings and Improvements 6,003      
Cost Capitalized Subsequent to Acquisition 38      
Gross Amount at which Carried at Close of Period        
Land  427      
Building and Improvements 6,041      
Total  6,468      
Accumulated Depreciation and Amortization (1,632)      
Skilled Nursing/Transitional Care | Louisville, KY 4        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,134      
Buildings and Improvements 9,166      
Cost Capitalized Subsequent to Acquisition 28      
Gross Amount at which Carried at Close of Period        
Land  1,134      
Building and Improvements 9,194      
Total  10,328      
Accumulated Depreciation and Amortization (2,554)      
Skilled Nursing/Transitional Care | Lexington, KY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,558      
Buildings and Improvements 4,311      
Cost Capitalized Subsequent to Acquisition 2,101      
Gross Amount at which Carried at Close of Period        
Land  2,558      
Building and Improvements 6,412      
Total  8,970      
Accumulated Depreciation and Amortization (1,321)      
Skilled Nursing/Transitional Care | Columbia, KY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  114      
Buildings and Improvements 11,141      
Cost Capitalized Subsequent to Acquisition 28      
Gross Amount at which Carried at Close of Period        
Land  114      
Building and Improvements 11,169      
Total  11,283      
Accumulated Depreciation and Amortization (2,719)      
Skilled Nursing/Transitional Care | Savannah, GA 1        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,194      
Buildings and Improvements 11,711      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  2,194      
Building and Improvements 11,711      
Total  13,905      
Accumulated Depreciation and Amortization (2,737)      
Skilled Nursing/Transitional Care | Durham, NC        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  470      
Buildings and Improvements 9,633      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  470      
Building and Improvements 9,633      
Total  10,103      
Accumulated Depreciation and Amortization (2,230)      
Skilled Nursing/Transitional Care | Raleigh, NC 1        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,155      
Buildings and Improvements 11,749      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,155      
Building and Improvements 11,749      
Total  12,904      
Accumulated Depreciation and Amortization (2,786)      
Skilled Nursing/Transitional Care | Raleigh, NC 2        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  926      
Buildings and Improvements 17,649      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  926      
Building and Improvements 17,649      
Total  18,575      
Accumulated Depreciation and Amortization (4,112)      
Skilled Nursing/Transitional Care | Wilmington, NC        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  611      
Buildings and Improvements 5,051      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  611      
Building and Improvements 5,051      
Total  5,662      
Accumulated Depreciation and Amortization (1,336)      
Skilled Nursing/Transitional Care | Winston-Salem, NC        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  879      
Buildings and Improvements 3,283      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  879      
Building and Improvements 3,283      
Total  4,162      
Accumulated Depreciation and Amortization (991)      
Skilled Nursing/Transitional Care | Lincolnton, NC        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  0      
Buildings and Improvements 9,967      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  0      
Building and Improvements 9,967      
Total  9,967      
Accumulated Depreciation and Amortization (2,372)      
Skilled Nursing/Transitional Care | Monroe, NC        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  166      
Buildings and Improvements 5,906      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  166      
Building and Improvements 5,906      
Total  6,072      
Accumulated Depreciation and Amortization (1,564)      
Skilled Nursing/Transitional Care | Zebulon, NC        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  594      
Buildings and Improvements 8,559      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  594      
Building and Improvements 8,559      
Total  9,153      
Accumulated Depreciation and Amortization (1,956)      
Skilled Nursing/Transitional Care | Rocky Mount, NC        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  0      
Buildings and Improvements 18,314      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  0      
Building and Improvements 18,314      
Total  18,314      
Accumulated Depreciation and Amortization (4,109)      
Skilled Nursing/Transitional Care | DeSoto, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  942      
Buildings and Improvements 6,033      
Cost Capitalized Subsequent to Acquisition 320      
Gross Amount at which Carried at Close of Period        
Land  942      
Building and Improvements 6,353      
Total  7,295      
Accumulated Depreciation and Amortization (1,655)      
Skilled Nursing/Transitional Care | Trinity, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  363      
Buildings and Improvements 3,852      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  363      
Building and Improvements 3,852      
Total  4,215      
Accumulated Depreciation and Amortization (1,081)      
Skilled Nursing/Transitional Care | Marshall, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  732      
Buildings and Improvements 4,288      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  683      
Building and Improvements 4,288      
Total  4,971      
Accumulated Depreciation and Amortization (1,186)      
Skilled Nursing/Transitional Care | Warren, MI        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,052      
Buildings and Improvements 25,539      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  2,052      
Building and Improvements 25,539      
Total  27,591      
Accumulated Depreciation and Amortization (6,591)      
Skilled Nursing/Transitional Care | Hamburg, NY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,026      
Buildings and Improvements 54,086      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,026      
Building and Improvements 54,086      
Total  55,112      
Accumulated Depreciation and Amortization (12,202)      
Skilled Nursing/Transitional Care | East Patchogue, NY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,181      
Buildings and Improvements 30,373      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  2,181      
Building and Improvements 30,373      
Total  32,554      
Accumulated Depreciation and Amortization (7,208)      
Skilled Nursing/Transitional Care | Williamsville, NY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,122      
Buildings and Improvements 46,413      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,122      
Building and Improvements 46,413      
Total  47,535      
Accumulated Depreciation and Amortization (10,281)      
Skilled Nursing/Transitional Care | Cheektowaga, NY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,164      
Buildings and Improvements 29,905      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,164      
Building and Improvements 29,905      
Total  31,069      
Accumulated Depreciation and Amortization (7,020)      
Skilled Nursing/Transitional Care | North Tonawanda, NY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  830      
Buildings and Improvements 29,488      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  830      
Building and Improvements 29,488      
Total  30,318      
Accumulated Depreciation and Amortization (6,919)      
Skilled Nursing/Transitional Care | West Seneca, NY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,325      
Buildings and Improvements 26,839      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,325      
Building and Improvements 26,839      
Total  28,164      
Accumulated Depreciation and Amortization (6,181)      
Skilled Nursing/Transitional Care | Beverly, MA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,410      
Buildings and Improvements 13,588      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  2,410      
Building and Improvements 13,588      
Total  15,998      
Accumulated Depreciation and Amortization (4,209)      
Skilled Nursing/Transitional Care | Lancaster, MA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  343      
Buildings and Improvements 7,733      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  343      
Building and Improvements 7,733      
Total  8,076      
Accumulated Depreciation and Amortization (1,851)      
Skilled Nursing/Transitional Care | New London, CT        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  505      
Buildings and Improvements 2,248      
Cost Capitalized Subsequent to Acquisition 550      
Gross Amount at which Carried at Close of Period        
Land  505      
Building and Improvements 2,798      
Total  3,303      
Accumulated Depreciation and Amortization (1,000)      
Skilled Nursing/Transitional Care | Enfield, CT        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  437      
Buildings and Improvements 16,461      
Cost Capitalized Subsequent to Acquisition 231      
Gross Amount at which Carried at Close of Period        
Land  437      
Building and Improvements 16,692      
Total  17,129      
Accumulated Depreciation and Amortization (4,083)      
Skilled Nursing/Transitional Care | Fishkill, NY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  964      
Buildings and Improvements 30,107      
Cost Capitalized Subsequent to Acquisition 581      
Gross Amount at which Carried at Close of Period        
Land  964      
Building and Improvements 30,632      
Total  31,596      
Accumulated Depreciation and Amortization (7,221)      
Skilled Nursing/Transitional Care | Highland, NY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  4,371      
Buildings and Improvements 11,473      
Cost Capitalized Subsequent to Acquisition 495      
Gross Amount at which Carried at Close of Period        
Land  4,371      
Building and Improvements 11,941      
Total  16,312      
Accumulated Depreciation and Amortization (2,994)      
Skilled Nursing/Transitional Care | Beacon, NY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  0      
Buildings and Improvements 25,400      
Cost Capitalized Subsequent to Acquisition 507      
Gross Amount at which Carried at Close of Period        
Land  0      
Building and Improvements 25,885      
Total  25,885      
Accumulated Depreciation and Amortization (6,358)      
Skilled Nursing/Transitional Care | Sudbury, MA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,017      
Buildings and Improvements 3,458      
Cost Capitalized Subsequent to Acquisition 421      
Gross Amount at which Carried at Close of Period        
Land  1,736      
Building and Improvements 2,264      
Total  4,000      
Accumulated Depreciation and Amortization 0      
Skilled Nursing/Transitional Care | Long Beach, CA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,939      
Buildings and Improvements 11,782      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  2,939      
Building and Improvements 11,690      
Total  14,629      
Accumulated Depreciation and Amortization (2,965)      
Skilled Nursing/Transitional Care | Anaheim, CA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,044      
Buildings and Improvements 14,167      
Cost Capitalized Subsequent to Acquisition 121      
Gross Amount at which Carried at Close of Period        
Land  2,044      
Building and Improvements 14,288      
Total  16,332      
Accumulated Depreciation and Amortization (3,489)      
Skilled Nursing/Transitional Care | Fairfield, CA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  586      
Buildings and Improvements 23,582      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  586      
Building and Improvements 23,582      
Total  24,168      
Accumulated Depreciation and Amortization (5,406)      
Skilled Nursing/Transitional Care | Baldwin Park, CA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,270      
Buildings and Improvements 17,063      
Cost Capitalized Subsequent to Acquisition 262      
Gross Amount at which Carried at Close of Period        
Land  2,270      
Building and Improvements 17,325      
Total  19,595      
Accumulated Depreciation and Amortization (4,134)      
Skilled Nursing/Transitional Care | Grand Terrace, CA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  432      
Buildings and Improvements 9,382      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  432      
Building and Improvements 9,382      
Total  9,814      
Accumulated Depreciation and Amortization (2,286)      
Skilled Nursing/Transitional Care | Pacifica, CA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,510      
Buildings and Improvements 27,397      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,510      
Building and Improvements 27,397      
Total  28,907      
Accumulated Depreciation and Amortization (6,193)      
Skilled Nursing/Transitional Care | Burien, WA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  823      
Buildings and Improvements 17,431      
Cost Capitalized Subsequent to Acquisition 204      
Gross Amount at which Carried at Close of Period        
Land  826      
Building and Improvements 17,636      
Total  18,462      
Accumulated Depreciation and Amortization (4,170)      
Skilled Nursing/Transitional Care | Seattle, WA 1        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  4,802      
Buildings and Improvements 7,927      
Cost Capitalized Subsequent to Acquisition 70      
Gross Amount at which Carried at Close of Period        
Land  4,802      
Building and Improvements 7,997      
Total  12,799      
Accumulated Depreciation and Amortization (2,121)      
Skilled Nursing/Transitional Care | Huntington Beach, CA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,312      
Buildings and Improvements 9,885      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  2,312      
Building and Improvements 9,885      
Total  12,197      
Accumulated Depreciation and Amortization (2,399)      
Skilled Nursing/Transitional Care | Chatsworth, CA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  7,841      
Buildings and Improvements 16,916      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  7,841      
Building and Improvements 16,916      
Total  24,757      
Accumulated Depreciation and Amortization (4,276)      
Skilled Nursing/Transitional Care | Woodland, CA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  504      
Buildings and Improvements 7,369      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  504      
Building and Improvements 7,369      
Total  7,873      
Accumulated Depreciation and Amortization (1,881)      
Skilled Nursing/Transitional Care | Danville, CA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,491      
Buildings and Improvements 17,157      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,491      
Building and Improvements 17,157      
Total  18,648      
Accumulated Depreciation and Amortization (4,058)      
Skilled Nursing/Transitional Care | Van Nuys, CA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,456      
Buildings and Improvements 16,462      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  2,456      
Building and Improvements 16,462      
Total  18,918      
Accumulated Depreciation and Amortization (3,751)      
Skilled Nursing/Transitional Care | Lomita, CA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,743      
Buildings and Improvements 14,734      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  2,743      
Building and Improvements 14,734      
Total  17,477      
Accumulated Depreciation and Amortization (3,648)      
Skilled Nursing/Transitional Care | Sacramento, CA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,846      
Buildings and Improvements 17,962      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  2,846      
Building and Improvements 17,962      
Total  20,808      
Accumulated Depreciation and Amortization (4,196)      
Skilled Nursing/Transitional Care | Issaquah, WA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  10,125      
Buildings and Improvements 7,771      
Cost Capitalized Subsequent to Acquisition 5      
Gross Amount at which Carried at Close of Period        
Land  10,125      
Building and Improvements 7,776      
Total  17,901      
Accumulated Depreciation and Amortization (2,182)      
Skilled Nursing/Transitional Care | Long Beach, CA 1        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  3,157      
Buildings and Improvements 22,067      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  3,157      
Building and Improvements 22,067      
Total  25,224      
Accumulated Depreciation and Amortization (5,282)      
Skilled Nursing/Transitional Care | Long Beach, CA 2        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,857      
Buildings and Improvements 5,878      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  2,857      
Building and Improvements 5,878      
Total  8,735      
Accumulated Depreciation and Amortization (1,518)      
Skilled Nursing/Transitional Care | Lodi, CA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  812      
Buildings and Improvements 21,059      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  812      
Building and Improvements 21,059      
Total  21,871      
Accumulated Depreciation and Amortization (4,691)      
Skilled Nursing/Transitional Care | Riverside, CA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,717      
Buildings and Improvements 13,806      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,717      
Building and Improvements 13,806      
Total  15,523      
Accumulated Depreciation and Amortization (3,597)      
Skilled Nursing/Transitional Care | Woodland, CA 1        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  278      
Buildings and Improvements 16,729      
Cost Capitalized Subsequent to Acquisition 286      
Gross Amount at which Carried at Close of Period        
Land  278      
Building and Improvements 17,015      
Total  17,293      
Accumulated Depreciation and Amortization (3,947)      
Skilled Nursing/Transitional Care | Bee Cave, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,107      
Buildings and Improvements 10,413      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  2,107      
Building and Improvements 10,413      
Total  12,520      
Accumulated Depreciation and Amortization (2,834)      
Skilled Nursing/Transitional Care | El Monte, CA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,058      
Buildings and Improvements 19,671      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  2,058      
Building and Improvements 19,671      
Total  21,729      
Accumulated Depreciation and Amortization (4,535)      
Skilled Nursing/Transitional Care | Shoreline, WA 1        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  8,861      
Buildings and Improvements 11,478      
Cost Capitalized Subsequent to Acquisition 302      
Gross Amount at which Carried at Close of Period        
Land  8,788      
Building and Improvements 11,780      
Total  20,568      
Accumulated Depreciation and Amortization (3,201)      
Skilled Nursing/Transitional Care | Elizabethtown, KY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  729      
Buildings and Improvements 0      
Cost Capitalized Subsequent to Acquisition 19,414      
Gross Amount at which Carried at Close of Period        
Land  729      
Building and Improvements 19,414      
Total  20,143      
Accumulated Depreciation and Amortization (2,071)      
Skilled Nursing/Transitional Care | Crown Point, IN        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,491      
Buildings and Improvements 14,665      
Cost Capitalized Subsequent to Acquisition 272      
Gross Amount at which Carried at Close of Period        
Land  1,491      
Building and Improvements 14,937      
Total  16,428      
Accumulated Depreciation and Amortization (1,014)      
Skilled Nursing/Transitional Care | Dyer, IN        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,859      
Buildings and Improvements 19,562      
Cost Capitalized Subsequent to Acquisition 500      
Gross Amount at which Carried at Close of Period        
Land  1,859      
Building and Improvements 20,062      
Total  21,921      
Accumulated Depreciation and Amortization (1,336)      
Senior Housing - Leased        
Real Estate and Accumulated Depreciation        
Encumbrances 21,698      
Initial Cost to Company        
Land  26,502      
Buildings and Improvements 332,107      
Cost Capitalized Subsequent to Acquisition 17,968      
Gross Amount at which Carried at Close of Period        
Land  28,082      
Building and Improvements 348,508      
Total  376,590      
Accumulated Depreciation and Amortization (90,236)      
Senior Housing - Leased | Rockport, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  789      
Buildings and Improvements 607      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  789      
Building and Improvements 475      
Total  1,264      
Accumulated Depreciation and Amortization (216)      
Senior Housing - Leased | Norman, OK        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  557      
Buildings and Improvements 2,663      
Cost Capitalized Subsequent to Acquisition 2,533      
Gross Amount at which Carried at Close of Period        
Land  557      
Building and Improvements 5,196      
Total  5,753      
Accumulated Depreciation and Amortization (310)      
Senior Housing - Leased | Topeka, KS        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  313      
Buildings and Improvements 5,492      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  313      
Building and Improvements 5,492      
Total  5,805      
Accumulated Depreciation and Amortization (1,272)      
Senior Housing - Leased | Salina, KS        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  584      
Buildings and Improvements 3,020      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  584      
Building and Improvements 3,020      
Total  3,604      
Accumulated Depreciation and Amortization (757)      
Senior Housing - Leased | Dover, NH        
Real Estate and Accumulated Depreciation        
Encumbrances 1,747      
Initial Cost to Company        
Land  801      
Buildings and Improvements 10,036      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  801      
Building and Improvements 8,317      
Total  9,118      
Accumulated Depreciation and Amortization (4,168)      
Senior Housing - Leased | Exeter, NH        
Real Estate and Accumulated Depreciation        
Encumbrances 1,407      
Initial Cost to Company        
Land  571      
Buildings and Improvements 7,183      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  571      
Building and Improvements 5,847      
Total  6,418      
Accumulated Depreciation and Amortization (2,984)      
Senior Housing - Leased | Nashua, NH        
Real Estate and Accumulated Depreciation        
Encumbrances 4,151      
Initial Cost to Company        
Land  0      
Buildings and Improvements 5,654      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  0      
Building and Improvements 4,566      
Total  4,566      
Accumulated Depreciation and Amortization (2,179)      
Senior Housing - Leased | Keene, NH        
Real Estate and Accumulated Depreciation        
Encumbrances 2,759      
Initial Cost to Company        
Land  304      
Buildings and Improvements 3,992      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  304      
Building and Improvements 3,241      
Total  3,545      
Accumulated Depreciation and Amortization (1,773)      
Senior Housing - Leased | Green Bay, WI        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  256      
Buildings and Improvements 2,262      
Cost Capitalized Subsequent to Acquisition 1,032      
Gross Amount at which Carried at Close of Period        
Land  256      
Building and Improvements 1,976      
Total  2,232      
Accumulated Depreciation and Amortization (894)      
Senior Housing - Leased | Cadillac, MI        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  217      
Buildings and Improvements 3,000      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  217      
Building and Improvements 2,920      
Total  3,137      
Accumulated Depreciation and Amortization (1,074)      
Senior Housing - Leased | Greenville, MI        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  684      
Buildings and Improvements 5,832      
Cost Capitalized Subsequent to Acquisition 372      
Gross Amount at which Carried at Close of Period        
Land  684      
Building and Improvements 5,965      
Total  6,649      
Accumulated Depreciation and Amortization (2,226)      
Senior Housing - Leased | Manistee, MI        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  952      
Buildings and Improvements 2,578      
Cost Capitalized Subsequent to Acquisition 2,547      
Gross Amount at which Carried at Close of Period        
Land  952      
Building and Improvements 5,076      
Total  6,028      
Accumulated Depreciation and Amortization (2,490)      
Senior Housing - Leased | Mason, MI        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  198      
Buildings and Improvements 4,131      
Cost Capitalized Subsequent to Acquisition 43      
Gross Amount at which Carried at Close of Period        
Land  198      
Building and Improvements 4,074      
Total  4,272      
Accumulated Depreciation and Amortization (1,564)      
Senior Housing - Leased | Alpena, MI        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  546      
Buildings and Improvements 13,139      
Cost Capitalized Subsequent to Acquisition 28      
Gross Amount at which Carried at Close of Period        
Land  546      
Building and Improvements 13,028      
Total  13,574      
Accumulated Depreciation and Amortization (4,443)      
Senior Housing - Leased | Fremont, NE        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  504      
Buildings and Improvements 17,670      
Cost Capitalized Subsequent to Acquisition 283      
Gross Amount at which Carried at Close of Period        
Land  504      
Building and Improvements 17,241      
Total  17,745      
Accumulated Depreciation and Amortization (5,191)      
Senior Housing - Leased | Norfolk, NE        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  217      
Buildings and Improvements 9,906      
Cost Capitalized Subsequent to Acquisition 4,978      
Gross Amount at which Carried at Close of Period        
Land  217      
Building and Improvements 14,231      
Total  14,448      
Accumulated Depreciation and Amortization (4,813)      
Senior Housing - Leased | Fort Wayne, IN        
Real Estate and Accumulated Depreciation        
Encumbrances 11,634      
Initial Cost to Company        
Land  2,300      
Buildings and Improvements 21,115      
Cost Capitalized Subsequent to Acquisition 2,747      
Gross Amount at which Carried at Close of Period        
Land  2,300      
Building and Improvements 23,091      
Total  25,391      
Accumulated Depreciation and Amortization (8,611)      
Senior Housing - Leased | Brandon, FL        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,283      
Buildings and Improvements 8,424      
Cost Capitalized Subsequent to Acquisition 1,006      
Gross Amount at which Carried at Close of Period        
Land  1,283      
Building and Improvements 8,720      
Total  10,003      
Accumulated Depreciation and Amortization (2,530)      
Senior Housing - Leased | Lecanto, FL        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,031      
Buildings and Improvements 5,577      
Cost Capitalized Subsequent to Acquisition 805      
Gross Amount at which Carried at Close of Period        
Land  1,023      
Building and Improvements 5,681      
Total  6,704      
Accumulated Depreciation and Amortization (1,892)      
Senior Housing - Leased | Zephyrhills, FL        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,688      
Buildings and Improvements 9,098      
Cost Capitalized Subsequent to Acquisition 546      
Gross Amount at which Carried at Close of Period        
Land  1,688      
Building and Improvements 8,878      
Total  10,566      
Accumulated Depreciation and Amortization (2,838)      
Senior Housing - Leased | Sun City West, AZ        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  930      
Buildings and Improvements 9,170      
Cost Capitalized Subsequent to Acquisition 248      
Gross Amount at which Carried at Close of Period        
Land  930      
Building and Improvements 9,418      
Total  10,348      
Accumulated Depreciation and Amortization (2,779)      
Senior Housing - Leased | Santa Fe, NM 1        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,866      
Buildings and Improvements 19,441      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  2,157      
Building and Improvements 21,736      
Total  23,893      
Accumulated Depreciation and Amortization (5,883)      
Senior Housing - Leased | Santa Fe, NM 2        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  670      
Buildings and Improvements 7,743      
Cost Capitalized Subsequent to Acquisition 430      
Gross Amount at which Carried at Close of Period        
Land  670      
Building and Improvements 8,380      
Total  9,050      
Accumulated Depreciation and Amortization (1,129)      
Senior Housing - Leased | Franklin, NH        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  292      
Buildings and Improvements 6,889      
Cost Capitalized Subsequent to Acquisition 211      
Gross Amount at which Carried at Close of Period        
Land  292      
Building and Improvements 7,110      
Total  7,402      
Accumulated Depreciation and Amortization (2,197)      
Senior Housing - Leased | Brenham, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  476      
Buildings and Improvements 11,912      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  476      
Building and Improvements 11,922      
Total  12,398      
Accumulated Depreciation and Amortization (3,530)      
Senior Housing - Leased | Keizer, OR        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,220      
Buildings and Improvements 31,783      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,220      
Building and Improvements 31,783      
Total  33,003      
Accumulated Depreciation and Amortization (7,152)      
Senior Housing - Leased | Lawrence, KS        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  584      
Buildings and Improvements 4,431      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  584      
Building and Improvements 4,431      
Total  5,015      
Accumulated Depreciation and Amortization (1,117)      
Senior Housing - Leased | Lafayette, CO        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,085      
Buildings and Improvements 19,243      
Cost Capitalized Subsequent to Acquisition 9      
Gross Amount at which Carried at Close of Period        
Land  1,883      
Building and Improvements 19,205      
Total  21,088      
Accumulated Depreciation and Amortization (4,465)      
Senior Housing - Leased | Knoxville, TN        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,603      
Buildings and Improvements 9,219      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,603      
Building and Improvements 9,219      
Total  10,822      
Accumulated Depreciation and Amortization (2,270)      
Senior Housing - Leased | Shavano Park, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,131      
Buildings and Improvements 11,541      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  2,131      
Building and Improvements 11,541      
Total  13,672      
Accumulated Depreciation and Amortization (2,598)      
Senior Housing - Leased | Jasper, IN        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  657      
Buildings and Improvements 25,226      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,156      
Building and Improvements 32,448      
Total  33,604      
Accumulated Depreciation and Amortization (3,202)      
Senior Housing - Leased | Florence, KY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,193      
Buildings and Improvements 34,130      
Cost Capitalized Subsequent to Acquisition 150      
Gross Amount at which Carried at Close of Period        
Land  1,193      
Building and Improvements 34,280      
Total  35,473      
Accumulated Depreciation and Amortization (1,689)      
Senior housing - managed portfolio        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  176,358      
Buildings and Improvements 1,720,468      
Cost Capitalized Subsequent to Acquisition 80,285      
Gross Amount at which Carried at Close of Period        
Land  176,907      
Building and Improvements 1,853,360      
Total  2,030,267      
Accumulated Depreciation and Amortization (349,213)      
Senior housing - managed portfolio | Dover, DE        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,797      
Buildings and Improvements 23,054      
Cost Capitalized Subsequent to Acquisition 711      
Gross Amount at which Carried at Close of Period        
Land  2,797      
Building and Improvements 24,797      
Total  27,594      
Accumulated Depreciation and Amortization (5,648)      
Senior housing - managed portfolio | Salem, OR        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,074      
Buildings and Improvements 19,421      
Cost Capitalized Subsequent to Acquisition 587      
Gross Amount at which Carried at Close of Period        
Land  1,074      
Building and Improvements 19,483      
Total  20,557      
Accumulated Depreciation and Amortization (5,252)      
Senior housing - managed portfolio | Kansas City, MO        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,325      
Buildings and Improvements 20,510      
Cost Capitalized Subsequent to Acquisition 2,218      
Gross Amount at which Carried at Close of Period        
Land  1,325      
Building and Improvements 25,598      
Total  26,923      
Accumulated Depreciation and Amortization (6,849)      
Senior housing - managed portfolio | Cincinnati, OH        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  3,089      
Buildings and Improvements 30,258      
Cost Capitalized Subsequent to Acquisition 75      
Gross Amount at which Carried at Close of Period        
Land  3,089      
Building and Improvements 30,403      
Total  33,492      
Accumulated Depreciation and Amortization (1,325)      
Senior housing - managed portfolio | Columbus, IN        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,781      
Buildings and Improvements 36,482      
Cost Capitalized Subsequent to Acquisition 197      
Gross Amount at which Carried at Close of Period        
Land  2,781      
Building and Improvements 36,740      
Total  39,521      
Accumulated Depreciation and Amortization (1,636)      
Senior housing - managed portfolio | McKinney, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,760      
Buildings and Improvements 44,397      
Cost Capitalized Subsequent to Acquisition 3,021      
Gross Amount at which Carried at Close of Period        
Land  2,760      
Building and Improvements 49,790      
Total  52,550      
Accumulated Depreciation and Amortization (13,654)      
Senior housing - managed portfolio | Louisville, KY 4        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,841      
Buildings and Improvements 21,827      
Cost Capitalized Subsequent to Acquisition 182      
Gross Amount at which Carried at Close of Period        
Land  1,841      
Building and Improvements 22,037      
Total  23,878      
Accumulated Depreciation and Amortization (3,574)      
Senior housing - managed portfolio | Winston-Salem, NC        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,995      
Buildings and Improvements 24,428      
Cost Capitalized Subsequent to Acquisition 1,159      
Gross Amount at which Carried at Close of Period        
Land  2,995      
Building and Improvements 26,424      
Total  29,419      
Accumulated Depreciation and Amortization (7,705)      
Senior housing - managed portfolio | Frankenmuth, MI        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  5,027      
Buildings and Improvements 20,929      
Cost Capitalized Subsequent to Acquisition 2,246      
Gross Amount at which Carried at Close of Period        
Land  5,027      
Building and Improvements 25,155      
Total  30,182      
Accumulated Depreciation and Amortization (7,727)      
Senior housing - managed portfolio | Gaylord, MI        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,024      
Buildings and Improvements 5,467      
Cost Capitalized Subsequent to Acquisition 231      
Gross Amount at which Carried at Close of Period        
Land  2,024      
Building and Improvements 5,753      
Total  7,777      
Accumulated Depreciation and Amortization (2,535)      
Senior housing - managed portfolio | Tawas, MI        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  258      
Buildings and Improvements 3,713      
Cost Capitalized Subsequent to Acquisition 624      
Gross Amount at which Carried at Close of Period        
Land  258      
Building and Improvements 4,475      
Total  4,733      
Accumulated Depreciation and Amortization (2,011)      
Senior housing - managed portfolio | Marshfield, WI        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  574      
Buildings and Improvements 8,733      
Cost Capitalized Subsequent to Acquisition 304      
Gross Amount at which Carried at Close of Period        
Land  574      
Building and Improvements 8,877      
Total  9,451      
Accumulated Depreciation and Amortization (3,120)      
Senior housing - managed portfolio | Woodstock, VA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  597      
Buildings and Improvements 5,465      
Cost Capitalized Subsequent to Acquisition 437      
Gross Amount at which Carried at Close of Period        
Land  597      
Building and Improvements 5,831      
Total  6,428      
Accumulated Depreciation and Amortization (1,965)      
Senior housing - managed portfolio | Allen, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,190      
Buildings and Improvements 45,767      
Cost Capitalized Subsequent to Acquisition 2,410      
Gross Amount at which Carried at Close of Period        
Land  2,190      
Building and Improvements 52,256      
Total  54,446      
Accumulated Depreciation and Amortization (14,228)      
Senior housing - managed portfolio | Gainesville, FL 1        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,139      
Buildings and Improvements 44,789      
Cost Capitalized Subsequent to Acquisition 2,267      
Gross Amount at which Carried at Close of Period        
Land  2,139      
Building and Improvements 48,687      
Total  50,826      
Accumulated Depreciation and Amortization (14,173)      
Senior housing - managed portfolio | Raleigh, NC        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,344      
Buildings and Improvements 37,506      
Cost Capitalized Subsequent to Acquisition 2,010      
Gross Amount at which Carried at Close of Period        
Land  2,344      
Building and Improvements 43,549      
Total  45,893      
Accumulated Depreciation and Amortization (12,437)      
Senior housing - managed portfolio | San Luis Obispo, CA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  4,992      
Buildings and Improvements 30,909      
Cost Capitalized Subsequent to Acquisition 1,382      
Gross Amount at which Carried at Close of Period        
Land  4,992      
Building and Improvements 34,478      
Total  39,470      
Accumulated Depreciation and Amortization (10,369)      
Senior housing - managed portfolio | Longview, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  805      
Buildings and Improvements 26,498      
Cost Capitalized Subsequent to Acquisition 1,605      
Gross Amount at which Carried at Close of Period        
Land  805      
Building and Improvements 27,794      
Total  28,599      
Accumulated Depreciation and Amortization (7,852)      
Senior housing - managed portfolio | Yuma, AZ        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  530      
Buildings and Improvements 21,775      
Cost Capitalized Subsequent to Acquisition 1,141      
Gross Amount at which Carried at Close of Period        
Land  530      
Building and Improvements 23,205      
Total  23,735      
Accumulated Depreciation and Amortization (6,511)      
Senior housing - managed portfolio | Nashville, TN        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,996      
Buildings and Improvements 19,368      
Cost Capitalized Subsequent to Acquisition 2,396      
Gross Amount at which Carried at Close of Period        
Land  1,996      
Building and Improvements 23,882      
Total  25,878      
Accumulated Depreciation and Amortization (6,346)      
Senior housing - managed portfolio | Branford, CT        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,403      
Buildings and Improvements 18,821      
Cost Capitalized Subsequent to Acquisition 1,667      
Gross Amount at which Carried at Close of Period        
Land  2,403      
Building and Improvements 23,254      
Total  25,657      
Accumulated Depreciation and Amortization (6,439)      
Senior housing - managed portfolio | Richmond, VA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,080      
Buildings and Improvements 19,545      
Cost Capitalized Subsequent to Acquisition 1,875      
Gross Amount at which Carried at Close of Period        
Land  1,080      
Building and Improvements 23,375      
Total  24,455      
Accumulated Depreciation and Amortization (6,948)      
Senior housing - managed portfolio | Auburn, AL        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  3,209      
Buildings and Improvements 17,326      
Cost Capitalized Subsequent to Acquisition 1,277      
Gross Amount at which Carried at Close of Period        
Land  3,209      
Building and Improvements 19,988      
Total  23,197      
Accumulated Depreciation and Amortization (5,670)      
Senior housing - managed portfolio | Menomonee Falls, WI        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,477      
Buildings and Improvements 18,778      
Cost Capitalized Subsequent to Acquisition 893      
Gross Amount at which Carried at Close of Period        
Land  1,477      
Building and Improvements 21,034      
Total  22,511      
Accumulated Depreciation and Amortization (5,850)      
Senior housing - managed portfolio | Glenville, NY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  978      
Buildings and Improvements 18,257      
Cost Capitalized Subsequent to Acquisition 1,272      
Gross Amount at which Carried at Close of Period        
Land  978      
Building and Improvements 21,168      
Total  22,146      
Accumulated Depreciation and Amortization (6,045)      
Senior housing - managed portfolio | Eustis, FL        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,152      
Buildings and Improvements 17,523      
Cost Capitalized Subsequent to Acquisition 713      
Gross Amount at which Carried at Close of Period        
Land  1,152      
Building and Improvements 18,568      
Total  19,720      
Accumulated Depreciation and Amortization (5,451)      
Senior housing - managed portfolio | Phoenix, AZ        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,567      
Buildings and Improvements 12,029      
Cost Capitalized Subsequent to Acquisition 1,198      
Gross Amount at which Carried at Close of Period        
Land  2,567      
Building and Improvements 13,091      
Total  15,658      
Accumulated Depreciation and Amortization (3,925)      
Senior housing - managed portfolio | Jonesboro, AR        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,782      
Buildings and Improvements 11,244      
Cost Capitalized Subsequent to Acquisition 1,195      
Gross Amount at which Carried at Close of Period        
Land  1,782      
Building and Improvements 12,916      
Total  14,698      
Accumulated Depreciation and Amortization (3,653)      
Senior housing - managed portfolio | Ogden, UT        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  794      
Buildings and Improvements 10,873      
Cost Capitalized Subsequent to Acquisition 1,515      
Gross Amount at which Carried at Close of Period        
Land  794      
Building and Improvements 14,063      
Total  14,857      
Accumulated Depreciation and Amortization (3,695)      
Senior housing - managed portfolio | Olympia, WA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,477      
Buildings and Improvements 23,767      
Cost Capitalized Subsequent to Acquisition 1,743      
Gross Amount at which Carried at Close of Period        
Land  2,477      
Building and Improvements 27,482      
Total  29,959      
Accumulated Depreciation and Amortization (7,712)      
Senior housing - managed portfolio | Windsor, ON        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,360      
Buildings and Improvements 16,855      
Cost Capitalized Subsequent to Acquisition 729      
Gross Amount at which Carried at Close of Period        
Land  1,334      
Building and Improvements 17,373      
Total  18,707      
Accumulated Depreciation and Amortization (4,780)      
Senior housing - managed portfolio | London, ON        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  960      
Buildings and Improvements 19,056      
Cost Capitalized Subsequent to Acquisition 775      
Gross Amount at which Carried at Close of Period        
Land  940      
Building and Improvements 19,640      
Total  20,580      
Accumulated Depreciation and Amortization (5,238)      
Senior housing - managed portfolio | Kelowna, BC        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,321      
Buildings and Improvements 8,308      
Cost Capitalized Subsequent to Acquisition 878      
Gross Amount at which Carried at Close of Period        
Land  2,275      
Building and Improvements 9,888      
Total  12,163      
Accumulated Depreciation and Amortization (2,624)      
Senior housing - managed portfolio | Waterloo, ON        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,823      
Buildings and Improvements 22,135      
Cost Capitalized Subsequent to Acquisition 482      
Gross Amount at which Carried at Close of Period        
Land  1,786      
Building and Improvements 22,049      
Total  23,835      
Accumulated Depreciation and Amortization (6,014)      
Senior housing - managed portfolio | Sarnia, ON        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,187      
Buildings and Improvements 20,346      
Cost Capitalized Subsequent to Acquisition 1,227      
Gross Amount at which Carried at Close of Period        
Land  1,162      
Building and Improvements 21,037      
Total  22,199      
Accumulated Depreciation and Amortization (1,890)      
Senior housing - managed portfolio | Kamloops, BC        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  679      
Buildings and Improvements 8,024      
Cost Capitalized Subsequent to Acquisition 300      
Gross Amount at which Carried at Close of Period        
Land  664      
Building and Improvements 8,390      
Total  9,054      
Accumulated Depreciation and Amortization (2,324)      
Senior housing - managed portfolio | Vernon, BC        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  843      
Buildings and Improvements 10,724      
Cost Capitalized Subsequent to Acquisition 449      
Gross Amount at which Carried at Close of Period        
Land  264      
Building and Improvements 11,177      
Total  11,441      
Accumulated Depreciation and Amortization (3,000)      
Senior housing - managed portfolio | Penticton, BC        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  763      
Buildings and Improvements 6,771      
Cost Capitalized Subsequent to Acquisition 436      
Gross Amount at which Carried at Close of Period        
Land  747      
Building and Improvements 7,681      
Total  8,428      
Accumulated Depreciation and Amortization (2,108)      
Senior housing - managed portfolio | Calgary, AB        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  3,908      
Buildings and Improvements 20,996      
Cost Capitalized Subsequent to Acquisition 1,436      
Gross Amount at which Carried at Close of Period        
Land  3,832      
Building and Improvements 21,794      
Total  25,626      
Accumulated Depreciation and Amortization (5,738)      
Senior housing - managed portfolio | Lake Stevens, WA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,559      
Buildings and Improvements 9,059      
Cost Capitalized Subsequent to Acquisition 243      
Gross Amount at which Carried at Close of Period        
Land  1,559      
Building and Improvements 9,351      
Total  10,910      
Accumulated Depreciation and Amortization (2,508)      
Senior housing - managed portfolio | Eugene, OR        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,428      
Buildings and Improvements 16,138      
Cost Capitalized Subsequent to Acquisition 263      
Gross Amount at which Carried at Close of Period        
Land  1,428      
Building and Improvements 16,145      
Total  17,573      
Accumulated Depreciation and Amortization (4,273)      
Senior housing - managed portfolio | Tualatin, OR        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  527      
Buildings and Improvements 14,659      
Cost Capitalized Subsequent to Acquisition 207      
Gross Amount at which Carried at Close of Period        
Land  527      
Building and Improvements 14,723      
Total  15,250      
Accumulated Depreciation and Amortization (3,882)      
Senior housing - managed portfolio | Fredericksburg, VA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,379      
Buildings and Improvements 21,209      
Cost Capitalized Subsequent to Acquisition 346      
Gross Amount at which Carried at Close of Period        
Land  1,379      
Building and Improvements 21,594      
Total  22,973      
Accumulated Depreciation and Amortization (5,947)      
Senior housing - managed portfolio | Round Rock, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  679      
Buildings and Improvements 13,642      
Cost Capitalized Subsequent to Acquisition 58      
Gross Amount at which Carried at Close of Period        
Land  679      
Building and Improvements 13,824      
Total  14,503      
Accumulated Depreciation and Amortization (3,907)      
Senior housing - managed portfolio | Henderson, NV        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,430      
Buildings and Improvements 21,850      
Cost Capitalized Subsequent to Acquisition 187      
Gross Amount at which Carried at Close of Period        
Land  1,430      
Building and Improvements 22,156      
Total  23,586      
Accumulated Depreciation and Amortization (5,688)      
Senior housing - managed portfolio | Cedar Park, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,035      
Buildings and Improvements 13,127      
Cost Capitalized Subsequent to Acquisition 553      
Gross Amount at which Carried at Close of Period        
Land  1,035      
Building and Improvements 14,513      
Total  15,548      
Accumulated Depreciation and Amortization (3,425)      
Senior housing - managed portfolio | Ramsey, MN        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,182      
Buildings and Improvements 13,280      
Cost Capitalized Subsequent to Acquisition 326      
Gross Amount at which Carried at Close of Period        
Land  1,182      
Building and Improvements 14,024      
Total  15,206      
Accumulated Depreciation and Amortization (3,584)      
Senior housing - managed portfolio | Marshfield, WI 1        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  500      
Buildings and Improvements 4,134      
Cost Capitalized Subsequent to Acquisition 143      
Gross Amount at which Carried at Close of Period        
Land  500      
Building and Improvements 4,439      
Total  4,939      
Accumulated Depreciation and Amortization (1,264)      
Senior housing - managed portfolio | Charleston, WV        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  419      
Buildings and Improvements 4,239      
Cost Capitalized Subsequent to Acquisition 1,133      
Gross Amount at which Carried at Close of Period        
Land  419      
Building and Improvements 4,863      
Total  5,282      
Accumulated Depreciation and Amortization (1,552)      
Senior housing - managed portfolio | Williamsport, PA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  296      
Buildings and Improvements 9,191      
Cost Capitalized Subsequent to Acquisition 1,056      
Gross Amount at which Carried at Close of Period        
Land  296      
Building and Improvements 9,931      
Total  10,227      
Accumulated Depreciation and Amortization (2,645)      
Senior housing - managed portfolio | Reading, PA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  684      
Buildings and Improvements 12,950      
Cost Capitalized Subsequent to Acquisition 412      
Gross Amount at which Carried at Close of Period        
Land  684      
Building and Improvements 13,322      
Total  14,006      
Accumulated Depreciation and Amortization (3,296)      
Senior housing - managed portfolio | Scott Depot, WV        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  230      
Buildings and Improvements 6,271      
Cost Capitalized Subsequent to Acquisition 857      
Gross Amount at which Carried at Close of Period        
Land  230      
Building and Improvements 6,786      
Total  7,016      
Accumulated Depreciation and Amortization (1,894)      
Senior housing - managed portfolio | Clarks Summit, PA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  406      
Buildings and Improvements 9,471      
Cost Capitalized Subsequent to Acquisition 1,590      
Gross Amount at which Carried at Close of Period        
Land  406      
Building and Improvements 10,307      
Total  10,713      
Accumulated Depreciation and Amortization (2,692)      
Senior housing - managed portfolio | Wyncote, PA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,781      
Buildings and Improvements 4,911      
Cost Capitalized Subsequent to Acquisition 1,502      
Gross Amount at which Carried at Close of Period        
Land  1,781      
Building and Improvements 6,715      
Total  8,496      
Accumulated Depreciation and Amortization (1,811)      
Senior housing - managed portfolio | Douglassville, PA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  611      
Buildings and Improvements 19,083      
Cost Capitalized Subsequent to Acquisition 634      
Gross Amount at which Carried at Close of Period        
Land  611      
Building and Improvements 19,562      
Total  20,173      
Accumulated Depreciation and Amortization (4,555)      
Senior housing - managed portfolio | Milford, DE        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,199      
Buildings and Improvements 18,786      
Cost Capitalized Subsequent to Acquisition 832      
Gross Amount at which Carried at Close of Period        
Land  1,199      
Building and Improvements 20,461      
Total  21,660      
Accumulated Depreciation and Amortization (4,568)      
Senior housing - managed portfolio | Oak Hill, WV        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  609      
Buildings and Improvements 2,636      
Cost Capitalized Subsequent to Acquisition 1,268      
Gross Amount at which Carried at Close of Period        
Land  609      
Building and Improvements 3,842      
Total  4,451      
Accumulated Depreciation and Amortization (1,502)      
Senior housing - managed portfolio | Lewisburg, WV        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  355      
Buildings and Improvements 5,055      
Cost Capitalized Subsequent to Acquisition 808      
Gross Amount at which Carried at Close of Period        
Land  355      
Building and Improvements 5,503      
Total  5,858      
Accumulated Depreciation and Amortization (1,562)      
Senior housing - managed portfolio | Winnebago, IL        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  263      
Buildings and Improvements 3,743      
Cost Capitalized Subsequent to Acquisition 39      
Gross Amount at which Carried at Close of Period        
Land  263      
Building and Improvements 3,835      
Total  4,098      
Accumulated Depreciation and Amortization (952)      
Senior housing - managed portfolio | Pewaukee, WI 1        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,019      
Buildings and Improvements 3,606      
Cost Capitalized Subsequent to Acquisition 52      
Gross Amount at which Carried at Close of Period        
Land  1,019      
Building and Improvements 3,663      
Total  4,682      
Accumulated Depreciation and Amortization (863)      
Senior housing - managed portfolio | Pewaukee, WI 2        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  661      
Buildings and Improvements 5,680      
Cost Capitalized Subsequent to Acquisition 41      
Gross Amount at which Carried at Close of Period        
Land  661      
Building and Improvements 5,858      
Total  6,519      
Accumulated Depreciation and Amortization (1,259)      
Senior housing - managed portfolio | Strasburg, VA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  666      
Buildings and Improvements 5,551      
Cost Capitalized Subsequent to Acquisition 417      
Gross Amount at which Carried at Close of Period        
Land  666      
Building and Improvements 6,024      
Total  6,690      
Accumulated Depreciation and Amortization (1,383)      
Senior housing - managed portfolio | Sarasota, FL        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,440      
Buildings and Improvements 22,541      
Cost Capitalized Subsequent to Acquisition 164      
Gross Amount at which Carried at Close of Period        
Land  1,440      
Building and Improvements 22,778      
Total  24,218      
Accumulated Depreciation and Amortization (4,789)      
Senior housing - managed portfolio | Beavercreek, OH        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,622      
Buildings and Improvements 24,215      
Cost Capitalized Subsequent to Acquisition 7,823      
Gross Amount at which Carried at Close of Period        
Land  1,622      
Building and Improvements 32,076      
Total  33,698      
Accumulated Depreciation and Amortization (8,276)      
Senior housing - managed portfolio | Richardson, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,282      
Buildings and Improvements 10,556      
Cost Capitalized Subsequent to Acquisition 474      
Gross Amount at which Carried at Close of Period        
Land  2,282      
Building and Improvements 12,296      
Total  14,578      
Accumulated Depreciation and Amortization (2,593)      
Senior housing - managed portfolio | Poway, CA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  3,693      
Buildings and Improvements 14,467      
Cost Capitalized Subsequent to Acquisition 1,144      
Gross Amount at which Carried at Close of Period        
Land  3,693      
Building and Improvements 16,050      
Total  19,743      
Accumulated Depreciation and Amortization (3,051)      
Senior housing - managed portfolio | McCordsville, IN        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,587      
Buildings and Improvements 31,315      
Cost Capitalized Subsequent to Acquisition 352      
Gross Amount at which Carried at Close of Period        
Land  1,587      
Building and Improvements 31,737      
Total  33,324      
Accumulated Depreciation and Amortization (5,253)      
Senior housing - managed portfolio | New Braunfels, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,312      
Buildings and Improvements 23,108      
Cost Capitalized Subsequent to Acquisition 1,095      
Gross Amount at which Carried at Close of Period        
Land  1,312      
Building and Improvements 25,065      
Total  26,377      
Accumulated Depreciation and Amortization (4,530)      
Senior housing - managed portfolio | Sellersburg, IN        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,060      
Buildings and Improvements 28,702      
Cost Capitalized Subsequent to Acquisition 5,973      
Gross Amount at which Carried at Close of Period        
Land  1,060      
Building and Improvements 34,741      
Total  35,801      
Accumulated Depreciation and Amortization (5,718)      
Senior housing - managed portfolio | Augusta, GA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  419      
Buildings and Improvements 24,958      
Cost Capitalized Subsequent to Acquisition 280      
Gross Amount at which Carried at Close of Period        
Land  459      
Building and Improvements 29,367      
Total  29,826      
Accumulated Depreciation and Amortization (4,393)      
Senior housing - managed portfolio | Anchorage, AK        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,965      
Buildings and Improvements 29,533      
Cost Capitalized Subsequent to Acquisition 204      
Gross Amount at which Carried at Close of Period        
Land  1,965      
Building and Improvements 29,834      
Total  31,799      
Accumulated Depreciation and Amortization (3,943)      
Senior housing - managed portfolio | Loveland, OH        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  3,691      
Buildings and Improvements 21,168      
Cost Capitalized Subsequent to Acquisition 179      
Gross Amount at which Carried at Close of Period        
Land  3,691      
Building and Improvements 21,466      
Total  25,157      
Accumulated Depreciation and Amortization (2,533)      
Senior housing - managed portfolio | Indianapolis, IN        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  4,950      
Buildings and Improvements 32,631      
Cost Capitalized Subsequent to Acquisition 203      
Gross Amount at which Carried at Close of Period        
Land  6,299      
Building and Improvements 42,018      
Total  48,317      
Accumulated Depreciation and Amortization (4,112)      
Senior housing - managed portfolio | Saginaw, MI        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,651      
Buildings and Improvements 29,283      
Cost Capitalized Subsequent to Acquisition 1,751      
Gross Amount at which Carried at Close of Period        
Land  1,651      
Building and Improvements 31,199      
Total  32,850      
Accumulated Depreciation and Amortization (3,305)      
Senior housing - managed portfolio | Madeira, OH        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,858      
Buildings and Improvements 42,670      
Cost Capitalized Subsequent to Acquisition 148      
Gross Amount at which Carried at Close of Period        
Land  2,858      
Building and Improvements 43,178      
Total  46,036      
Accumulated Depreciation and Amortization (3,576)      
Senior housing - managed portfolio | Fishers, IN        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,159      
Buildings and Improvements 20,793      
Cost Capitalized Subsequent to Acquisition 72      
Gross Amount at which Carried at Close of Period        
Land  2,159      
Building and Improvements 20,945      
Total  23,104      
Accumulated Depreciation and Amortization (753)      
Senior housing - managed portfolio | Hattiesburg, MS        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,160      
Buildings and Improvements 46,635      
Cost Capitalized Subsequent to Acquisition 71      
Gross Amount at which Carried at Close of Period        
Land  2,160      
Building and Improvements 46,788      
Total  48,948      
Accumulated Depreciation and Amortization (780)      
Senior housing - managed portfolio | Lebanon, OH        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  7,435      
Buildings and Improvements 49,870      
Cost Capitalized Subsequent to Acquisition 36      
Gross Amount at which Carried at Close of Period        
Land  7,435      
Building and Improvements 49,938      
Total  57,373      
Accumulated Depreciation and Amortization (734)      
Senior housing - managed portfolio | Moline, IL        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,049      
Buildings and Improvements 34,854      
Cost Capitalized Subsequent to Acquisition 145      
Gross Amount at which Carried at Close of Period        
Land  2,049      
Building and Improvements 35,009      
Total  37,058      
Accumulated Depreciation and Amortization (416)      
Senior housing - managed portfolio | Gainesville, FL 2        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  4,005      
Buildings and Improvements 14,112      
Cost Capitalized Subsequent to Acquisition 99      
Gross Amount at which Carried at Close of Period        
Land  4,005      
Building and Improvements 14,252      
Total  18,257      
Accumulated Depreciation and Amortization (151)      
Senior housing - managed portfolio | St. Charles, MO        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  3,179      
Buildings and Improvements 25,312      
Cost Capitalized Subsequent to Acquisition 95      
Gross Amount at which Carried at Close of Period        
Land  3,179      
Building and Improvements 25,412      
Total  28,591      
Accumulated Depreciation and Amortization (256)      
Senior housing - managed portfolio | Bethlehem, PA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  6,001      
Buildings and Improvements 32,964      
Cost Capitalized Subsequent to Acquisition 124      
Gross Amount at which Carried at Close of Period        
Land  6,001      
Building and Improvements 33,099      
Total  39,100      
Accumulated Depreciation and Amortization (329)      
Senior housing - managed portfolio | Jasper, GA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,554      
Buildings and Improvements 18,818      
Cost Capitalized Subsequent to Acquisition 1,399      
Gross Amount at which Carried at Close of Period        
Land  1,554      
Building and Improvements 20,228      
Total  21,782      
Accumulated Depreciation and Amortization (188)      
Senior housing - managed portfolio | Niceville, FL        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  4,654      
Buildings and Improvements 30,677      
Cost Capitalized Subsequent to Acquisition 200      
Gross Amount at which Carried at Close of Period        
Land  4,654      
Building and Improvements 30,894      
Total  35,548      
Accumulated Depreciation and Amortization (149)      
Senior housing - managed portfolio | St. Clair Shores, MI        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  7,291      
Buildings and Improvements 36,675      
Cost Capitalized Subsequent to Acquisition 17      
Gross Amount at which Carried at Close of Period        
Land  7,291      
Building and Improvements 36,694      
Total  43,985      
Accumulated Depreciation and Amortization (177)      
Senior housing - managed portfolio | Sparks, NV 2        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  6,611      
Buildings and Improvements 27,752      
Cost Capitalized Subsequent to Acquisition 3      
Gross Amount at which Carried at Close of Period        
Land  6,611      
Building and Improvements 27,755      
Total  34,366      
Accumulated Depreciation and Amortization (136)      
Senior housing - managed portfolio | Decatur, GA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  7,911      
Buildings and Improvements 15,914      
Cost Capitalized Subsequent to Acquisition 4      
Gross Amount at which Carried at Close of Period        
Land  7,911      
Building and Improvements 15,918      
Total  23,829      
Accumulated Depreciation and Amortization (39)      
Behavioral Health        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  57,049      
Buildings and Improvements 346,847      
Cost Capitalized Subsequent to Acquisition 72,730      
Gross Amount at which Carried at Close of Period        
Land  57,049      
Building and Improvements 416,764      
Total  473,813      
Accumulated Depreciation and Amortization (90,644)      
Behavioral Health | New London, CT        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  356      
Buildings and Improvements 152      
Cost Capitalized Subsequent to Acquisition 3,665      
Gross Amount at which Carried at Close of Period        
Land  356      
Building and Improvements 3,817      
Total  4,173      
Accumulated Depreciation and Amortization (1,319)      
Behavioral Health | Aurora, CO        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,874      
Buildings and Improvements 12,829      
Cost Capitalized Subsequent to Acquisition 1,950      
Gross Amount at which Carried at Close of Period        
Land  2,874      
Building and Improvements 14,563      
Total  17,437      
Accumulated Depreciation and Amortization (4,869)      
Behavioral Health | Colorado Springs, CO        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,210      
Buildings and Improvements 9,490      
Cost Capitalized Subsequent to Acquisition 2,765      
Gross Amount at which Carried at Close of Period        
Land  1,210      
Building and Improvements 11,815      
Total  13,025      
Accumulated Depreciation and Amortization (2,697)      
Behavioral Health | Bluffton, IN        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  254      
Buildings and Improvements 5,105      
Cost Capitalized Subsequent to Acquisition 1,486      
Gross Amount at which Carried at Close of Period        
Land  254      
Building and Improvements 6,591      
Total  6,845      
Accumulated Depreciation and Amortization (1,991)      
Behavioral Health | Morrilton, AR        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  508      
Buildings and Improvements 0      
Cost Capitalized Subsequent to Acquisition 3,024      
Gross Amount at which Carried at Close of Period        
Land  508      
Building and Improvements 3,024      
Total  3,532      
Accumulated Depreciation and Amortization (531)      
Behavioral Health | Glendale, AZ        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,501      
Buildings and Improvements 67,046      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,501      
Building and Improvements 67,046      
Total  68,547      
Accumulated Depreciation and Amortization (14,657)      
Behavioral Health | Tempe, AZ        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  3,137      
Buildings and Improvements 50,073      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  3,137      
Building and Improvements 50,073      
Total  53,210      
Accumulated Depreciation and Amortization (11,191)      
Behavioral Health | Covina, CA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  23,472      
Buildings and Improvements 71,542      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  23,472      
Building and Improvements 71,542      
Total  95,014      
Accumulated Depreciation and Amortization (16,247)      
Behavioral Health | Ventura, CA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  8,089      
Buildings and Improvements 43,645      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  8,089      
Building and Improvements 43,645      
Total  51,734      
Accumulated Depreciation and Amortization (10,776)      
Behavioral Health | San Diego, CA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  8,403      
Buildings and Improvements 55,015      
Cost Capitalized Subsequent to Acquisition 7,599      
Gross Amount at which Carried at Close of Period        
Land  8,403      
Building and Improvements 62,549      
Total  70,952      
Accumulated Depreciation and Amortization (15,924)      
Behavioral Health | Carmel, IN        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  963      
Buildings and Improvements 4,347      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  963      
Building and Improvements 4,347      
Total  5,310      
Accumulated Depreciation and Amortization (988)      
Behavioral Health | Louisville, KY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,078      
Buildings and Improvements 8,305      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,078      
Building and Improvements 8,305      
Total  9,383      
Accumulated Depreciation and Amortization (1,686)      
Behavioral Health | Monroeville, PA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,034      
Buildings and Improvements 1,758      
Cost Capitalized Subsequent to Acquisition 18,545      
Gross Amount at which Carried at Close of Period        
Land  2,034      
Building and Improvements 18,202      
Total  20,236      
Accumulated Depreciation and Amortization (2,599)      
Behavioral Health | Gulf Breeze, FL        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  498      
Buildings and Improvements 1,480      
Cost Capitalized Subsequent to Acquisition 3,767      
Gross Amount at which Carried at Close of Period        
Land  498      
Building and Improvements 5,247      
Total  5,745      
Accumulated Depreciation and Amortization (505)      
Behavioral Health | Greenville, SC        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,197      
Buildings and Improvements 9,496      
Cost Capitalized Subsequent to Acquisition 21,550      
Gross Amount at which Carried at Close of Period        
Land  1,197      
Building and Improvements 31,055      
Total  32,252      
Accumulated Depreciation and Amortization (2,911)      
Behavioral Health | Raytown, MO        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,475      
Buildings and Improvements 6,564      
Cost Capitalized Subsequent to Acquisition 8,379      
Gross Amount at which Carried at Close of Period        
Land  1,475      
Building and Improvements 14,943      
Total  16,418      
Accumulated Depreciation and Amortization (1,753)      
Specialty Hospitals and Other        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  20,434      
Buildings and Improvements 204,759      
Cost Capitalized Subsequent to Acquisition 369      
Gross Amount at which Carried at Close of Period        
Land  20,434      
Building and Improvements 205,064      
Total  225,498      
Accumulated Depreciation and Amortization (58,291)      
Specialty Hospitals and Other | Arlington, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  0      
Buildings and Improvements 44,217      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  0      
Building and Improvements 44,217      
Total  44,217      
Accumulated Depreciation and Amortization (9,468)      
Specialty Hospitals and Other | Conroe, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,935      
Buildings and Improvements 25,003      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  2,935      
Building and Improvements 25,003      
Total  27,938      
Accumulated Depreciation and Amortization (6,052)      
Specialty Hospitals and Other | Orange, CA        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  2,060      
Buildings and Improvements 5,538      
Cost Capitalized Subsequent to Acquisition 200      
Gross Amount at which Carried at Close of Period        
Land  2,060      
Building and Improvements 5,738      
Total  7,798      
Accumulated Depreciation and Amortization (1,324)      
Specialty Hospitals and Other | Houston, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  3,001      
Buildings and Improvements 14,581      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  3,001      
Building and Improvements 14,581      
Total  17,582      
Accumulated Depreciation and Amortization (3,179)      
Specialty Hospitals and Other | Florence, KY        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  3,866      
Buildings and Improvements 26,447      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  3,866      
Building and Improvements 26,447      
Total  30,313      
Accumulated Depreciation and Amortization (5,768)      
Specialty Hospitals and Other | Sunnyvale, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  4,020      
Buildings and Improvements 57,620      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  4,020      
Building and Improvements 57,620      
Total  61,640      
Accumulated Depreciation and Amortization (24,973)      
Specialty Hospitals and Other | Spring, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  1,319      
Buildings and Improvements 15,153      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  1,319      
Building and Improvements 15,153      
Total  16,472      
Accumulated Depreciation and Amortization (3,310)      
Specialty Hospitals and Other | Maxwell, TX 1        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  902      
Buildings and Improvements 2,384      
Cost Capitalized Subsequent to Acquisition 1      
Gross Amount at which Carried at Close of Period        
Land  902      
Building and Improvements 2,384      
Total  3,286      
Accumulated Depreciation and Amortization (603)      
Specialty Hospitals and Other | Maxwell, TX 2        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  901      
Buildings and Improvements 1,198      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  901      
Building and Improvements 1,198      
Total  2,099      
Accumulated Depreciation and Amortization (366)      
Specialty Hospitals and Other | Maxwell, TX 3        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  456      
Buildings and Improvements 2,632      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  456      
Building and Improvements 2,632      
Total  3,088      
Accumulated Depreciation and Amortization (628)      
Specialty Hospitals and Other | San Marcos, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  51      
Buildings and Improvements 359      
Cost Capitalized Subsequent to Acquisition 62      
Gross Amount at which Carried at Close of Period        
Land  51      
Building and Improvements 359      
Total  410      
Accumulated Depreciation and Amortization (88)      
Specialty Hospitals and Other | Seguin, TX 1        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  539      
Buildings and Improvements 2,627      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  539      
Building and Improvements 2,627      
Total  3,166      
Accumulated Depreciation and Amortization (797)      
Specialty Hospitals and Other | Seguin, TX 2        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  228      
Buildings and Improvements 3,407      
Cost Capitalized Subsequent to Acquisition 79      
Gross Amount at which Carried at Close of Period        
Land  228      
Building and Improvements 3,486      
Total  3,714      
Accumulated Depreciation and Amortization (881)      
Specialty Hospitals and Other | Kingsbury, TX        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  104      
Buildings and Improvements 2,788      
Cost Capitalized Subsequent to Acquisition 27      
Gross Amount at which Carried at Close of Period        
Land  104      
Building and Improvements 2,814      
Total  2,918      
Accumulated Depreciation and Amortization (651)      
Specialty Hospitals and Other | Seguin, TX 3        
Real Estate and Accumulated Depreciation        
Encumbrances 0      
Initial Cost to Company        
Land  52      
Buildings and Improvements 805      
Cost Capitalized Subsequent to Acquisition 0      
Gross Amount at which Carried at Close of Period        
Land  52      
Building and Improvements 805      
Total  857      
Accumulated Depreciation and Amortization $ (203)      
v3.25.4
SCHEDULE III - REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION - Rollforward of Real Estate and Accumulated Depreciation (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Real estate:      
Balance at the beginning of the year $ 5,615,764 $ 5,638,347 $ 5,872,688
Acquisitions 395,247 130,886 86,626
Improvements 39,004 48,810 86,073
Impairment (10,636) (25,819) (18,853)
Sale of real estate (118,294) (115,066) (379,272)
Foreign currency translation 7,172 (12,432) 3,394
Other (17,217) (48,962) (12,309)
Balance at the end of the year 5,911,040 5,615,764 5,638,347
Accumulated depreciation:      
Balance at the beginning of the year (1,102,030) (1,021,086) (913,345)
Depreciation expense (167,811) (162,019) (171,278)
Impairment 3,314 7,890 4,432
Sale of real estate 26,299 21,286 49,585
Foreign currency translation (1,652) 2,937 (747)
Other 17,217 48,962 10,267
Balance at the end of the year $ (1,224,663) $ (1,102,030) $ (1,021,086)
v3.25.4
SCHEDULE IV - MORTGAGE LOANS ON REAL ESTATE (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]      
Principal Balance $ 335,600 $ 335,600 $ 319,000
Aggregate cost for federal income tax purposes 337,800    
SEC Schedule, 12-29, Real Estate Companies, Investment in Movement in Mortgage Loans on Real Estate [Roll Forward]      
Balance at the beginning of the year 335,600 319,000 319,000
Additions during period:      
New mortgage loans 0 16,600 0
Balance at the end of the year 335,600 $ 335,600 $ 319,000
Mortgages      
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]      
Prior Liens 0    
Principal Balance 335,600    
Book Value 335,600    
Additions during period:      
Balance at the end of the year $ 335,600    
Mortgages | Recovery Centers of America      
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]      
Contractual Interest Rate 7.50%    
Prior Liens $ 0    
Principal Balance 300,000    
Book Value 300,000    
Additions during period:      
Balance at the end of the year $ 300,000    
Mortgages | River Vista      
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]      
Contractual Interest Rate 10.00%    
Prior Liens $ 0    
Principal Balance 19,000    
Book Value 19,000    
Additions during period:      
Balance at the end of the year $ 19,000    
Mortgages | Symphony Chesterton      
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]      
Contractual Interest Rate 9.50%    
Prior Liens $ 0    
Principal Balance 16,600    
Book Value 16,600    
Additions during period:      
Balance at the end of the year $ 16,600